
<html lang="en"     class="pb-page"  data-request-id="0cc16c51-6fd1-4430-a59b-59bcd54d49a8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c00944;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose" /></meta><meta name="dc.Creator" content="Kentaro  Futatsugi" /></meta><meta name="dc.Creator" content="Aaron C.  Smith" /></meta><meta name="dc.Creator" content="Meihua  Tu" /></meta><meta name="dc.Creator" content="Brian  Raymer" /></meta><meta name="dc.Creator" content="Kay  Ahn" /></meta><meta name="dc.Creator" content="Steven B.  Coffey" /></meta><meta name="dc.Creator" content="Matthew S.  Dowling" /></meta><meta name="dc.Creator" content="Dilinie P.  Fernando" /></meta><meta name="dc.Creator" content="Jemy A.  Gutierrez" /></meta><meta name="dc.Creator" content="Kim  Huard" /></meta><meta name="dc.Creator" content="Jayasankar  Jasti" /></meta><meta name="dc.Creator" content="Amit S.  Kalgutkar" /></meta><meta name="dc.Creator" content="John D.  Knafels" /></meta><meta name="dc.Creator" content="Jayvardhan  Pandit" /></meta><meta name="dc.Creator" content="Kevin D.  Parris" /></meta><meta name="dc.Creator" content="Sylvie  Perez" /></meta><meta name="dc.Creator" content="Jeffrey A.  Pfefferkorn" /></meta><meta name="dc.Creator" content="David A.  Price" /></meta><meta name="dc.Creator" content="Tim  Ryder" /></meta><meta name="dc.Creator" content="Andre  Shavnya" /></meta><meta name="dc.Creator" content="Ingrid A.  Stock" /></meta><meta name="dc.Creator" content="Andy S.  Tsai" /></meta><meta name="dc.Creator" content="Gregory J.  Tesz" /></meta><meta name="dc.Creator" content="Benjamin A.  Thuma" /></meta><meta name="dc.Creator" content="Yan  Weng" /></meta><meta name="dc.Creator" content="Hanna M.  Wisniewska" /></meta><meta name="dc.Creator" content="Gang  Xing" /></meta><meta name="dc.Creator" content="Jun  Zhou" /></meta><meta name="dc.Creator" content="Thomas V.  Magee" /></meta><meta name="dc.Description" content="Increased fructose consumption and its subsequent metabolism have been implicated in metabolic disorders such as nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) and insulin resist..." /></meta><meta name="Description" content="Increased fructose consumption and its subsequent metabolism have been implicated in metabolic disorders such as nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) and insulin resist..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 10, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00944" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00944" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00944" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00944" /></link>
        
    
    

<title>Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00944" /></meta><meta property="og:title" content="Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0016.jpeg" /></meta><meta property="og:description" content="Increased fructose consumption and its subsequent metabolism have been implicated in metabolic disorders such as nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) and insulin resistance. Ketohexokinase (KHK) converts fructose to fructose-1-phosphate (F1P) in the first step of the metabolic cascade. Herein we report the discovery of a first-in-class KHK inhibitor, PF-06835919 (8), currently in phase 2 clinical trials. The discovery of 8 was built upon our originally reported, fragment-derived lead 1 and the recognition of an alternative, rotated binding mode upon changing the ribose-pocket binding moiety from a pyrrolidinyl to an azetidinyl ring system. This new binding mode enabled efficient exploration of the vector directed at the Arg-108 residue, leading to the identification of highly potent 3-azabicyclo[3.1.0]hexane acetic acid-based KHK inhibitors by combined use of parallel medicinal chemistry and structure-based drug design." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00944"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00944">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00944&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00944&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00944&amp;href=/doi/10.1021/acs.jmedchem.0c00944" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 13546-13560</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00272" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.0c00948" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kentaro Futatsugi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kentaro Futatsugi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For K.F.; phone, 617-551-3268; email, <a href="/cdn-cgi/l/email-protection#90dbf5fee4f1e2ffbef6e5e4f1e4e3e5f7f9d0e0f6f9eaf5e2bef3fffd"><span class="__cf_email__" data-cfemail="87cce2e9f3e6f5e8a9e1f2f3e6f3f4f2e0eec7f7e1eefde2f5a9e4e8ea">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kentaro++Futatsugi">Kentaro Futatsugi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3137-9212" title="Orcid link">http://orcid.org/0000-0003-3137-9212</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aaron C. Smith</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aaron C. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For A.C.S.; phone, 860-715-0156; email, <a href="/cdn-cgi/l/email-protection#f3b292819c9ddda09e9a879bc1b383959a899681dd909c9e"><span class="__cf_email__" data-cfemail="edac8c9f8283c3be80849985dfad9d8b8497889fc38e8280">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aaron+C.++Smith">Aaron C. Smith</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6796-5155" title="Orcid link">http://orcid.org/0000-0001-6796-5155</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Meihua Tu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Meihua Tu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Meihua++Tu">Meihua Tu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian Raymer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian Raymer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Raymer">Brian Raymer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kay Ahn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kay Ahn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kay++Ahn">Kay Ahn</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9139-1534" title="Orcid link">http://orcid.org/0000-0001-9139-1534</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steven B. Coffey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steven B. Coffey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steven+B.++Coffey">Steven B. Coffey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew S. Dowling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew S. Dowling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+S.++Dowling">Matthew S. Dowling</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5140-764X" title="Orcid link">http://orcid.org/0000-0002-5140-764X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dilinie P. Fernando</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dilinie P. Fernando</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dilinie+P.++Fernando">Dilinie P. Fernando</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jemy A. Gutierrez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jemy A. Gutierrez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jemy+A.++Gutierrez">Jemy A. Gutierrez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kim Huard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kim Huard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kim++Huard">Kim Huard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jayasankar Jasti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayasankar Jasti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayasankar++Jasti">Jayasankar Jasti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amit S. Kalgutkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit S. Kalgutkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit+S.++Kalgutkar">Amit S. Kalgutkar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9701-756X" title="Orcid link">http://orcid.org/0000-0001-9701-756X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John D. Knafels</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John D. Knafels</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Knafels">John D. Knafels</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jayvardhan Pandit</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayvardhan Pandit</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayvardhan++Pandit">Jayvardhan Pandit</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin D. Parris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin D. Parris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Parris">Kevin D. Parris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sylvie Perez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sylvie Perez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sylvie++Perez">Sylvie Perez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey A. Pfefferkorn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey A. Pfefferkorn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Pfefferkorn">Jeffrey A. Pfefferkorn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David A. Price</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David A. Price</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Price">David A. Price</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tim Ryder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tim Ryder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tim++Ryder">Tim Ryder</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andre Shavnya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andre Shavnya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andre++Shavnya">Andre Shavnya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ingrid A. Stock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ingrid A. Stock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ingrid+A.++Stock">Ingrid A. Stock</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andy S. Tsai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andy S. Tsai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andy+S.++Tsai">Andy S. Tsai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory J. Tesz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory J. Tesz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+J.++Tesz">Gregory J. Tesz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin A. Thuma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin A. Thuma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+A.++Thuma">Benjamin A. Thuma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Weng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Weng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Weng">Yan Weng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanna M. Wisniewska</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanna M. Wisniewska</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanna+M.++Wisniewska">Hanna M. Wisniewska</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gang Xing</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gang Xing</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Xing">Gang Xing</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Drug Safety R&D, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Zhou">Jun Zhou</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Thomas V. Magee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas V. Magee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+V.++Magee">Thomas V. Magee</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00944&amp;href=/doi/10.1021%2Facs.jmedchem.0c00944" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 13546–13560</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 10, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 June 2020</li><li><span class="item_label"><b>Published</b> online</span>10 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00944" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00944</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D13546%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKentaro%2BFutatsugi%252C%2BAaron%2BC.%2BSmith%252C%2BMeihua%2BTu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D22%26contentID%3Dacs.jmedchem.0c00944%26title%3DDiscovery%2Bof%2BPF-06835919%253A%2BA%2BPotent%2BInhibitor%2Bof%2BKetohexokinase%2B%2528KHK%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BMetabolic%2BDisorders%2BDriven%2Bby%2Bthe%2BOverconsumption%2Bof%2BFructose%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D13560%26publicationDate%3DNovember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00944"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3293</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00944" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kentaro&quot;,&quot;last_name&quot;:&quot;Futatsugi&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;C. Smith&quot;},{&quot;first_name&quot;:&quot;Meihua&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Raymer&quot;},{&quot;first_name&quot;:&quot;Kay&quot;,&quot;last_name&quot;:&quot;Ahn&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;B. Coffey&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;S. Dowling&quot;},{&quot;first_name&quot;:&quot;Dilinie&quot;,&quot;last_name&quot;:&quot;P. Fernando&quot;},{&quot;first_name&quot;:&quot;Jemy&quot;,&quot;last_name&quot;:&quot;A. Gutierrez&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;Huard&quot;},{&quot;first_name&quot;:&quot;Jayasankar&quot;,&quot;last_name&quot;:&quot;Jasti&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;S. Kalgutkar&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Knafels&quot;},{&quot;first_name&quot;:&quot;Jayvardhan&quot;,&quot;last_name&quot;:&quot;Pandit&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Parris&quot;},{&quot;first_name&quot;:&quot;Sylvie&quot;,&quot;last_name&quot;:&quot;Perez&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Pfefferkorn&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Price&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;Ryder&quot;},{&quot;first_name&quot;:&quot;Andre&quot;,&quot;last_name&quot;:&quot;Shavnya&quot;},{&quot;first_name&quot;:&quot;Ingrid&quot;,&quot;last_name&quot;:&quot;A. Stock&quot;},{&quot;first_name&quot;:&quot;Andy&quot;,&quot;last_name&quot;:&quot;S. Tsai&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;J. Tesz&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;A. Thuma&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Weng&quot;},{&quot;first_name&quot;:&quot;Hanna&quot;,&quot;last_name&quot;:&quot;M. Wisniewska&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Xing&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;V. Magee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;13546-13560&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00944&quot;},&quot;abstract&quot;:&quot;Increased fructose consumption and its subsequent metabolism have been implicated in metabolic disorders such as nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) and insulin resistance. Ketohexokinase (KHK) converts fructose to fructose-1-phosphate (F1P) in the first step of the metabolic cascade. Herein we report the discovery of a first-in-class KHK inhibitor, PF-06835919 (8), currently in phase 2 clinical trials. The discovery of 8 was built upon our originally reported, fragment-derived lead 1 and the recognition of an alternative, rotated binding mode upon changing the ribose-pocket binding moiety from a pyrrolidinyl to an azetidinyl ring system. This new binding mode enabled efficient exploration of the vector directed at the Arg-108 residue, leading to the identification of highly potent 3-azabicyclo[3.1.0]hexane acetic acid-based KHK inhibitors by combined use of parallel medicinal chemistry and structure-based drug design.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00944&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00944" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00944&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00944" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00944&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00944" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00944&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00944&amp;href=/doi/10.1021/acs.jmedchem.0c00944" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00944" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00944" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00944%26sid%3Dliteratum%253Aachs%26pmid%3D32910646%26genre%3Darticle%26aulast%3DFutatsugi%26date%3D2020%26atitle%3DDiscovery%2Bof%2BPF-06835919%253A%2BA%2BPotent%2BInhibitor%2Bof%2BKetohexokinase%2B%2528KHK%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BMetabolic%2BDisorders%2BDriven%2Bby%2Bthe%2BOverconsumption%2Bof%2BFructose%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D22%26spage%3D13546%26epage%3D13560%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/jmcmar.2020.63.issue-22/20201125/jmcmar.2020.63.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0016.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Increased fructose consumption and its subsequent metabolism have been implicated in metabolic disorders such as nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) and insulin resistance. Ketohexokinase (KHK) converts fructose to fructose-1-phosphate (F1P) in the first step of the metabolic cascade. Herein we report the discovery of a first-in-class KHK inhibitor, PF-06835919 (<b>8</b>), currently in phase 2 clinical trials. The discovery of <b>8</b> was built upon our originally reported, fragment-derived lead <b>1</b> and the recognition of an alternative, rotated binding mode upon changing the ribose-pocket binding moiety from a pyrrolidinyl to an azetidinyl ring system. This new binding mode enabled efficient exploration of the vector directed at the Arg-108 residue, leading to the identification of highly potent 3-azabicyclo[3.1.0]hexane acetic acid-based KHK inhibitors by combined use of parallel medicinal chemistry and structure-based drug design.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The utilization of the simple sugar fructose as a common food additive and sweetener has increased in recent decades. As a result, fructose is now a common sweetening ingredient in many foods, usually in the form of high-fructose corn syrup (HFCS). Fructose metabolism, unlike its isomer glucose, is not subject to feedback regulation and excess fructose consumption promotes metabolic disease in humans.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Specifically, fructose intake has been associated with nonalcoholic fatty liver disease (NAFLD),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> insulin resistance,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and cardiovascular disease (CVD).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In support of the concept that fructose may promote deleterious metabolic effects, when dietary fructose was replaced with starch (a glucose polymer), steatosis and insulin resistance were reversed in human subjects.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Ketohexokinase (KHK) initiates the metabolic cascade by phosphorylation of the 1-hydroxyl position of fructose utilizing adenosine triphosphate (ATP) as a cofactor, generating fructose-1-phosphate (F1P) and adenosine diphosphate (ADP).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Two isoforms of KHK exist, KHK-A and KHK-C.<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> KHK-C is the primary enzyme for fructose metabolism as it has both a lower <i>K</i><sub>M</sub> and a higher <i>V</i><sub>max</sub> than KHK-A.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Upon oral ingestion, fructose is primarily metabolized by the intestines, followed by the liver, pancreas, and kidney, all tissues expressing KHK-C.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Inhibition of KHK has been considered a promising therapeutic hypothesis for the treatment of metabolic diseases supported by studies in KHK-null mice, demonstrating protection from fructose induced hyperlipidemia, insulin resistance, obesity, and NAFLD.<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7,9)</a></div><div class="NLM_p">To date, three structurally distinct small molecule KHK inhibitors have been reported in literature.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> A previous report from Pfizer disclosed compound <b>1</b> discovered through a combination of fragment-based screening, structure-based drug design (SBDD) and parallel medicinal chemistry (PMC).<a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> Compound <b>1</b> demonstrated several positive attributes of a lead (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), including low metabolic turnover in human liver microsomes (HLM), high aqueous solubility, and minimal off-target activity. The favorable pharmacokinetic profile of <b>1</b> in rats enabled preclinical in vivo pharmacology studies, which demonstrated robust target engagement as determined by a dose-dependent decrease in F1P formation in liver and kidney with concomitant increases in plasma fructose concentrations. As previously described, compound <b>1</b> was shown to bind at the ATP site of KHK with four notable interactions within this binding site (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B): (1) the (<i>S</i>)-3-methylpyrrolidin-3-ol group occupancy of the ATP-ribose pocket with the methyl group filling a small but crucial subpocket defined by Phe-260 (normally filled by the methylene of the ATP ribose side chain), (2) a hydrogen-bonding interaction between the nitrile group and a conserved water that forms a hydrogen-bond with the backbone NH of Phe-245 and the backbone CO of Cys-282, (3) the trifluoromethyl group filling the hydrophobic pocket defined by the Pro-246–247 residues, and (4) the (3<i>S</i>,4<i>S</i>)-pyrrolidine-3,4-diol hydrogen bonding interactions between the hydroxyls and Glu-227 and Asn-107, thus polar interactions at the solvent exposed edge opening of the ATP pocket. Our goal for a clinical candidate was to increase the potency significantly by taking full advantage of these elements of the binding pocket and possibly adding additional interactions, all while retaining the advantageous clearance and permeability properties of <b>1</b>. Herein we report the discovery of a first-in-class clinical candidate PF-06835919 (<b>8</b>), a potent inhibitor of KHK demonstrating >40-fold improvement of potency over the lead (<b>1</b>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) In vitro profile of <b>1</b>. (B) Co-crystal structure of <b>1</b> in human KHK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ">5WBZ</a>), highlighting four different interaction subregions in the ATP pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial observation was that the (3<i>S</i>,4<i>S</i>)-pyrrolidine-3,4-diol (<i>trans</i>) substituent could be converted to the achiral <i>cis</i> analogue <b>2</b> without compromising potency or changing the binding mode. This change simplified subsequent analogue synthesis, thus <b>2</b> was used as a template for optimizing other changes in the molecule, the ribose binding element in particular. Limited examination to modify the trifluoromethyl group of <b>2</b> and its related system did not lead to potency improvement among tested (data not shown). Hence, the trifluoromethyl group was kept unchanged during the course of potency optimization reported here.</div><div class="NLM_p">Structurally diverse primary and secondary amine monomers were chosen for replacement of the (<i>S</i>)-3-methylpyrrolidin-3-ol, with emphasis on ring structures with varying methyl substituents using standard S<sub>N</sub>Ar chemistry. Docking-based calculations along with estimated physicochemical properties of the target molecules were also factored into the choice of amines for coupling. This effort led to the rapid identification of <b>3</b>, a (2<i>S</i>,3<i>R</i>)-2-methylazetidin-3-ol, with comparable potency relative to <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Genesis of the azetidine-based KHK inhibitor <b>3</b>. (B) Compound <b>3</b> (shown in green) in the KHK crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W">6W0W</a>). For comparison, compound <b>2</b> (shown in dark gray) was overlaid (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0N">6W0N</a>). (C) Detailed view of compound <b>3</b> (shown in green) in the KHK crystal structure. A sphere represents a simulated water by HydroSite analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Significantly, X-ray crystallographic analysis after soaking <b>3</b> into KHK crystals revealed a rotated binding mode relative to <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The azetidinyl group of <b>3</b> was positioned deeper in the ribose pocket while maintaining the hydrophobic interaction of the methyl substituent in the Phe-260 subpocket. The hydroxyl group of the azetidine ring of <b>3</b> formed a hydrogen-bonding interaction with the backbone CO of Ala-226. The trifluoromethyl group was bound in the Pro-246–247 hydrophobic region and thus unchanged relative to the previous poses. Notably, the conserved water molecule was displaced by the rotated binding mode such that the nitrile of <b>3</b> bound directly to the backbone NH of Phe-245. In addition, the rotation placed the vector of the <i>cis</i>-dihydroxypyrrolidine substituent in line with the Arg-108 residue at the polar back portion of the ATP binding site normally occupied by the triphosphate side chain in KHK.</div><div class="NLM_p">We sought to exploit this vector in the direction of Arg-108 in an effort to improve potency, possibly utilizing a Coulombic interaction.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Additionally, a HydroSite<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> calculation predicted a high-energy virtual “water” molecule in this pocket (Δ<i>G</i>, Δ<i>H</i>, and −<i>T</i>Δ<i>S</i> are 3.04, 0.64, and 2.4 kcal/mol, respectively) present within the hydrogen-bonding distance between Arg-108, a backbone carbonyl oxygen atom of Thr-253, and a backbone NH of Gly-257, respectively, suggesting the possibility of making energetically favorable interactions with an appropriately chosen side chain attachment in this region (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C).</div><div class="NLM_p">By employing previously described sequential S<sub>N</sub>Ar reactions, a diverse array of primary and secondary amines possessing polar functional groups were rapidly examined through PMC after both calculated property and docking-based<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> prioritization. The initial exploration of this vector culminated in the identification of the pivotal compound <b>4</b> possessing a 3-azabicyclo[3.1.0]hexane ring system as one of the most potent neutral azetidine analogues among those tested from this PMC effort (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Genesis of <b>4</b> bearing the 3-azabicyclo[3.1.0]hexane group. (B) The binding mode of compound <b>4</b> (shown in green; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0X">6W0X</a>). Arg-108 and Thr-253 are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of <b>4</b> in human KHK (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) showed that the terminal hydroxyl group on the newly introduced 3-azabicyclo[3.1.0]hexane ring system effectively reached proximally to Arg-108. This terminal hydroxyl group of <b>4</b> indirectly forms a hydrogen-bonding interaction with Arg-108 through a bound water, while within the hydrogen-bonding distance with the backbone carbonyl oxygen atom of Thr-253, respectively. Relative binding poses between the progenitor analogue <b>3</b> and <b>4</b> are otherwise largely comparable suggesting that the rest of the key protein–ligand interactions identified in <b>3</b> were maintained for <b>4</b>. Taken together, the conformationally rigid 3-azabicyclo[3.1.0]hexane ring of <b>4</b> was considered as a more efficient spacer to reach the targeted buried area nearby Arg-108 relative to the monocyclic pyrrolidine-based ring system.</div><div class="NLM_p">With compound <b>4</b> in hand, further optimization of the terminal polar groups on the 3-azabicyclo[3.1.0]hexane ring system of <b>4</b> was targeted as the next design strategy to improve potency. Among the polar groups known to interact with the arginine residue, the carboxylic acid group was considered as one of the top candidates given its potential to form a strong ionic interaction with the guanidinium group of Arg-108.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">With this in mind, the spacer length between the 3-azabicyclo[3.1.0]hexane ring and the terminal carboxylic acid group was varied to optimize the targeted interaction with Arg-108 (compounds <b>5</b> and <b>6</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>6</b>, with a one carbon spacer between the 3-azabicyclo[3.1.0]hexane ring and the terminal carboxylic acid group, demonstrated a significant potency improvement over <b>4</b> (>20-fold potency boost). It was apparent that the optimal spacer length between the terminal carboxylic acid group and the 3-azabicyclo[3.1.0]hexane unit was critical in order to achieve significant potency improvement (compounds <b>5</b> vs <b>6</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). X-ray crystallographic analysis of the compound <b>6</b> bound in human KHK protein was instructive (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Carboxylic Acid Analogues of <b>4</b> with Various Spacer Length</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0014.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Human KHK potency reported as the geometric mean of at least three replicates. Numbers in parentheses are 95% confidence interval.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The geometric mean of two replicates.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">The experimental log <i>D</i> using shake-flask method at pH = 7.4.</p></div></div><div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Co-crystal structure of <b>6</b> in human KHK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Y">6W0Y</a>) highlighting key hydrogen-bonding interactions. Gly-257 and Gly-255 (backbone NH’s within the hydrogen-bonding distances), a bound water, and Arg-108 are highlighted. The dotted lines indicate potential hydrogen-bonding distances.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The overall binding mode of <b>6</b> was determined to be comparable to that of the neutral azetidine analogue <b>4</b> except that additional polar interactions with the newly introduced carboxylic acid group of compound <b>6</b> were evident from the X-ray structure. Within the proximity of the carboxylic acid group of <b>6</b>, one of the oxygen atoms of carboxylate group was well-positioned to interact with cationic guanidinium group of Arg-108. In addition, the backbone NH of Gly-255 and Gly-257, respectively, as well as a bound water nearby, were all within the hydrogen-bonding distance. Thus, a complex network of polar interactions through the carboxylic acid group of <b>6</b> is likely responsible for the significant potency improvement achieved by <b>6</b>, and not solely a Coulombic interaction.</div><div class="NLM_p">The significant potency improvement demonstrated by <b>6</b>, coupled with its favorable physicochemical property space (MW = 396, log <i>D</i> = 1, TPSA = 101), prompted us to profile compound <b>6</b> in depth as an advanced lead (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Because the potency of <b>6</b> approached the enzyme concentration used in the initial biochemical assay ([KHK] = 10 nM), a more sensitive biochemical assay was developed using the same substrate concentrations but with 10-fold less enzyme while monitoring the reaction over a longer period of time. Compound <b>6</b> showed KHK IC<sub>50</sub> of 1 nM under this new assay format. Compound <b>6</b> demonstrated moderate cell permeability and exhibited low metabolic turnover in HLM supplemented with cytochrome P450 (CYP) cofactor NADPH. Incubation of <b>6</b> in human hepatocytes (HHEPs), however, resulted in relatively high turnover, indicating that <b>6</b> was subject to metabolism by a non-CYP enzyme(s). Follow-up metabolite identification studies in human and rat hepatocytes revealed that <b>6</b> was principally subject to a uridine glucuronosyl transferase (UGT) mediated glucuronidation on its secondary hydroxyl group (Supporting Information (SI), <a class="ref internalNav" href="#notes-1" aria-label="Figure S1">Figure S1</a>). The carboxylic acid moiety was ruled out as the site of glucuronidation because inclusion of hydroxylamine in the incubation mixture did not result in the formation of the corresponding hydroxamic acid product, which is expected from the reaction of the amine nucleophile with the acyl glucuronide metabolite<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (SI, <a class="ref internalNav" href="#notes-1" aria-label="Figures S1,S2">Figures S1,S2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile of the Compound <b>6</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">MW 396, log <i>D</i> 1<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>, TPSA 101, p<i>K</i><sub>a</sub> 4.3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hKHK IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">[KHK] = 10 nM</td><td class="colsep0 rowsep0" align="center">0.006 (0.005–0.006)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hKHK IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">[KHK] = 1 nM</td><td class="colsep0 rowsep0" align="center">0.001 (0.001–0.003)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM CL<sub>int,app</sub></td><td class="colsep0 rowsep0" rowspan="2" align="center"> </td><td class="colsep0 rowsep0" rowspan="2" align="center" valign="middle"><11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(μL/min/mg)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HHEPs CL<sub>int,app</sub></td><td class="colsep0 rowsep0" rowspan="2" align="center"> </td><td class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(μL/min/million cells)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center" valign="middle">5.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The experimental log <i>D</i> using shake-flask method at pH = 7.4.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Human KHK potency reported as the geometric mean of at least three replicates. Numbers in parentheses are 95% confidence interval.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">The geometric mean of two replicates.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Apparent intrinsic clearance (CL<sub>int,app</sub>) obtained from isolated human liver microsomes.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Apparent intrinsic clearance (CL<sub>int,app</sub>) obtained from human hepatocytes cells.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">A permeability assay using low-efflux MDCKII cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div></div></div><div class="NLM_p">The next phase of the optimization was centered on balancing potency, metabolic clearance attributed to glucuronidation, and passive permeability. Metabolite identification studies described above were instrumental in formulating the design strategy toward reducing glucuronidation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Specifically, modifications of the cyanopyridine core and the hydroxyl azetidine group of <b>6</b> were targeted to reduce glucuronidation through reduction of log <i>D</i> and/or removal of the hydroxyl group on the azetidine ring (the proposed site of glucuronidation). The pyrimidine core was considered as a bioisostere of the cyanopyridine group with lower log <i>D</i>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The optimization effort within the scope of this design strategy is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. The more sensitive biochemical assay format described above was used for the optimization efforts presented in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Design strategy to reduce glucuronidation of <b>6</b> by UGTs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of Compound <b>6</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Human KHK potency using 1 nM KHK protein, reported as the geometric mean of at least three replicates.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The geometric mean of two replicates.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">The experimental log <i>D</i> measured using the shake-flask method at pH = 7.4.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Apparent intrinsic clearance (CL<sub>int,app</sub>) measured from human hepatocytes cells.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last"><sup><i>f</i></sup>A permeability assay using low-efflux MDCKII cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div></div><div></div></div><div class="NLM_p">The pyrimidine analogue <b>7</b> showed significant improvement in metabolic stability in human hepatocytes, presumably due to the reduction of lipophilicity (ΔlogD (<b>6</b> → <b>7</b>) = −0.9). Against backdrops of decrease in KHK potency and permeability relative to <b>6</b>, a significant improvement in clearance prompted us to shift the focus to the pyrimidine analogue <b>7</b> with the goal to increase permeability while maintaining low metabolic clearance in human hepatocytes. To this end, <i>des</i>-hydroxyazetidine analogue <b>8</b> was targeted with the expectation to improve permeability through reduction of hydrogen bond donor counts while concomitantly removing the site of glucuronidation in order to mitigate an increase in clearance. Compound <b>8</b> showed comparable KHK potency relative to <b>7</b>. Gratifyingly, compound <b>8</b> maintained low metabolic turnover in human hepatocytes while significantly improving permeability. Upon the basis of improvements in clearance and permeability over <b>6</b>, compound <b>8</b> was selected for further in vitro characterizations (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary Table of Pharmacology and in Vitro ADME Data for Compound <b>8</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">compound <b>8</b>: MW 356, log <i>D</i> 1<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>, TPSA 70, p<i>K</i><sub>a</sub> 4.4, 3.6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human KHK-C IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">[ATP], [fructose] at <i>K</i><sub>m</sub></td><td class="colsep0 rowsep0" align="center">0.010 (0.008–0.011)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human KHK-C IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">[ATP] = 2 mM, [fructose] = 8 mM</td><td class="colsep0 rowsep0" align="center">0.028 (0.024–0.031)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human KHK-A IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">[ATP] = 2 mM, [fructose] = 8 mM</td><td class="colsep0 rowsep0" align="center">0.17 (0.15–0.19)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat KHK IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">[ATP] = 2 mM, [fructose] = 8 mM</td><td class="colsep0 rowsep0" align="center">0.21(0.18–0.23)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human hepatocytes CL<sub>int,app</sub> (μL/min/million cells)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thermodynamic solubility<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(mg/mL) 2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub> (human/rat)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">0.08/0.02</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The experimental log <i>D</i> measured using the shake-flask method at pH = 7.4.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Human or rat KHK potency reported as the geometric mean of at least three replicates. Numbers in parentheses are 95% confidence interval.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Apparent intrinsic clearance (CL<sub>int,app</sub>) measured from human hepatocytes cells using the relay method for low clearance compounds.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">A permeability assay using low-efflux MDCKII cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Solubility of crystalline <b>8</b> in FaSSIF (final pH = 6.2).</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Fraction unbound in plasma.</p></div></div></div><div class="NLM_p">Selected in vitro characterization of <b>8</b> is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. To evaluate potency of <b>8</b> under physiologically relevant substrate concentrations, the IC<sub>50</sub> was measured at 2 mM ATP and 8 mM fructose. In this setting, the IC<sub>50</sub> of <b>8</b> increased to 0.028 μM from 0.01 μM under substrate concentrations at <i>K</i><sub>m</sub>, suggesting a degree of competition with at least one of the substrates (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>i). At physiological substrate concentrations, compound <b>8</b> showed a 6-fold higher IC<sub>50</sub> value against human KHK-A relative to human KHK-C while inhibiting rat KHK with an IC<sub>50</sub> of 0.21 μM. The higher IC<sub>50</sub> value of compound <b>8</b> in KHK-A can be reasoned with a mutation of Leu-112 in KHK-C to Tyr-112 in KHK-A. Tyr-112 in KHK-A would likely attenuate the critical Arg-108 interaction with the carboxyl group of compound <b>8</b> through a hydrogen bond network (Arg-108 → Glu-29 → Lys-174 → Tyr-112). In addition, compound <b>8</b> was highly selective against other sugar kinases, showing >3000-fold selectivity for human KHK-C compared to human ribokinase, glucokinase, hexokinase-1, and hexokinase-2 (SI, <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>). By using a relay method for low clearance compounds in human hepatocytes,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> the apparent intrinsic clearance of <b>8</b> was determined to be 1.2 μL/min/million cells, suggestive of very low metabolic turnover. The thermodynamic solubility of the crystalline form of <b>8</b> was measured in simulated fasted intestinal fluid with bile salts (FaSSIF). Consistent with its amphoteric nature (acidic p<i>K</i><sub>a</sub> = 4.4, basic p<i>K</i><sub>a</sub> = 3.6), it showed high solubility in this media. Compound <b>8</b> showed low, but measurable fraction unbound in plasma across the species.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Biochemical characterizations of <b>8</b>. (i) Effect of substrate concentrations on KHK-C IC<sub>50</sub>. (ii) tight binding inhibition of KHK-C by <b>8</b>. (iii) Modality of compound <b>8</b> inhibition. (iv) Reversibility of compound <b>8</b> inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Detailed biochemical characterization of <b>8</b> was further conducted to reveal its inhibition mechanism (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The IC<sub>50</sub> dependence of <b>8</b> on enzyme concentration indicates tight binding inhibition under these assay conditions (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>ii). Varying concentrations of ATP, but not fructose, had a significant effect, and the Lineweaver–Burke plot (1/rate vs 1/[ATP]) reveals a mixed noncompetitive mechanism (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>iii). While a purely noncompetitive binding modality displays equivalent affinities for the free enzyme and the enzyme–substrate complex, mixed-type noncompetitive inhibition describes cases where these affinities are different.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Despite the dual affinity of the inhibitor for both free and substrate-bound forms of the enzyme, compound <b>8</b> prefers binding to the free enzyme by 19-fold and essentially behaves like a competitive inhibitor of ATP (SI, <a class="ref internalNav" href="#notes-1" aria-label="Figure S3">Figure S3</a>). Applying the correct mathematical model for mixed noncompetitive inhibition gave an inhibition constant (<i>K</i><sub>i</sub>) of 4.53 nM for <b>8</b> (SI, <a class="ref internalNav" href="#notes-1" aria-label="Figure S4">Figure S4</a>). Despite tight binding inhibition of <b>8</b>, there was no evidence of time-dependence, and rapid dilution conditions allowed measurement of a regain in activity which supports a reversible mechanism (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>iv; SI, <a class="ref internalNav" href="#notes-1" aria-label="Figure S5 and Table S2">Figure S5 and Table S2</a>). Taken together, compound <b>8</b> was determined to be a potent reversible inhibitor of recombinant human KHK-C through a mixed noncompetitive mechanism.</div><div class="NLM_p">The cocrystal structure of <b>8</b> in human KHK is shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. The binding mode of <b>8</b> was comparable to that of <b>6</b>, retaining multiple polar interactions by the carboxylate group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Because of the change from the cyano pyridine core to the pyrimidine core (<b>6</b> → <b>8</b>), the replaced conserved water molecule seen in cocrystal structure of <b>1</b> in human KHK was observed in this binding mode with <b>8</b>. Compound <b>8</b> makes a hydrogen-bonding interaction with a conserved water through the pyrimidine nitrogen, while a conserved water makes a hydrogen-bonding interaction with the backbone NH of Phe-245. A pairwise comparison (compound <b>7</b> → compound <b>6</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) suggests replacing a conserved water molecule likely contributed to 14-fold improvement in potency (0.014 μM → 0.001 μM). However, this permutation is also associated with increase in lipophilicity (log <i>D</i> 0.1 → 1) and metabolic clearance (HHEP Cl<sub>int,app</sub> < 2 → 26) in this matched molecular pair. From the optimization perspective, the value of replacing this conserved water molecule is likely chemo-type dependent, and it needs to be balanced with other design parameters beyond potency.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Binding mode of <b>8</b> in the crystal structure highlighting key hydrogen-bonding interactions (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Z">6W0Z</a>). Backbone NHs of Phe-245, Gly-257, and Gly-255, two bound waters, and Arg-108 are highlighted. The dotted lines indicate potential hydrogen-bonding distances.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of attractive in vitro disposition attributes of <b>8</b>, the in vivo pharmacokinetic properties of <b>8</b> was determined in rats and dogs, the preclinical species for safety assessments in the program (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Following IV administration, <b>8</b> demonstrated low total plasma clearance (CL<sub>p</sub>) and low steady state distribution volume (<i>V</i><sub>dss</sub>), leading to moderate-to-long elimination half-lives (<i>t</i><sub>1/2</sub>) in rats and dogs, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Moreover, <b>8</b> demonstrated negligible renal excretion as unchanged parent in both animal species. The corresponding oral bioavailability (<i>F</i>) of the crystalline form of <b>8</b> was high (>90%) in both species, consistent with a combination of high aqueous solubility, high passive permeability, and low metabolic clearance as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. With the robust in vivo pharmacokinetic profile demonstrated, compound <b>8</b> was evaluated for KHK inhibition in vivo by utilizing Sprague–Dawley rats as previously described (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by the Pfizer Institutional Animal Care and Use Committee. Sprague–Dawley rats were administered vehicle or increasing doses of compound <b>8</b> followed by iv administration of fructose. Two minutes after the administration of fructose, rats were euthanized and liver and kidney tissues were removed and snap-frozen in liquid nitrogen. F1P was quantified in liver and kidney homogenates by liquid chromatography/mass spectrometry (LC/MS) as previously described.<a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> F1P decreased dose dependently with measured ED<sub>50</sub> values of 1.93 mg/kg in liver and 4.74 mg/kg in kidney (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The observed dose-dependent decrease in hepatic and kidney F1P as depicted in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> indicates inhibition of liver and kidney KHK.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. in Vivo Pharmacokinetic Profile of <b>8</b> in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center">species</th><th class="colsep0 rowsep0" rowspan="2" align="center">route</th><th class="colsep0 rowsep0" align="center">dose</th><th class="colsep0 rowsep0" align="center">CL<sub>p</sub></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–24)</sub></th><th class="colsep0 rowsep0" align="center"><i>F</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">(mg/kg)</th><th class="colsep0 rowsep0" align="center">(mL/min/kg)</th><th class="colsep0 rowsep0" align="center">(h)</th><th class="colsep0 rowsep0" align="center">(L/kg)</th><th class="colsep0 rowsep0" align="center">(ng/mL)</th><th class="colsep0 rowsep0" align="center">(h)</th><th class="colsep0 rowsep0" align="center">(ng·h/mL)</th><th class="colsep0 rowsep0" align="center">(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">rat</td><td class="colsep0 rowsep0" rowspan="2" align="center">iv</td><td class="colsep0 rowsep0" rowspan="2" align="center">1</td><td class="colsep0 rowsep0" align="center">0.358</td><td class="colsep0 rowsep0" align="center">7.71</td><td class="colsep0 rowsep0" align="center">0.20</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td><td class="colsep0 rowsep0" align="center">41800</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">(0.361, 0.354)</td><td class="colsep0 rowsep0" align="center">(6.89,8.52)</td><td class="colsep0 rowsep0" align="center">(0.18, 0.22)</td><td class="colsep0 rowsep0" align="center">(42500, 41000)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"> </td><td class="colsep0 rowsep0" rowspan="2" align="center">po</td><td class="colsep0 rowsep0" rowspan="2" align="center">5</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td><td class="colsep0 rowsep0" align="center">24100</td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">210000</td><td class="colsep0 rowsep0" rowspan="2" align="center">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">(5.46, 5.93)</td><td class="colsep0 rowsep0" align="center">(34400, 13700)</td><td class="colsep0 rowsep0" align="center">(0.25, 4.0)</td><td class="colsep0 rowsep0" align="center">(245000, 175000)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="10" align="left">        </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1.31 ± 0.55</td><td class="colsep0 rowsep0" align="center">5.57 ± 1.77</td><td class="colsep0 rowsep0" align="center">0.165 ± 0.04</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">14600 ± 6900</td><td class="colsep0 rowsep0" align="center">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"> </td><td class="colsep0 rowsep0" rowspan="2" align="center">po</td><td class="colsep0 rowsep0" rowspan="2" align="center">5</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td><td class="colsep0 rowsep0" rowspan="2" align="center">3.4</td><td class="colsep0 rowsep0" rowspan="2" align="center">NA</td><td class="colsep0 rowsep0" align="center">31900</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">157000</td><td class="colsep0 rowsep0" rowspan="2" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">(31300, 32500)</td><td class="colsep0 rowsep0" align="center">(0.5, 0.5)</td><td class="colsep0 rowsep0" align="center">(137000, 177000)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Pharmacokinetic parameters were calculated from plasma concentration–time data and are reported as mean ± SD (for <i>n</i> = 3) and mean (for <i>n</i> = 2) with individual values provided in parentheses. Intravenous (iv) pharmacokinetics were conducted in male gender of each species (Wistar Han rats and beagle dogs). Solution formulation for the iv dose included 12.5% SBECD in 50 mM TRIS buffer (pH 8.0). The po (oral) studies, crystalline <b>8</b> was administered as suspension in 0.5% methylcellulose.</p></div></div></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Hepatic and renal concentration of fructose 1-phosphate (F1P) following oral administrations of <b>8</b> and iv fructose bolus in Sprague–Dawley rats. A nonlinear dose–response curve was fitted to a variable slope (four parameter) using GraphPad Prism, and the calculated ED<sub>50</sub> values for kidney and liver F1P reduction are reported. Data are presented as mean values (±standard error) with <i>n</i> = 7–8 per data points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>8</b> was further profiled in a battery of in vitro assays to determine its potential as a development candidate. No measurable reversible and/or time-dependent inhibition of cytochrome P450 enzymes (IC<sub>50</sub> > 100 μM against CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, and 3A4), and no induction of CYP1A2, 2B6, and 3A4 at 30 μM was observed. Compound <b>8</b> exhibited a clean off-target selectivity profile as assessed by the CEREP panel (<53% at 30 μM). No significant inhibitions were observed on hERG (human ether-a-go-go-related gene, patch clamp IC<sub>50</sub> > 100 μM), various kinases in the kinase selectivity panel, and PDE selectivity panel (the lowest IC<sub>50</sub> = 11 μM against PDE10A, SI, <a class="ref internalNav" href="#notes-1" aria-label="Table S3">Table S3</a>). Compound <b>8</b> did not present genetic toxicology risks as evidenced by negative findings in an Ames test and an in vitro micronucleus assay in TK6 cells. Furthermore, in vivo exploratory toxicology studies in rats and dogs revealed no development-limiting toxicity findings. On the basis of its favorable overall profile, compound <b>8</b> (PF-06835919) was selected as a clinical candidate.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemistry to make the described pyridine analogues is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Amines described in <a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a> were employed in sequential S<sub>N</sub>Ar chemistry beginning with commercially available dichloropyridine <b>9</b>. The first S<sub>N</sub>Ar reaction proceeds at room temperature to install the 6-position substituent selectively. The second S<sub>N</sub>Ar reaction proceeds at elevated temperatures to install the 2-position substituent leading to pyridines <b>2</b>–<b>4</b>. For ester-containing intermediates, a hydrolysis reaction was used in step 3 to form pyridine acids <b>5</b> and <b>6</b>.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyridines <b>2</b>–<b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>11</b>, Et<sub>3</sub>N, DMF; (b) <b>12</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (c) (i) <i>rac</i>-<b>13</b>, Et<sub>3</sub>N, DMF, 60 °C, (ii) SFC separation; (d) (i) <b>14</b>, K<sub>2</sub>CO<sub>3</sub>, NaHCO<sub>3</sub>, 85%, (ii) <b>13</b>/(<i>R</i>)-CSA, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 85 °C, 53%; (e) (i) <b>15</b>, Et<sub>3</sub>N, DMF, (ii) <b>13</b>·HCl, Et<sub>3</sub>N, CH<sub>3</sub>CN, 60 °C, (iii) 2 M NaOH, EtOH; (f) (i) <b>16</b>, NaHCO<sub>3</sub>, EtOH, (ii) <b>13</b>/(<i>R</i>)-CSA, NaHCO<sub>3</sub>, EtOH, 80 °C, (iii) 1 M NaOH, EtOH, 44% over three steps.</p></p></figure><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Precedented Amines Used in S<sub>N</sub>Ar Chemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of azetidine <b>13</b> is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Following modifications of literature conditions,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> (2<i>E</i>)-buten-1-ol <b>18</b> was treated with bromine to from dibromide <b>19</b> which was then reacted with potassium hydroxide to form epibromohydrin <b>20</b>. Treatment with benzhydryl amine led to displacement of the bromide and concomitant epoxide opening to form protected azetidine <i>rac</i>-<b>21</b>, which could be separated via SFC on a chiral column or taken forward to hydrogenolysis to remove the benzhydryl protecting group and provide <i>rac</i>-<b>13</b>. Treatment of <i>rac</i>-<b>21</b> with (<i>R</i>)-camphor sulfonic acid (CSA) under classical chiral resolution conditions led to the isolation of the single enantiomer of <b>21</b> as a salt with (<i>R</i>)-CSA. Hydrogenolysis of the protecting group then led to the isolation of the <b>13</b>/(<i>R</i>)-CSA salt that could be used directly in the S<sub>N</sub>Ar chemistry.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Azetidine <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Br<sub>2</sub>, CHCl<sub>3</sub>, 0–15 °C; (b) aq KOH, THF, 15 °C to rt; (c) Ph<sub>2</sub>CHNH<sub>2</sub>, NaHCO<sub>3</sub>, EtOH, rt to 80 °C; 37% over three steps; (d) Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (55 psi), EtOH, quant, or (i) SFC separation, (ii) 4 M HCl in dioxane, EtOH, Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (50 psi), 89%; (e) (i) (<i>R</i>)-CSA, EtOH, (ii) MTBE crystallization, (iii) CH<sub>2</sub>Cl<sub>2</sub>, EtOAc recrystallization; 32% over two steps; (f) Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (60 psi), MeOH, 95%.</p></p></figure><div class="NLM_p">The synthesis of amino ethyl esters <b>16</b> and <b>26</b> are shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Starting from benzyl protected amino alcohol <b>22</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> activation of the alcohol as the mesylate and S<sub>N</sub>2 displacement with sodium cyanide led to formation of nitrile <b>23</b>. Acid-mediated solvolysis led to formation of the ester and hydrogenolysis of the benzyl protecting group led to amino ester <b>16</b>. Methyl ester <b>26</b> was employed in larger scale syntheses of <b>8</b> because it could be stored as a stable solid intermediate, in contrast to ethyl ester <b>16</b>, which was an oil that partially decomposed upon long-term storage. Improvements were also made during homologation step: (1) conversion of the alcohol to the chloride with thionyl chloride and formation of the HCl salt led to a more stable intermediate than the analogous mesylate and (2) after free-basing the salt, the chloride was displaced with sodium cyanide and the HCl salt of <b>23</b> was formed. Solvolysis with methanol rather than ethanol also led to a solid amino ester HCl salt rather than an oil. Benzyl deprotection then led to amino methyl ester hydrochloride <b>26</b> that was used directly in the S<sub>N</sub>Ar chemistry.</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Amino Esters <b>16</b> and <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) Et<sub>3</sub>N, MsCl, DMF, THF, 0–10 °C, (ii) NaCN, DMF, 73%, over two steps; (b) (i) HCl, MeOH, (ii) SOCl<sub>2</sub>, PhCH<sub>3</sub>, 91%, (iii) NaCN, DMF, 93%; (c) (i) H<sub>2</sub>SO<sub>4</sub>, EtOH, 80 °C, 82%, (ii) Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (50 psi), 50 °C, 91%; (d) (i) AcCl, MeOH, 0–65 °C, 82%, (ii) HCl, MeOH, 88%, (iii) Pd(OH)<sub>2</sub>, H<sub>2</sub> (100 psi), MeOH, 70 °C, 99%.</p></p></figure><div class="NLM_p">Pyrimidine <b>7</b> was synthesized in an analogous manner to <b>6</b>, but the chemistry began with commercially available dichloropyrimidine <b>24</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Pyrimidine <b>8</b> was scaled up under similar conditions, but the first S<sub>N</sub>Ar reaction was conducted with methyl aminoester <b>26</b> and cryogenic temperatures were used to maximize selectivity. After a second S<sub>N</sub>Ar with (<i>S</i>)-methylazetidine (<b>17</b>)/(<i>R</i>)-CSA salt,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> followed by saponification, <b>8</b> was recrystallized from MTBE–heptane.</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthesis of Pyrimidines <b>7</b> and <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>16</b>, NaHCO<sub>3</sub>, EtOH, 81%; (b) <b>26</b>·HCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, −70 to −60 °C; (c) <b>13</b>/(<i>R</i>)-CSA, Et<sub>3</sub>N, CH<sub>3</sub>CN, 70 °C, 87%; (d) <b>17</b>/(<i>R</i>)-CSA, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 60 °C; (e) aq NaOH, EtOH, 97%; (f) (i) aq NaOH, MeOH, (ii) crystallization from MTBE–heptane, 73% yield over four steps.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, highly potent and selective acidic KHK inhibitors were identified starting from the pyrrolidine-based lead <b>1</b>. The initial phase of lead optimization focused on potency improvement. Early realization of rotations in the binding mode driven by the azetidine-based inhibitors was a critical step toward targeting Arg-108 and a simulated high-energy water proximal to Arg-108. Subsequent optimization through combination of PMC and the ionization-switch through SBDD led to the identification of highly potent KHK inhibitors bearing 3-azabicyclo[3.1.0]hexane acetic acid group. Final optimization efforts toward striking the balance of potency, glucuronidation metabolism, and cell permeability profile were achieved by strategic removal of the hydroxyl group (the major site of the glucuronidation metabolism) and the use of the pyrimidyl central core, culminating in the discovery of <b>8</b> (PF-06835919) as a clinical candidate. To our knowledge, PF-06835919 represents a first-in-class small molecule KHK inhibitor to have entered clinical trials. PF-06835919 is currently being evaluated in phase 2 clinical trials for the treatment of NAFLD/NASH. Detailed pharmacological characterizations of PF-06835919 will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41373" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41373" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General</h3><div class="NLM_p">Unless otherwise noted, the reported experiments followed these general guidelines: All chemicals, reagents, and solvents were purchased from commercial sources when available and used without further purification. Air and moisture-sensitive reactions were carried out under an atmosphere of nitrogen, magnetically stirred, and monitored by thin layer chromatography (TLC), liquid chromatography–mass spectrometry (LCMS), or high performance liquid chromatography (HPLC). Reactions were carried out at room temperature (∼23 °C). Silica gel chromatography was performed using an Isco or Biotage automated purification system with prepackaged columns. Concentration under reduced pressure (in vacuo) was performed by rotary evaporation at 25–45 °C. Purified compounds were further dried under high vacuum with or without heat to remove residual solvent. <sup>1</sup>H NMR spectra were obtained with a spectrometer at 600 or 400 MHz. Chemical shifts were referenced to the residual <sup>1</sup>H solvent signals (CDCl<sub>3</sub>, δ 7.27; DMSO-<i>d</i><sub>6</sub>, δ 2.50; CD<sub>3</sub>OD, δ 3.31). Signals are listed as follows: chemical shift in ppm; multiplicity identified as br, broad; s, singlet; d, doublet; t, triplet; m, multiplet; coupling constants (<i>J</i>) in Hz. For amines described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, amines <b>11</b>, <b>14</b>, and <b>15</b> are commercially available. Amines <b>12</b><a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> and <b>17</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> were synthesized according to the reported procedures. All tested compounds (compounds <b>2</b>–<b>8</b>) showed >95% purity as determined by either HPLC or LCMS (% purity values of all test compounds were reported at the end of their synthesis in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> below).</div><div class="NLM_p last">Detailed protocols for X-ray crystallography, in vitro human and rat KHK inhibition assays, and animal experimental methods have been described previously by Huard et al.<a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> For more sensitive human KHK inhibition assay, 1 nM purified KHK was used and absorbance was monitored for 3 h while the rest of assay conditions remained identical to previously described method.<a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of Analogues and Intermediates</h3><div class="NLM_p">2-Chloro-6-((3<i>R</i>,4<i>S</i>)-3,4-dihydroxypyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile (<b>10</b>). To a solution of <b>9</b> (60 mg, 0.25 mmol) and <b>11</b> (68.5 mg, 0.249 mmol) in dry DMF (1 mL) was added triethylamine (126 mg, 1.24 mmol). The mixture was stirred at 30 °C for 6 h. The mixture was diluted with water and extracted with EtOAc (10 mL × 3). The organic layer was washed with saturated aqueous ammonium chloride, brine, dried over sodium sulfate, filtered, and concentrated. The residue was purified by prep-TLC (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 20:1) to provide <b>10</b> (60 mg, 78%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.78 (s, 1H), 4.39–4.33 (m, 1H), 4.31–4.25 (m, 1H), 3.79 (dd, <i>J</i> = 5.5, 13.1 Hz, 1H), 3.72 (dd, <i>J</i> = 6.0, 11.0 Hz, 1H), 3.62 (dd, <i>J</i> = 4.5, 13.1 Hz, 1H), 3.44 (dd, <i>J</i> = 5.5, 10.5 Hz, 1H).</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 6-[(3<i>R</i>,4<i>S</i>)-3,4-Dihydroxypyrrolidin-1-yl]-2-[(3<i>S</i>)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile (<b>2</b>)</h4><div class="NLM_p last">A mixture of <b>10</b> (60 mg, 0.20 mmol), <b>12</b> (21.7 mg, 0.215 mmol), and potassium carbonate (53.9 mg, 0.390 mmol) in dry DMF (1 mL) was stirred at 60 °C for 3 h. The mixture was purified by reverse phase preparative HPLC to provide <b>2</b> (23 mg, 31%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.13 (s, 1H), 4.36–4.20 (m, 2H), 4.04–3.92 (m, 1H), 3.85 (ddd, <i>J</i> = 3.0, 7.7, 10.9 Hz, 1H), 3.80–3.51 (m, 5H), 3.42–3.33 (m, 1H), 2.09–1.85 (m, 2H), 1.44 (s, 3H). LCMS calcd for C<sub>16</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>: 373.2, found 372.9. HPLC 99.05% purity.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>rac</i>-(2<i>R</i>)-2-[(1<i>R</i>)-1-Bromoethyl]oxirane (<i>rac</i>-<b>20</b>)</h4><div class="NLM_p last">A solution of (2<i>E</i>)-buten-1-ol (967 g, 13.4 mol) in chloroform (10 L) was treated with bromine (2.15 kg, 13.4 mol) over the course of 2 h at 0 °C. The mixture was stirred at 15 °C for 30 min. The mixture was quenched with saturated sodium thiosulfate solution (500 mL) at 15 °C. This reaction was repeated in two additional vessels, and the three reaction mixtures were combined and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 5 L). The combined organics were concentrated in vacuo to give <i>rac</i>-(2<i>R</i>,3<i>S</i>)-dibromobutan-1-ol <b>19</b> (10.5 kg, quant) as a yellow oil, which was taken to the next step without further purification. Three separate reaction vessels were each charged with <i>rac</i>-<b>19</b> (3.33 kg, 12.7 mol) in THF (9 L) and KOH (711 g, 12.7 mol) in water (6 L) was added dropwise at 15 °C. The reaction mixtures were stirred at rt for 2 h. The three reaction mixtures were combined, and the organic layer was separated. The aqueous phase was extracted with EtOAc (3 × 5 L). The combined organic layers were washed with brine (3 × 5 L), dried with sodium sulfate, filtered, and concentrated in vacuo to provide <i>rac</i>-<b>20</b> (6.5 kg, quant) as a yellow oil, which was taken to next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.81 (quin, <i>J</i> = 6.9 Hz, 1H), 3.18 (ddd, <i>J</i> = 2.5, 4.0, 7.0 Hz, 1H), 2.90 (t, <i>J</i> = 4.3 Hz, 1H), 2.70 (dd, <i>J</i> = 2.5, 4.5 Hz, 1H), 1.67 (d, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>trans</i>-1-Benzhydryl-2-methylazetidin-3-ol (<i>rac</i>-<b>21</b>)</h4><div class="NLM_p last">Two separate reaction vessels were each charged with a solution of <i>rac</i>-<b>20</b> (3.28 kg, 16.2 mol) and benzhydrylamine (2.97 kg, 16.2 mol) in anhydrous ethanol (5.41 L). NaHCO<sub>3</sub> (2.07 kg, 24.3 mol) was added, and the mixture was stirred at rt for 80 h. The mixture was then stirred at 65 °C for an additional 24 h. The two reaction mixtures were cooled to rt, combined, and filtered. The filtrate was concentrated and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 L), washed with saturated aqueous ammonium chloride (2 × 5 L), dried over sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by column chromatography on silica gel eluting with petroleum ether/EtOAc (50:1 to 1:1) to provide <i>rac</i>-<b>21</b> (3.18 kg, ∼80% purity, 37% yield) as a yellow oil that was taken forward without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.47–7.09 (m, 10H), 4.38 (s, 1H), 3.80 (q, <i>J</i> = 6.5 Hz, 1H), 3.56 (t, <i>J</i> = 7.0 Hz, 1H), 3.05 (quin, <i>J</i> = 6.3 Hz, 1H), 2.58 (t, <i>J</i> = 7.5 Hz, 1H), 0.72 (d, <i>J</i> = 6.0 Hz, 3H).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>trans</i>-2-Methylazetidin-3-ol (<i>rac</i>-<b>13</b>)</h4><div class="NLM_p last">To a solution of <i>rac</i>-<b>21</b> (200 mg, 0.789 mmol) in EtOH (15 mL) was added Pd(OH)<sub>2</sub>/C (122 mg, 0.868 mmol). The mixture was stirred at rt for 15 h under 55 psi of H<sub>2</sub> atmosphere. The mixture was filtered and concentrated in vacuo to provide <i>rac</i>-<b>13</b> (180 mg, 100%) as an off-white solid containing some diphenylmethane impurity that was taken forward without additional purification.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-[(3<i>R</i>,4<i>S</i>)-3,4-Dihydroxypyrrolidin-1-yl]-2-[(2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile (<b>3</b>)</h4><div class="NLM_p last">A mixture of <i>rac</i>-<b>13</b> (180 mg, 2.07 mmol), <b>10</b> (318 mg, 1.03 mmol), and triethylamine (314 mg, 3.10 mmol) in dry DMF (5 mL) was stirred at 60 °C overnight. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and saturated ammonium chloride solution, and the layers were separated. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was first purified by prep-TLC (CH<sub>2</sub>Cl<sub>2</sub>:MeOH = 10:1), and chiral SFC was then used to separate enantiomers and provide <b>3</b> (40 mg, 5.4%) as peak 2; column, AD (250 × 30 mm, 5 μm); mobile phase, 20% ethanol NH<sub>4</sub>OH; flow rate, 60 mL/min. LCMS calcd for C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>: 359.1, found 358.9. HPLC 98.56% purity, 95.3% ee.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (2<i>S</i>,3<i>R</i>)-1-(Diphenylmethyl)-3-hydroxy-2-methylazetidinium[(1<i>R</i>,4<i>S</i>)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonate (<b>21</b>/(<i>R</i>)-CSA)</h4><div class="NLM_p last">To a solution of (1<i>R</i>)-(−)-camphor-10-sulfonic acid (2.7 kg, 12 mol) in ethanol (8 L) was added a solution of <i>rac</i>-<b>21</b> (3.18 kg, 11.7 mol) in ethanol (2 L). The resulting solution was evaporated to remove EtOH. The residue was treated with methyl <i>tert</i>-butyl ether (5 L) and concentrated in vacuo until ∼1 L of solvent remained. The residue was treated with additional methyl <i>tert</i>-butyl ether (5 L) and filtered. The filter cake was dried in vacuo to give a white solid (3.5 kg) which was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (7.6 L), and EtOAc (10.9 L) was added. The mixture was stirred at rt for 30 min, resulting in the precipitation of white solids which were collected by filtration. The filter cake was suspended in CH<sub>2</sub>Cl<sub>2</sub> (10.6 L), stirred at rt for 10 min, and then EtOAc (10.6 L) was added to the solution. The mixture was stirred at rt for 30 min, and the resulting white precipitates were collected by filtration. The filter cake was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10.6 L), stirred at rt for 10 min, and then EtOAc (10.6 L) was added. The reaction mixture was stirred at rt for 30 min, and the precipitated solids were collected by filtration to give a white solid (1.3 kg, 95.2% ee by chiral SFC analysis). This material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (7 L) and heated to reflux temperature for 40 min. EtOAc (3.5 L) was added, and the mixture was stirred at 40 °C for an additional 20 min and white solids precipitated. The solids were collected by filtration. The filter cake was dried in vacuo to give <b>21/</b>(<i>R</i>)-CSA (1.1 kg, 98.2% ee by chiral SFC, 32% yield) as a white solid. [α]<sub>D</sub><sup>20</sup> = −28.2° (<i>c</i> 1.0, CH<sub>3</sub>OH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.20 (br s, 1H), 7.67–7.57 (m, 4H), 7.51–7.35 (m, 6H), 6.31 (br s, 1H), 5.82 (d, <i>J</i> = 10.0 Hz, 1H), 4.38–4.27 (m, 1H), 4.23–4.12 (m, 2H), 3.69–3.58 (m, 1H), 2.96 (d, <i>J</i> = 14.6 Hz, 1H), 2.80–2.61 (m, 1H), 2.46 (d, <i>J</i> = 14.6 Hz, 1H), 2.25 (td, <i>J</i> = 3.6, 18.3 Hz, 1H), 1.95 (t, <i>J</i> = 4.3 Hz, 1H), 1.88 (dt, <i>J</i> = 3.8, 7.7 Hz, 1H), 1.81 (d, <i>J</i> = 18.1 Hz, 1H), 1.37–1.25 (m, 2H), 1.07 (s, 3H), 0.96 (d, <i>J</i> = 6.5 Hz, 3H), 0.76 (s, 3H).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (2<i>S</i>,3<i>R</i>)-3-Hydroxy-2-methylazetidin-1-ium[(1<i>R</i>,4<i>S</i>)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonate (<b>13</b>/(<i>R</i>)-CSA)</h4><div class="NLM_p last">A mixture of <b>21</b>/(<i>R</i>)-CSA (18.96 g, 39.04 mmol) in methanol (60 mL) was treated with 10% palladium hydroxide on carbon (1.11 g) in a stainless-steel reaction vessel. The reaction vessel was flushed with nitrogen gas then filled with hydrogen gas (60 psi). The reaction mixture was stirred at rt for 17 h, then repressurized with hydrogen gas (55 psi). After an additional 24 h, the reaction mixture was flushed with nitrogen gas and filtered through a plug of Celite, eluting with methanol (4 × 80 mL). The combined filtrates were evaporated to give a white oily semisolid. This material was suspended in heptane (100 mL), the sides of the flask were scrapped with a spatula, and the heptanes were decanted. This process was repeated two times, and the solids were suspended in heptanes (200 mL) and stirred at rt for 2.5 h. The solids were collected by filtration, suspended in heptanes (100 mL), and stirred at rt for 1 h. The solids were collected by filtration, suspended in heptanes (120 mL) and stirred vigorously for 24 h. The solids were collected by filtration to give <b>13</b>/(<i>R</i>)-CSA (11.8 g, 95%) as a white solid. [α]<sub>D</sub><sup>22</sup> = −72.6° (<i>c</i> 1.0, CH<sub>3</sub>OH). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 4.30 (q, <i>J</i> = 6.8 Hz, 1H), 4.25 (quin, <i>J</i> = 6.6 Hz, 1H), 4.03 (dd, <i>J</i> = 7.6, 10.6, 1H), 3.77–3.72 (m, 1H), 3.31–3.27 (m, 1H), 2.77 (d, <i>J</i> = 15.3 Hz, 1H), 2.69–2.59 (m, 1H), 2.34 (td, <i>J</i> = 3.7, 18.5 Hz, 1H), 2.09–1.99 (m, 2H), 1.89 (d, <i>J</i> = 18.8 Hz, 1H), 1.65–1.58 (m, 1H), 1.51 (d, <i>J</i> = 6.5 Hz, 3H), 1.45–1.35 (m, 1H), 1.12 (s, 3H), 0.85 (s, 3H).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>S</i>,3<i>R</i>)-2-Methylazetidin-3-ol (<b>13</b>·HCl)</h4><div class="NLM_p last"><i>rac</i>-<b>21</b> was separated via SFC on a chiral column to produce the single enantiomer <b>21</b> as peak 1 (column: Lux Cellulose-1, 250 mm × 21.2 mm, 5 μm; eluent: 80% CO<sub>2</sub>, 20% methanol [with 0.2% 7 N NH<sub>3</sub> in methanol]; 80.0 mL/min, backpressure 120 bar). To a 300 mL Parr reactor was added a solution of <b>21</b> (4.99 g, 19.7 mmol) in ethanol (50 mL) followed by the addition of 4 M hydrogen chloride in dioxane (20 mL, 80 mmol) and 20% palladium hydroxide on carbon (2.77 g, 19.7 mmol). The reactor was sealed and purged with nitrogen three times then with hydrogen two times. The hydrogen pressure was increased to 50 psi, and the reaction was stirred for 18 h at rt. The reaction was purged with nitrogen three times then filtered through a plug of Celite and washed with ethanol. The filtrate was concentrated under reduced pressure. NMR analysis determined that the reaction was not complete. The crude material was redissolved in ethanol (60 mL), followed by the addition of 4 M hydrogen chloride in dioxane (20 mL, 80 mmol) and 20% palladium hydroxide on carbon (2770 mg, 19.7 mmol). The reactor was sealed and purged with nitrogen three times followed by hydrogen two times. The hydrogen pressure was increased to 50 psi and was stirred for 22 h at room temperature. The reaction was purged with nitrogen three times then filtered through a plug of Celite and washed with ethanol. The filtrate was concentrated in vacuo then ethyl ether (100 mL) was added and the mixture concentrated in vacuo. Ethyl ether (150 mL) was added and decanted away. This procedure was repeated two additional times, and the resulting crude material was dried under high vacuum for 18 h to provide <b>13·</b>HCl (2.16 g, 89%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 4.36–4.19 (m, 2H), 4.03 (dd, <i>J</i> = 7.0, 10.5 Hz, 1H), 3.79–3.69 (m, 1H), 1.51 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Chloro-6-((1<i>R</i>,5<i>S</i>,6<i>r</i>)-6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexan-3-yl)-4-(trifluoromethyl)nicotinonitrile</h4><div class="NLM_p last">A vial was charged with ((1<i>R</i>,5<i>S</i>,6<i>R</i>)-3-azabicyclo[3.1.0]hexan-6-yl)methanol (71 mg, 0.63 mmol), <b>9</b> (132 mg, 0.548 mmol), and ethanol (2.5 mL). Sodium bicarbonate (92 mg, 1.1 mmol) was then added, and the vial was sealed and reacted at rt for 18 h. The reaction was cooled to rt then diluted with EtOAc and water. The layers were separated, and the organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo. Flash column chromatography (0–75% EtOAc/heptane) was then used to provide 2-chloro-6-((1<i>R</i>,5<i>S</i>,6<i>R</i>)-6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexan-3-yl)-4-(trifluoromethyl)nicotinonitrile (148 mg, 85%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.75 (s, 1H), 3.96 (br d, <i>J</i> = 12.1 Hz, 1H), 3.75–3.67 (m, 1H), 3.64 (dd, <i>J</i> = 4.5, 11.5 Hz, 2H), 3.48 (d, <i>J</i> = 7.0 Hz, 2H), 1.80–1.69 (m, 2H), 0.89 (tt, <i>J</i> = 3.4, 6.7 Hz, 1H). C<sub>13</sub>H<sub>11</sub>ClF<sub>3</sub>N<sub>3</sub>O (M + H)<sup>+</sup>: 318.1, found 318.1.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-[(1<i>R</i>,5<i>S</i>,6<i>S</i>)-6-(Hydroxymethyl)-3-azabicyclo[3.1.0]hex-3-yl]-2-[(2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile (<b>4</b>)</h4><div class="NLM_p last">A vial was charged with 2-chloro-6-((1<i>R</i>,5<i>S</i>,6<i>r</i>)-6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexan-3-yl)-4-(trifluoromethyl)nicotinonitrile (62 mg, 0.20 mmol), <b>13</b>/(<i>R</i>)-CSA (125 mg, 0.39 mmol), and acetonitrile (1 mL). Hünig’s base (0.14 mL, 0.78 mmol) was then added, and the vial was sealed then heated to 85 °C for 2 h. The reaction was cooled to rt and diluted with EtOAc and 1 M sodium hydroxide. The layers were separated, and the organic was washed with half-saturated ammonium chloride solution followed by brine. The mixture was dried over sodium sulfate, filtered, and concentrated in vacuo. Flash column chromatography (20–100% EtOAc/heptane) was then used to provide <b>4</b> (38 mg, 53%) as white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.14 (s, 1H), 4.66 (ddd, <i>J</i> = 1.0, 6.6, 7.8 Hz, 1H), 4.30 (quin, <i>J</i> = 5.8 Hz, 1H), 4.14 (td, <i>J</i> = 4.7, 6.6 Hz, 1H), 4.06–3.82 (m, 1H), 3.79 (dd, <i>J</i> = 4.9, 9.2 Hz, 1H), 3.73–3.50 (m, 3H), 3.47 (d, <i>J</i> = 7.0 Hz, 2H), 1.68 (br s, 2H), 1.49 (d, <i>J</i> = 6.6 Hz, 3H), 0.86 (tt, <i>J</i> = 3.3, 6.8 Hz, 1H). LCMS calcd for C<sub>17</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 369.2, found 369.3. LCMS: >99% purity.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl(1<i>R</i>,5<i>S</i>,6<i>r</i>)-3-(6-chloro-5-cyano-4-(trifluoromethyl)pyridin-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxylate</h4><div class="NLM_p last">A mixture of <b>1</b> (135 mg, 0.956 mmol), <b>9</b> (230 mg, 0.956 mmol), and triethylamine (290 mg, 2.87 mmol) in dry DMF (5 mL) was stirred at 20 °C for 16 h. The mixture was diluted with water (40 mL) and extracted with EtOAc (20 mL × 3). The organic layer was washed with saturated aqueous ammonium chloride (50 mL) and brine, dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (EtOAc in petroleum ether from 0 to 20%) to provide the title compound (247 mg, 75%) as light-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.50 (s, 1H), 4.19–3.93 (m, 2H), 3.82–3.62 (m, 2H), 3.72 (s, 3H), 2.40–2.32 (m, 2H), 1.55 (t, <i>J</i> = 3.3 Hz, 1H).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl(1<i>R</i>,5<i>S</i>,6<i>S</i>)-3-(5-cyano-6-((2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl)-4-(trifluoromethyl)pyridin-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxylate</h4><div class="NLM_p last">To a mixture of methyl (1<i>R</i>,5<i>S</i>,6<i>r</i>)-3-(6-chloro-5-cyano-4-(trifluoromethyl)pyridin-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxylate (100 mg, 0.289 mmol) and <b>13</b>·HCl (40 mg, 0.32 mmol) in acetonitrile (5 mL) was added triethylamine (87.8 mg, 0.868 mmol) and the reaction stirred at 60 °C for 18 h. Additional <b>13</b>·HCl (40 mg, 0.32 mmol) was added and stirred at 60 °C for an additional 16 h. The mixture was diluted with saturated aqueous ammonium chloride (50 mL) and extracted with EtOAc (20 mL × 3). The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated in vacuo. The residue was purified by prep TLC (20:1 CH<sub>2</sub>Cl<sub>2</sub>:MeOH) to provide the title compound (84 mg, 73%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.99 (s, 1H), 4.79 (ddd, <i>J</i> = 1.0, 3.0, 9.5 Hz, 1H), 4.36 (quin, <i>J</i> = 5.8 Hz, 1H), 4.26 (q, <i>J</i> = 5.0 Hz, 1H), 3.93 (dd, <i>J</i> = 4.5, 9.5 Hz, 1H), 3.71 (s, 3H), 3.69–3.54 (m, 3H), 2.36–2.25 (m, 2H), 2.25–2.12 (m, 1H), 1.53 (t, <i>J</i> = 3.0 Hz, 1H), 1.50 (d, <i>J</i> = 6.0 Hz, 3H).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (1<i>R</i>,5<i>S</i>,6<i>S</i>)-3-{5-Cyano-6-[(2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl}-3-azabicyclo[3.1.0]hexane-6-carboxylic Acid (<b>5</b>)</h4><div class="NLM_p last">To a solution of methyl (1<i>R</i>,5<i>S</i>,6<i>S</i>)-3-(5-cyano-6-((2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl)-4-(trifluoromethyl)pyridin-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxylate (80 mg, 0.20 mmol) in EtOH (6 mL) was added 2 M aqueous NaOH (2 mL, 4 mmol). The colorless reaction solution stirred at 20 °C for 16 h. The mixture was concentrated in vacuo, and water (30 mL) was added. Then 2 M HCl was added to adjust the pH to 5, and the mixture was extracted with EtOAc (3 × 40 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. Reverse phase preparative HPLC was used to provide <b>5</b> (32 mg, 41%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.16 (s, 1H), 4.72–4.63 (m, 1H), 4.31 (quin, <i>J</i> = 5.8 Hz, 1H), 4.18–4.11 (m, 1H), 4.05–3.75 (m, 3H), 3.72–3.55 (m, 2H), 2.31–2.22 (m, 2H), 1.50 (d, <i>J</i> = 6.5 Hz, 3H), 1.44 (t, <i>J</i> = 3.0 Hz, 1H). LCMS calcd for C<sub>17</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>: 383.1, found 382.9. HPLC purity >99%.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> [(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-Benzyl-3-azabicyclo[3.1.0]hex-6-yl]acetonitrile (<b>23</b>)</h4><div class="NLM_p last">To a solution of <b>22</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (95.0 g, 396 mmol) in dry THF (1.23 L) and DMF (95 mL) was added triethylamine (241 g, 2.38 mol) at 0 °C. The mixture was stirred at 0 °C for 5 min and treated with methanesulfonyl chloride (82.22 g, 717.8 mmol) dropwise over 5 min. The mixture was stirred at 10 °C for 16 h. The reaction was quenched with addition of saturated NaHCO<sub>3</sub> (1000 mL), and then the mixture was extracted with methyl <i>tert</i>-butyl ether (5 × 500 mL). The organic phase was concentrated in vacuo to give [(1<i>R</i>,5<i>S</i>,6<i>r</i>)-3-benzyl-3-azabicyclo[3.1.0]hex-6-yl]methylmethanesulfonate (99 g, 89%) as a brown oil that was taken on without further purification. To a solution of this oil in DMF (700 mL) was added sodium cyanide (18.49 g, 377.3 mmol) at 20 °C. The mixture was stirred at 20 °C for 16 h. Saturated aqueous NaHCO<sub>3</sub> was added to the reaction (200 mL), and the mixture was extracted with methyl <i>tert</i>-butyl ether (2 × 150 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a brown oil (50 g). The brown oil was purified by column chromatography on silica gel eluting with petroleum ether/EtOAc (10:1 to 5:1) to give <b>23</b> (37 g, 73%, two steps) as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO) δ 7.42–7.02 (m, 5H), 3.54 (s, 2H), 2.87 (d, <i>J</i> = 8.5 Hz, 2H), 2.46 (d, <i>J</i> = 6.5 Hz, 2H), 2.28 (d, <i>J</i> = 8.5 Hz, 2H), 1.43–1.28 (m, 3H). LC-MS(APCI) calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub> (M + H)<sup>+</sup>: 212.1, found 213.1.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ethyl[(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-benzyl-3-azabicyclo[3.1.0]hex-6-yl]acetate</h4><div class="NLM_p last">To ethanol (215 mL) was added concentrated sulfuric acid (108 mL) at 0 °C. The mixture was stirred at 10 °C for 5 min, then recooled to 0 °C. A solution of <b>23</b> (37 g, 170 mmol) in EtOH (95 mL) was added to the mixture of EtOH and sulfuric acid at 0 °C. The mixture was stirred at 80 °C for 16 h. The mixture was adjusted to pH 9 with 5 M NaOH at 0 °C, and the product was extracted with EtOAc (5 × 500 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a yellow oil (45 g). The yellow oil was purified by column chromatography on silica gel eluting with petroleum ether/EtOAc (10:1 to 5:1) to give the title compound (37 g, 82%) as yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.36–7.15 (m, 5H), 4.04 (q, <i>J</i> = 7.0 Hz, 2H), 3.53 (s, 2H), 2.86 (d, <i>J</i> = 8.5 Hz, 2H), 2.27 (br d, <i>J</i> = 8.5 Hz, 2H), 2.17 (d, <i>J</i> = 7.5 Hz, 2H), 1.37–1.29 (m, 1H), 1.22 (br s, 2H), 1.16 (t, <i>J</i> = 7.0 Hz, 3H). LCMS (APCI) calcd for C<sub>16</sub>H<sub>21</sub>NO<sub>2</sub> (M + H)<sup>+</sup>: 260.2, found 260.1.</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Ethyl(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-azabicyclo[3.1.0]hex-6-ylacetate (<b>16</b>)</h4><div class="NLM_p last">To a solution of ethyl [(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-benzyl-3-azabicyclo[3.1.0]hex-6-yl]acetate (37 g, 140 mmol) in EtOH (1500 mL) was added 10% palladium hydroxide on carbon (5 g, 4 mmol). The mixture was degassed and refilled three times with nitrogen and degassed and then refilled for three times with hydrogen gas. The mixture was stirred under an atmosphere of hydrogen (50 PSI) at 50 °C for 16 h. The cooled reaction mixture was flushed with nitrogen, filtered, and the filter cake washed with MeOH (500 mL). The filtrate was concentrated in vacuo to give <b>16</b> (22 g, 91%) as yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.04 (q, <i>J</i> = 7.0 Hz, 2H), 2.79 (d, <i>J</i> = 11.0 Hz, 2H), 2.59 (d, <i>J</i> = 11.0 Hz, 2H), 2.21 (d, <i>J</i> = 7.0 Hz, 2H), 1.23–1.10 (m, 5H), 0.86 (tt, <i>J</i> = 3.3, 7.0 Hz, 1H). LCMS (ES<sup>+</sup>) calcd for C<sub>9</sub>H<sub>15</sub>NO<sub>2</sub> (M + H)<sup>+</sup>: 170.1, found 170.1.</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Ethyl{(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-[6-chloro-5-cyano-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetate</h4><div class="NLM_p last">A suspension of <b>9</b> (2.4 g, 9.8 mmol), <b>16</b> (1.7 g, 9.8 mmol), and NaHCO<sub>3</sub> (2.6 g, 31 mmol) in ethanol (25 mL) was stirred at rt overnight. The reaction mixture was concentrated, diluted with saturated aqueous NaHCO<sub>3</sub>, and extracted with EtOAc (3 × 25 mL). The combined organics were washed with water, dried over sodium sulfate, filtered, and concentrated. The crude was purified by silica gel chromatography (10–35% EtOAc in <i>n</i>-heptane) to afford the title compound as an off-white solid (2.2 g, 57%) which contained excess heptane (16 mol %). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.90 (s, 1H), 4.06 (q, <i>J</i> = 7 Hz, 2H), 3.86–3.73 (m, 2H), 3.60 (ddd, <i>J</i> = 4.7, 11.6, 15.3 Hz, 2H), 2.44–2.24 (m, 2H), 1.74–1.57 (m, 2H), 1.19 (t, <i>J</i> = 7.0 Hz, 3H), 0.92–0.75 (m, 1H). LCMS (ES<sup>+</sup>) calcd for C<sub>16</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 374.1, found 374.2.</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> [(1<i>R</i>,5<i>S</i>,6<i>R</i>)-3-{5-Cyano-6-[(2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic Acid (<b>6</b>)</h4><div class="NLM_p last">Ethyl{(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-[6-chloro-5-cyano-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetate (2.1 g, 5.7 mmol), <b>13</b>/(<i>R</i>)-CSA (2.0 g, 6.2 mmol), and NaHCO<sub>3</sub> (1.7 g, 20 mmol) were suspended in ethanol and stirred at 80 °C for 18 h. The reaction was diluted with saturated NaHCO<sub>3</sub> (200 mL) and extracted with EtOAc (3 × 100 mL). The combined organics were dried over sodium sulfate, filtered, and concentrated in vacuo to provide a white solid (2.5 g) that was taken forward without further purification. This solid was then treated with ethanol (80 mL) and 1 M sodium hydroxide (40 mL, 40 mmol), and the reaction was stirred at rt for 1 h. The reaction was concentrated, diluted with water (25 mL), acidified with 1 M HCl to pH 2, and extracted with EtOAc (3 × 25 mL). The combined organics were dried over sodium sulfate, filtered, and concentrated to afford a white solid. The white solid was combined with product from another preparation using the same conditions to provide 1.1 g for purification. The white solid was slurried at reflux for 3 h in MTBE/<i>n</i>-heptane and then at rt for 5 days. The slurry was then filtered and the filter cake washed with <i>n</i>-heptane to afford the title compound as a white solid (2.4 g, 73%) that contained significant amounts of MTBE and <i>n</i>-heptane. The solid was then dissolved in refluxing EtOAc and hot-filtered. The filtrate was concentrated and recrystallized from EtOAc/<i>n</i>-heptane. The solid was collected by vacuum filtration and dried in a vacuum oven at 50 °C for 2 h to afford <b>6</b> as a white solid (1.4 g, 60% recrystallization yield). mp 189.9–196.8 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (br s, 1H), 6.22 (s, 1H), 5.63 (br s, 1H), 4.54 (t, <i>J</i> = 7.6 Hz, 1H), 4.20 (quin, <i>J</i> = 5.7 Hz, 1H), 4.10–3.98 (m, 1H), 3.94–3.60 (m, 3H), 3.59–3.41 (m, 2H), 2.30–2.18 (m, 2H), 1.72–1.54 (m, 2H), 1.40 (d, <i>J</i> = 6.5 Hz, 3H), 0.74 (br s, 1H). LCMS (ES<sup>+</sup>) calcd for C<sub>18</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>: 397.1, found 397.1. HPLC: 100% purity.</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl{(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-[2-chloro-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetate (<b>25</b>)</h4><div class="NLM_p last"><b>16</b> (86 mg, 0.51 mmol) was dissolved in ethanol (1.2 mL) then NaHCO<sub>3</sub> (155 mg, 1.84 mmol) was added, followed by the dropwise addition of 2,4-dichloro-6-(trifluoromethyl)pyrimidine <b>24</b> (100 mg, 0.46 mmol). The mixture was stirred at rt for 16 h. The reaction was diluted with water and EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc (× 3). The combined organics were concentrated in vacuo, and flash column chromatography was used to provide <b>25</b> (130 mg, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.47 (s, 1H), 4.16 (q, <i>J</i> = 7.0 Hz, 2H), 4.06 (d, <i>J</i> = 12.5 Hz, 1H), 3.68–3.52 (m, 3H), 2.47–2.35 (m, 1H), 2.32–2.18 (m, 1H), 1.73–1.59 (m, 2H), 1.28 (t, <i>J</i> = 7.2 Hz, 3H), 0.93 (tt, <i>J</i> = 3.5, 7.2 Hz, 1H). LCMS(AP<sup>+</sup>) calcd for C<sub>14</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 350.1, found 349.8.</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Ethyl[(1<i>R</i>,5<i>S</i>,6<i>R</i>)-3-{2-[(2<i>S</i>,3<i>R</i>)-3-hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetate (<b>28</b>)</h4><div class="NLM_p last">A 20 mL vial was charged with <b>25</b> (130 mg, 0.37 mmol), <b>13</b>/(<i>R</i>)-CSA (160 mg, 0.52 mmol), triethylamine (0.26 mL, 1.9 mmol), and acetonitrile (2 mL). The vial was sealed and heated to 70 °C for 3 h. The reaction was cooled to rt and diluted with water and EtOAc. The layers were separated, and the aqueous layer extracted with EtOAc. The combined organic layers were concentrated in vacuo, and flash column chromatography was used to provide <b>28</b> (130 mg, 87%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 5.97 (s, 1H), 4.35–4.25 (m, 1H), 4.25–4.19 (m, 1H), 4.20–4.09 (m, 3H), 4.07–3.87 (m, 1H), 3.75 (dd, <i>J</i> = 5.0, 9.7 Hz, 1H), 3.66–3.36 (m, 3H), 2.31 (d, <i>J</i> = 6.5 Hz, 2H), 2.00–1.87 (m, 1H), 1.61–1.53 (m, 2H), 1.52 (d, <i>J</i> = 6.5 Hz, 3H), 1.28 (t, <i>J</i> = 7.0 Hz, 3H), 0.97–0.86 (m, 1H). LCMS (AP<sup>+</sup>) calcd for C<sub>18</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup>: 401.2, found 401.4.</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> [(1<i>R</i>,5<i>S</i>,6<i>R</i>)-3-{2-[(2<i>S</i>,3<i>R</i>)-3-Hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic Acid (<b>7</b>)</h4><div class="NLM_p last">A mixture of <b>28</b> (410 mg, 1.02 mmol) in ethanol (10 mL) was added to a solution of NaOH (202 mg, 4.95 mmol) in water (1.41 mL) and stirred for 4 h at rt. The reaction was concentrated to a white solid and quenched with 1 M KHSO<sub>4</sub> and diluted with EtOAc. The layers were separated, and the aqueous was extracted with EtOAc (× 4). The combined organic layers were concentrated to yield <b>7</b> (370 mg, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.97 (s, 1H), 4.30 (dd, <i>J</i> = 6.2, 9.4 Hz, 1H), 4.25–4.11 (m, 2H), 3.98 (br s, 1H), 3.75 (dd, <i>J</i> = 4.7, 9.4 Hz, 1H), 3.69–3.43 (m, 3H), 2.44–2.31 (m, 2H), 1.59 (br s, 2H), 1.52 (d, <i>J</i> = 6.2 Hz, 3H), 0.94 (tt, <i>J</i> = 3.4, 7.1 Hz, 1H). LCMS (ES<sup>–</sup>) calcd for C<sub>16</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> (M – H)<sup>-</sup>: 371.1, found 371.2. HPLC: >99% purity.</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (1<i>R</i>,5<i>S</i>,6<i>r</i>)-3-Benzyl-6-(chloromethyl)-3-azabicyclo[3.1.0]hexane</h4><div class="NLM_p last">To a stirred solution of <b>22</b> (620 g, 3.05 mol) in methanol (600 mL) was added 4 M HCl in methanol (6.2 L) at 10 °C over a period of 45 min, and the mixture was stirred for 15 min. The reaction mixture was slowly heated to 25–30 °C for 2 h. The solvent was evaporated under reduced pressure. The crude product was triturated with ether (1.5 L) to give [(1<i>R</i>,5<i>S</i>,6<i>r</i>)-3-benzyl-3-azabicyclo[3.1.0]hex-6-yl]methanol hydrochloride (703 g) as pale-brown solid which was used without further purification. To a stirred solution of this salt (699 g) in toluene (1.4 L) was added thionyl chloride (693 g, 5.83 mol) at 5–10 °C over a period of 30 min and stirred for 15 min. The reaction temperature was slowly warmed to 45 °C and stirred for 30 min. The reaction mixture was cooled to rt and concentrated under reduced pressure. The crude product was diluted with EtOAc (5 L) and saturated NaHCO<sub>3</sub> solution (3 L) and stirred for 1 h, then the layers were separated. The aqueous layer was further extracted with EtOAc (2 × 2 L). The combined organic layers were washed with brine solution (2 L), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to give the title compound (611 g, 91%) as a brown liquid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.30 (t, <i>J</i> = 7.6 Hz, 2H), 7.25–7.20 (m, 3H), 3.56–3.51 (m, 4H), 2.87 (d, <i>J</i> = 8.8 Hz, 2H), 2.29 (d, <i>J</i> = 8.8 Hz, 2H), 1.57–1.54 (m, 1H), 1.43 (br s, 2H).</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> [(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-Benzyl-3-azabicyclo[3.1.0]hex-6-yl]acetonitrile (<b>23</b>)</h4><div class="NLM_p last">To a stirred solution of (1<i>R</i>,5<i>S</i>,6<i>r</i>)-3-benzyl-6-(chloromethyl)-3-azabicyclo[3.1.0]hexane (664 g, 2.99 mol) in DMF (2.9 L) was added sodium cyanide (191 g, 3.89 mol) at rt, and the mixture was slowly heated to 50 °C for 48 h. The reaction mixture was cooled to rt, quenched with water (10 L), and extracted with EtOAc (3 × 4 L). The combined organic layers were washed with water (5 L), brine (3 L), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure. The crude product was purified using column chromatography eluting with 20% EtOAc in petroleum ether to give <b>23</b> (593 g, 93%) as a brown liquid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.32–7.26 (m, 2H), 7.26–7.20 (m, 3H), 3.54 (s, 2H), 2.87 (d, <i>J</i> = 8.8 Hz, 2H), 2.45 (d, <i>J</i> = 6.5 Hz, 2H), 2.28 (d, <i>J</i> = 8.2 Hz, 2H), 1.41–1.33 (m, 3H). GCMS calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub> (<i>m</i>/<i>z</i>): 212.1, found 212.2.</div></div><div id="sec5_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl[(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-benzyl-3-azabicyclo[3.1.0]hex-6-yl]acetate</h4><div class="NLM_p last">Acetyl chloride (2.21 kg, 28.3 mol) was added to methanol (3.77 L) at 0 °C over a period of 1 h. The reaction temperature was slowly heated to 45 °C for 30 min. The reaction mixture was again cooled to 0 °C, and a solution of <b>23</b> (400 g, 1.88 mol) in methanol (700 mL) was added over a period of 2 h at 0 °C. The resulting solution was slowly heated to 65 °C for 4 h. The reaction mixture was cooled to rt and concentrated under reduced pressure. The crude was dissolved in EtOAc (6 L) and saturated NaHCO<sub>3</sub> solution (4 L) and stirred for 1 h. The layers were separated, and the aqueous layer was further extracted with EtOAc (2 × 1 L). The combined organic layers were washed with brine solution (2 L), dried over anhydrous sodium sulfate, and evaporated under reduced pressure to give the title compound (377 g, 82%) as a brown liquid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.34–7.17 (m, 5H), 3.68 (s, 3H), 3.62–3.55 (s, 2H), 3.04–2.96 (m, 2H), 2.39–2.31 (m, 2H), 2.19 (d, <i>J</i> = 7.0 Hz, 2H), 1.54–1.50 (m, 1H), 1.24 (s, 2H).</div></div><div id="sec5_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl2-((1<i>R</i>,5<i>S</i>,6<i>S</i>)-3-azabicyclo[3.1.0]hexan-6-yl)acetate Hydrochloride (<b>26</b>·HCl)</h4><div class="NLM_p last">To a solution of methyl [(1<i>R</i>,5<i>S</i>,6<i>s</i>)-3-benzyl-3-azabicyclo[3.1.0]hex-6-yl]acetate (542 g, 2.21 mol) in methanol (550 mL) was added 4 M HCl in methanol (5.4 L) at 10 °C over a period of 30 min. The reaction mixture was warmed to rt and stirred for 2 h. The solvent was evaporated under reduced pressure. The crude product was triturated with ether (1.5 L) to give an off-white solid (545 g, 88% yield) that was used directly in the next step. The crude product (420 g, 1.49 mol) was dissolved in methanol (4 L) in an autoclave and treated with 10% Pd(OH)<sub>2</sub>/C (41.4 g, 50% wet) under nitrogen, and the autoclave was evacuated twice with nitrogen and placed under an atmosphere of hydrogen gas (100 psi) and heated to 70 °C for 8 h. The reaction mixture was cooled to rt and stirred for 4 h. The reaction mixture was filtered through a bed of Celite, washing with methanol (2 × 1 L). The filtrate was evaporated under reduced pressure. The crude product was triturated with ether (1 L) and the solids were collected by filtration to give <b>26</b>·HCl (345 g, 99% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.37 (br s, 2H), 3.60 (s, 3H), 3.27–3.15 (m, 4H), 2.31 (d, <i>J</i> = 7.0 Hz, 2H), 1.60 (br s, 2H), 1.31–1.10 (m, 1H).</div></div><div id="sec5_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl{(1<i>R</i>,5<i>S</i>,6<i>S</i>)-3-[2-chloro-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetate (<b>27</b>)</h4><div class="NLM_p last">To a solution of <b>26</b>·HCl (120.2 g, 627.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1250 mL), <b>24</b> (145.7 g, 671.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added dropwise at −72 °C; the addition funnel was washed with CH<sub>2</sub>Cl<sub>2</sub> (50 mL), and the wash was added into the reaction flask. Hünig’s base (273 mL, 1.57 mol) was added over 10 min with the reaction temperature maintained between −70 °C to −60 °C. The mixture was stirred at −65 °C to −63 °C for 1 h and then warmed to 25 °C over 3 h. The resulting clear solution was concentrated to ∼1/5 of the initial volume. To the obtained heavy slurry, MTBE (700 mL), and heptane (700 mL) were added, and the resulting slurry was stirred at 25 °C for 10 min then solids were filtered off and washed with MTBE–heptane (4:1). The combined mother liquor was concentrated in vacuo to an oil, which was combined with heptane (1.2 L). The obtained heterogeneous mixture was stirred at 25 °C for 2.5 days. A white solid formed. The liquid was decanted, and the solid was washed with heptane (200 mL) and dried under a flow of nitrogen to provide crude <b>27</b> (190 g), which was taken forward to the next step without additional purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.47 (s, 1H), 4.07 (d, <i>J</i> = 12.5 Hz, 1H), 3.71 (s, 3H), 3.68–3.53 (m, 3H), 2.49–2.36 (m, 1H), 2.34–2.21 (m, 1H), 1.73–1.60 (m, 2H), 0.93 (tt, <i>J</i> = 3.5, 7.0 Hz, 1H).</div></div><div id="sec5_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl[(1<i>R</i>,5<i>S</i>,6<i>R</i>)-3-{2-[(2<i>S</i>)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetate (<b>29</b>)</h4><div class="NLM_p last">Crude <b>27</b> was dissolved in acetonitrile (1.5 L) and (2<i>S</i>)-Me-azetidine (<b>17</b>)/(<i>R</i>)-CSA salt<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (223.0 g, 735 mmol) was added. The mixture was stirred at 60 °C, and Hünig’s base (77.0 mL, 442 mmol) was added during 3 h. The mixture was stirred for 3 h, and then Hünig’s base (180 mL, 1.03 mol) was added over 3 h and the mixture was stirred at 60 °C for 18 h. Additional (<i>S</i>)-2-Me-azetidine/(<i>R</i>)-CSA salt (18.0 g, 59 mmol) was added, and the mixture was stirred at 60 °C for another 18 h. The mixture was concentrated to ∼1/4 of the initial volume, and the resultant yellow oil was partitioned between 500 mL of water, 400 mL of heptane, and 400 mL of MTBE. The aqueous phase was separated and extracted again with MTBE–heptane (1:1) mixture (2 × 150 mL). The combined organic extract was washed with 120 mL of saturated NaHCO<sub>3</sub> (120 mL) and then stirred with silica gel (70 g) and anhydrous MgSO<sub>4</sub> (70 g). Solids were filtered off, and the clear solution was concentrated to obtain 216.6 g of <b>29</b> as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.91 (s, 1H), 4.48–4.37 (m, 1H), 4.05–3.87 (m, 3H), 3.70 (s, 3H), 3.64–3.50 (m, 1H), 3.50–3.41 (m, 2H), 2.37 (dtd, <i>J</i> = 4.7, 8.6, 10.9 Hz, 1H), 2.31 (d, <i>J</i> = 7.4 Hz, 2H), 1.93 (tdd, <i>J</i> = 6.6, 9.0, 10.9 Hz, 1H), 1.59–1.52 (m, 2H), 1.49 (d, <i>J</i> = 6.2 Hz, 3H), 0.92 (tt, <i>J</i> = 3.4, 7.1 Hz, 1H). LCMS (ES<sup>+</sup>) calcd for C<sub>17</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 371.2, found 371.1.</div></div><div id="sec5_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> [(1<i>R</i>,5<i>S</i>,6<i>R</i>)-3-{2-[(2S)-2-Methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic Acid (<b>8</b>)</h4><div class="NLM_p last">To a stirred solution of <b>29</b> (216.6 g, 584 mmol) in methanol (650 mL) was added a solution of sodium hydroxide (35.1 g, 877 mmol) in water (70 mL) in small portions under stirring at 5 to 15 °C. The mixture became clear in 30 min. The clear solution was stirred at RT for 3 h, then concentrated to ∼1/3 of the initial volume, and the residue was diluted with water (750 mL) and brine (250 mL), then washed with a mixture of MTBE (260 mL) and heptane (130 mL). The organic wash was discarded. The aqueous phase was washed with MTBE–heptane (2:1) mixture (2 × 300 mL) and the organic layers discarded. The aqueous layer was then combined with MTBE (250 mL) and heptane (250 mL) and cooled to 0 °C. Slowly under stirring at 0 to 4 °C, 6 M aq HCl (130 mL) was added, followed by 1 M aq KHSO<sub>4</sub> (150 mL), and the obtained mixture was stirred for 15 min. The organic phase was separated, and the aqueous phase was additionally extracted with a mixture of MTBE (170 mL) and heptane (170 mL). The combined organic extract was washed with water–brine (1:1) mixture (150 mL), dried over anhydrous MgSO<sub>4</sub> (60 g) and SiO<sub>2</sub> (60 g), filtered, and concentrated to give a colorless oil. It was combined (as a concentrated solution in MTBE) with another batch, which was prepared using identical conditions on the same scale. The combined MTBE solution was concentrated in vacuo, then heptane (2000 mL) was added and the suspension was concentrated again, with gradual increase of vacuum to obtain the desired product as a colorless glass (406.0 g). To obtain the crystalline form of <b>8</b>, a portion of this material (196 g) was dissolved in MTBE (220 mL) at 60–63 °C and stirred slowly, and heptane (1500 mL) was added during 20 min at 55–60 °C. The mixture was seeded with crystalline title compound (50 mg). The mixture was stirred at 60 °C for 30 min, then additional heptane (1700 mL) was added during 20 min. The heterogeneous mixture was stirred at 60 °C for 2 h and then slowly cooled to 25 °C and stirred for 20 h. A small amount of solid was stuck on the flask walls but could be easily returned into the slurry with a spatula, and the mixture was further stirred at 25 °C for 24 h. The solids were filtered off, washed with 5% MTBE in heptane, and dried in vacuo at 50 °C for 48 h to obtain <b>8</b> as a white crystalline solid (178.2 g, 73% over four steps). Note: Crystalline <b>8</b> has also been obtained using similar purification conditions without seeding. mp 122–123 °C, [α]<sub>D</sub> = +86.3° (CDCl<sub>3</sub>, <i>c</i> = 1.37). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.84 (br s, 1H), 5.92 (s, 1H), 4.51–4.38 (m, 1H), 4.10–3.89 (m, 3H), 3.66–3.53 (m, 1H), 3.53–3.41 (m, 2H), 2.46–2.30 (m, 3H), 1.94 (tdd, <i>J</i> = 7.0, 9.0, 10.9 Hz, 1H), 1.63–1.55 (m, 2H), 1.50 (d, <i>J</i> = 6.2 Hz, 3H), 0.94 (tt, <i>J</i> = 3.4,7.1 Hz, 1H). LCMS (ES<sup>+</sup>) calcd for C<sub>16</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 357.2, found 357.3. HPLC purity: 99.78%.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Animal Pharmacokinetic Studies</h3><div class="NLM_p last">All experiments involving animals were conducted in our American Animal Association Laboratory Animal Care (AAALAC)-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Male Wistar-Hannover rats (weighing 240–350 g) underwent jugular vein cannulation (JVC) surgery at BioDuro, or in-house at Pfizer Inc., (Groton, CT). Rats were housed one per cage in an AAALAC accredited facility and maintained under standard conditions of temperature (22 °C ± 2 °C), relative humidity (50%), and light and dark cycle (12/12 h). Rats were allowed to acclimate to their environment for 1 week. In-life and bioanalytical studies were conducted at BioDuro (Beijing, China) or in-house (Pfizer Inc., Groton, CT). Pharmacokinetic studies in male beagle dogs (weighing 8–10 kg) were conducted at Pfizer Inc., (Groton, CT). Dogs were housed in an AAALAC accredited facility. Rats received a 1 mg/kg intravenous dose of <b>8</b> (formulated in 10% DMSO/30% PEG400/60% water in a volume of 2 mL/kg) or a 5 mg/kg PO dose of <b>8</b> (administered as a suspension in 0.5% methyl cellulose in a volume of 5 mL/kg). Blood samples were collected in K2EDTA-treated tubes at the following time-points after dosing, 0.083, 0.25, 0.5, 1, 2, 4, 7, and 24 h via tail vein bleed. Blood samples were immediately centrifuged for plasma collection and stored at −80 °C prior to analysis of the parent compound by LC-MS/MS. Dogs (<i>n</i> = 3) received either a 1 mg/kg iv dose of <b>8</b> delivered by a volume of 0.3 mL/kg in 12.5% SBECD in 50 mM TRIS buffer (pH 8.0) or a 5 mg/kg po dose delivered by a volume of 1.5 mL/kg as a suspension in 0.5% methyl cellulose. Blood samples were collected via jugular vein into a syringe then transferred into K2EDTA-treated vacutainer tubes at the following time-points after dosing, 0.083, 0.25, 0.5, 1, 2, 4, 7, 12, 24, 48, and 72 h (IV) and 0.25, 0.5, 1, 2, 4, 7, and 24 h (PO). Blood samples were centrifuged to obtain plasma and stored at −80 °C prior to analysis of <b>8</b> by LC-MS/MS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00944" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00944?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00944</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Metabolite identification studies of compound <b>6</b>; supplementary in vitro pharmacology studies of compound <b>8</b>; in vitro selectivity data for compound <b>8</b>; maps of interactions between hKHK and compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b>; data collection of refinement statistics for the crystal structures of compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b>; procedures for growing a single crystal of <b>21</b>/(<i>R</i>)-<b>CSA</b> and associated data; HPLC traces of selected tested compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_001.pdf">jm0c00944_si_001.pdf (1.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_002.csv">jm0c00944_si_002.csv (0.83 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for hKHK bound to compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b> have been deposited to the RCSB with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0N">6W0N</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W">6W0W</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0X">6W0X</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Y">6W0Y</a>,  and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Z">6W0Z</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c00944" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kentaro Futatsugi</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3137-9212" title="Orcid link">http://orcid.org/0000-0003-3137-9212</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#96ddf3f8e2f7e4f9b8f0e3e2f7e2e5e3f1ffd6e6f0ffecf3e4b8f5f9fb"><span class="__cf_email__" data-cfemail="f5be909b8194879adb93808194818680929cb585939c8f9087db969a98">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron C. Smith</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6796-5155" title="Orcid link">http://orcid.org/0000-0001-6796-5155</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7b3a1a091415552816120f13493b0b1d12011e0955181416"><span class="__cf_email__" data-cfemail="1e5f7f6c7170304d73776a762c5e6e7877647b6c307d7173">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meihua Tu</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Raymer</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kay Ahn</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9139-1534" title="Orcid link">http://orcid.org/0000-0001-9139-1534</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven B. Coffey</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew S. Dowling</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5140-764X" title="Orcid link">http://orcid.org/0000-0002-5140-764X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dilinie P. Fernando</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jemy A. Gutierrez</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim Huard</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayasankar Jasti</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit S. Kalgutkar</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9701-756X" title="Orcid link">http://orcid.org/0000-0001-9701-756X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Knafels</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayvardhan Pandit</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Parris</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvie Perez</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Pfefferkorn</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Price</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim Ryder</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andre Shavnya</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingrid A. Stock</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andy S. Tsai</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory J. Tesz</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin A. Thuma</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Weng</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanna M. Wisniewska</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Xing</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Internal Medicine Research Unit, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Zhou</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Drug Safety R&D, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas V. Magee</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Inc. Medicine Design, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4576-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Karen Atkinson for supporting in vitro ADME studies; James Bradow for assistance with chiral separations; Yang Cong, Jeff Culp, and Tim Subashi for protein productions; Paula M. Loria for in vitro pharmacology studies; Jared Milbank for cheminformatics support; Brian Samas and Ivan Samardjiev for crystallography studies; Veena Somayaji for statistical analysis; Ka Ning Yip for assistance with solid form studies.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma concentration versus time curve</p></td></tr><tr><td class="NLM_term">CL<sub>p</sub></td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int,app</sub></td><td class="NLM_def"><p class="first last">metabolic intrinsic clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal plasma concentration</p></td></tr><tr><td class="NLM_term">CSA</td><td class="NLM_def"><p class="first last">camphorsulfonic acid</p></td></tr><tr><td class="NLM_term">CVD</td><td class="NLM_def"><p class="first last">cardiovascular disease</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">F1P</td><td class="NLM_def"><p class="first last">fructose-1-phosphate</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u,p</sub></td><td class="NLM_def"><p class="first last">unbound fraction in plasma</p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">simulated fasted intestinal fluid with bile salts</p></td></tr><tr><td class="NLM_term">GC/MS</td><td class="NLM_def"><p class="first last">gas chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hours</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go gene</p></td></tr><tr><td class="NLM_term">HFCS</td><td class="NLM_def"><p class="first last">high-fructose corn syrup</p></td></tr><tr><td class="NLM_term">HHEP</td><td class="NLM_def"><p class="first last">human hepatocytes</p></td></tr><tr><td class="NLM_term">hKHK</td><td class="NLM_def"><p class="first last">human ketohexokinase</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous administration</p></td></tr><tr><td class="NLM_term">KHK</td><td class="NLM_def"><p class="first last">ketohexokinase</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cell line</p></td></tr><tr><td class="NLM_term">Ms</td><td class="NLM_def"><p class="first last">methanesulfonyl</p></td></tr><tr><td class="NLM_term">MTBE</td><td class="NLM_def"><p class="first last">methyl <i>t</i>-butyl ether</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NAFLD</td><td class="NLM_def"><p class="first last">nonalcoholic fatty liver disease</p></td></tr><tr><td class="NLM_term">NASH</td><td class="NLM_def"><p class="first last">nonalcoholic steatohepatitis</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">PMC</td><td class="NLM_def"><p class="first last">parallel medicinal chemistry</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">rac</td><td class="NLM_def"><p class="first last">racemic</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">SBECD</td><td class="NLM_def"><p class="first last">sulfobuthylether-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar suface area</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time of first occurrence of <i>C</i><sub>max</sub></p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">uridine glucuronosyl transferase</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>dss</sub></td><td class="NLM_def"><p class="first last">steady-state volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stanhope, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyachenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGahan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otokozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beysen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerstein, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havel, P. J.</span></span> <span> </span><span class="NLM_article-title">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1172/JCI37385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1172%2FJCI37385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=19381015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=1322-1334&author=K.+L.+Stanhopeauthor=J.+M.+Schwarzauthor=N.+L.+Keimauthor=S.+C.+Griffenauthor=A.+A.+Bremerauthor=J.+L.+Grahamauthor=B.+Hatcherauthor=C.+L.+Coxauthor=A.+Dyachenkoauthor=W.+Zhangauthor=J.+P.+McGahanauthor=A.+Seibertauthor=R.+M.+Kraussauthor=S.+Chiuauthor=E.+J.+Schaeferauthor=M.+Aiauthor=S.+Otokozawaauthor=K.+Nakajimaauthor=T.+Nakanoauthor=C.+Beysenauthor=M.+K.+Hellersteinauthor=L.+Berglundauthor=P.+J.+Havel&title=Consuming+fructose-sweetened%2C+not+glucose-sweetened%2C+beverages+increases+visceral+adiposity+and+lipids+and+decreases+insulin+sensitivity+in+overweight%2Fobese+humans&doi=10.1172%2FJCI37385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span></div><div class="casAuthors">Stanhope, Kimber L.; Schwarz, Jean Marc; Keim, Nancy L.; Griffen, Steven C.; Bremer, Andrew A.; Graham, James L.; Hatcher, Bonnie; Cox, Chad L.; Dyachenko, Artem; Zhang, Wei; McGahan, John P.; Seibert, Anthony; Krauss, Ronald M.; Chiu, Sally; Schaefer, Ernst J.; Ai, Masumi; Otokozawa, Seiko; Nakajima, Katsuyuki; Nakano, Takamitsu; Beysen, Carine; Hellerstein, Marc K.; Berglund, Lars; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1322-1334</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance.  To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 wk.  Although both groups exhibited similar wt. gain during the intervention, visceral adipose vol. was significantly increased only in subjects consuming fructose.  Fasting plasma triglyceride concns. increased by approx. 10% during 10 wk of glucose consumption but not after fructose consumption.  In contrast, hepatic de novo lipogenesis (DNL) and the 23-h postprandial triglyceride AUC were increased specifically during fructose consumption.  Similarly, markers of altered lipid metab. and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concns. of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption.  In addn., fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose.  These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGNXGbG-wmzLVg90H21EOLACvtfcHk0lgRS-tbdmn1DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D&md5=aeac5902da6dc4d0ae1a023f3b22d536</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1172%2FJCI37385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI37385%26sid%3Dliteratum%253Aachs%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DGriffen%26aufirst%3DS.%2BC.%26aulast%3DBremer%26aufirst%3DA.%2BA.%26aulast%3DGraham%26aufirst%3DJ.%2BL.%26aulast%3DHatcher%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DDyachenko%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMcGahan%26aufirst%3DJ.%2BP.%26aulast%3DSeibert%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DChiu%26aufirst%3DS.%26aulast%3DSchaefer%26aufirst%3DE.%2BJ.%26aulast%3DAi%26aufirst%3DM.%26aulast%3DOtokozawa%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DBeysen%26aufirst%3DC.%26aulast%3DHellerstein%26aufirst%3DM.%2BK.%26aulast%3DBerglund%26aufirst%3DL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DConsuming%2520fructose-sweetened%252C%2520not%2520glucose-sweetened%252C%2520beverages%2520increases%2520visceral%2520adiposity%2520and%2520lipids%2520and%2520decreases%2520insulin%2520sensitivity%2520in%2520overweight%252Fobese%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D1322%26epage%3D1334%26doi%3D10.1172%2FJCI37385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swarbrick, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanhope, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havel, P. J.</span></span> <span> </span><span class="NLM_article-title">Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1017/S0007114508968252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1017%2FS0007114508968252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=18384705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlehtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=947-952&author=M.+M.+Swarbrickauthor=K.+L.+Stanhopeauthor=S.+S.+Elliottauthor=J.+L.+Grahamauthor=R.+M.+Kraussauthor=M.+P.+Christiansenauthor=S.+C.+Griffenauthor=N.+L.+Keimauthor=P.+J.+Havel&title=Consumption+of+fructose-sweetened+beverages+for+10+weeks+increases+postprandial+triacylglycerol+and+apolipoprotein-B+concentrations+in+overweight+and+obese+women&doi=10.1017%2FS0007114508968252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women</span></div><div class="casAuthors">Swarbrick, Michael M.; Stanhope, Kimber L.; Elliott, Sharon S.; Graham, James L.; Krauss, Ronald M.; Christiansen, Mark P.; Griffen, Steven C.; Keim, Nancy L.; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">947-952</span>CODEN:
                <span class="NLM_cas:coden">BJNUAV</span>;
        ISSN:<span class="NLM_cas:issn">0007-1145</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Fructose consumption in the USA has increased over the past three decades.  During this time, obesity, insulin resistance and the metabolic syndrome have also increased in prevalence.  While diets high in fructose have been shown to promote insulin resistance and increase TAG concns. in animals, there are insufficient data available regarding the long-term metabolic effects of fructose consumption in humans.  The objective of the present study was to investigate the metabolic effects of 10-wk consumption of fructose-sweetened beverages in human subjects under energy-balanced conditions in a controlled research setting.  Following a 4-wk wt.-maintaining complex carbohydrate diet, seven overweight or obese (BMI 26·8-33·3 kg/m2) postmenopausal women were fed an isoenergetic intervention diet, which included a fructose-sweetened beverage with each meal, for 10 wk.  The intervention diet provided 15 % of energy from protein, 30 % from fat and 55 % from carbohydrate (30 % complex carbohydrate, 25 % fructose).  Fasting and postprandial glucose, insulin, TAG and apoB concns. were measured.  Fructose consumption increased fasting glucose concns. and decreased meal-assocd. glucose and insulin responses (P = 0·0002, P = 0·007 and P = 0·013, resp.).  Moreover, after 10 wk of fructose consumption, 14 h postprandial TAG profiles were significantly increased, with the area under the curve at 10 wk being 141 % higher than at baseline (P = 0·04).  Fructose also increased fasting apoB concns. by 19 % (P = 0·043 v. baseline).  In summary, consumption of fructose-sweetened beverages increased postprandial TAG and fasting apoB concns., and the present results suggest that long-term consumption of diets high in fructose could lead to an increased risk of CVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxN4Z-TVdcwbVg90H21EOLACvtfcHk0ljLbwpBpQmaBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlehtrrM&md5=f2a74325880c3ce3aeaf732521cf4f5c</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1017%2FS0007114508968252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114508968252%26sid%3Dliteratum%253Aachs%26aulast%3DSwarbrick%26aufirst%3DM.%2BM.%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DElliott%26aufirst%3DS.%2BS.%26aulast%3DGraham%26aufirst%3DJ.%2BL.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DChristiansen%26aufirst%3DM.%2BP.%26aulast%3DGriffen%26aufirst%3DS.%2BC.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DConsumption%2520of%2520fructose-sweetened%2520beverages%2520for%252010%2520weeks%2520increases%2520postprandial%2520triacylglycerol%2520and%2520apolipoprotein-B%2520concentrations%2520in%2520overweight%2520and%2520obese%2520women%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2008%26volume%3D100%26spage%3D947%26epage%3D952%26doi%3D10.1017%2FS0007114508968252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmalek, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unalp-Arida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, A. M.</span></span> <span> </span><span class="NLM_article-title">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1961</span>– <span class="NLM_lpage">1971</span>, <span class="refDoi"> DOI: 10.1002/hep.23535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Fhep.23535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=20301112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1961-1971&author=M.+F.+Abdelmalekauthor=A.+Suzukiauthor=C.+Guyauthor=A.+Unalp-Aridaauthor=R.+Colvinauthor=R.+J.+Johnsonauthor=A.+M.+Diehl&title=Increased+fructose+consumption+is+associated+with+fibrosis+severity+in+patients+with+nonalcoholic+fatty+liver+disease&doi=10.1002%2Fhep.23535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span></div><div class="casAuthors">Abdelmalek, Manal F.; Suzuki, Ayako; Guy, Cynthia; Unalp-Arida, Aynur; Colvin, Ryan; Johnson, Richard J.; Diehl, Anna Mae</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1961-1971</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption.  Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls.  Because fructose elicits metabolic perturbations that may be hepatotoxic, we investigated the relationship between fructose consumption and disease severity in NAFLD.  We studied 427 adults enrolled in the NASH Clin. Research Network for whom Block food questionnaire data were collected within 3 mo of a liver biopsy.  Fructose consumption was estd. based on reporting (frequency × amt.) of Kool-aid, fruit juices, and nondietary soda intake, expressed as servings per wk, and classified into none, min. to moderate (<7 servings/wk), and daily (≥7 servings/wk).  The assocn. of fructose intake with metabolic and histol. features of NAFLD was analyzed using multiple linear and ordinal logistic regression analyses with and without controlling for other confounding factors.  Increased fructose consumption was univariately assocd. with decreased age (P < 0.0001), male sex (P < 0.0001), hypertriglyceridemia (P < 0.04), low high-d. lipoprotein (HDL) cholesterol (<0.0001), decreased serum glucose (P < 0.001), increased calorie intake (P < 0.0001), and hyperuricemia (P < 0.0001).  After controlling for age, sex, BMI, and total calorie intake, daily fructose consumption was assocd. with lower steatosis grade and higher fibrosis stage (P < 0.05 for each).  In older adults (age ≥ 48 years), daily fructose consumption was assocd. with increased hepatic inflammation (P < 0.05) and hepatocyte ballooning (P = 0.05).  Conclusion: In patients with NAFLD, daily fructose ingestion is assocd. with reduced hepatic steatosis but increased fibrosis.  These results identify a readily modifiable environmental risk factor that may ameliorate disease progression in patients with NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoelIWrtgd0ZrVg90H21EOLACvtfcHk0ljLbwpBpQmaBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D&md5=7b9b16653f15980048b9bc3148262989</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1002%2Fhep.23535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.23535%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DC.%26aulast%3DUnalp-Arida%26aufirst%3DA.%26aulast%3DColvin%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26aulast%3DDiehl%26aufirst%3DA.%2BM.%26atitle%3DIncreased%2520fructose%2520consumption%2520is%2520associated%2520with%2520fibrosis%2520severity%2520in%2520patients%2520with%2520nonalcoholic%2520fatty%2520liver%2520disease%26jtitle%3DHepatology%26date%3D2010%26volume%3D51%26spage%3D1961%26epage%3D1971%26doi%3D10.1002%2Fhep.23535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nseir, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosovski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assy, N.</span></span> <span> </span><span class="NLM_article-title">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2009.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.jhep.2009.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=19765850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2009&pages=918-924&author=A.+Abidauthor=O.+Tahaauthor=W.+Nseirauthor=R.+Farahauthor=M.+Grosovskiauthor=N.+Assy&title=Soft+drink+consumption+is+associated+with+fatty+liver+disease+independent+of+metabolic+syndrome&doi=10.1016%2Fj.jhep.2009.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span></div><div class="casAuthors">Abid, Ali; Taha, Ola; Nseir, William; Farah, Raymond; Grosovski, Maria; Assy, Nimer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">918-924</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background/Aims: The independent role of soft drink consumption in non-alc. fatty liver disease (NAFLD) patients remains unclear.  We aimed to assess the assocn. between consumption of soft drinks and fatty liver in patients with or without metabolic syndrome.  Methods: We recruited 31 patients (age: 43 ± 12 years) with NAFLD and risk factors for metabolic syndrome, 29 patients with NAFLD and without risk factors for metabolic syndrome, and 30 gender- and age-matched individuals without NAFLD.  The degree of fatty infiltration was measured by ultrasound.  Data on phys. activity and intake of food and soft drinks were collected during two 7-day periods over 6 mo using a food questionnaire.  Insulin resistance, inflammation, and oxidant-antioxidant markers were measured.  Results: We found that 80% of patients with NAFLD had excessive intake of soft drink beverages (>500 cm3/day) compared to 17% of healthy controls (p < 0.001).  The NAFLD group consumed five times more carbohydrates from soft drinks compared to healthy controls (40% vs. 8%, p < 0.001).  Seven percent of patients consumed one soft drink per day, 55% consumed two or three soft drinks per day, and 38% consumed more than four soft drinks per day for most days and for the 6-mo period.  The most common soft drinks were Coca-Cola (regular: 32%; diet: 21%) followed by fruit juices (47%).  Patients with NAFLD with metabolic syndrome had similar malonyldialdehyde, paraoxonase, and C-reactive protein (CRP) levels but higher homeostasis model assessment (HOMA) and higher ferritin than NAFLD patients without metabolic syndrome (HOMA: 8.3 ± 8 vs. 3.7 ± 3.7 mg/dL, p < 0.001; ferritin: 186 ± 192 vs. 87 ± 84 mg/dL, p < 0.01).  Logistic regression anal. showed that soft drink consumption is a strong predictor of fatty liver (odds ratio: 2.0; p < 0.04) independent of metabolic syndrome and CRP level.  Conclusions: NAFLD patients display higher soft drink consumption independent of metabolic syndrome diagnosis.  These findings might optimize NAFLD risk stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMa47NLmenfrVg90H21EOLACvtfcHk0lgV1_kzQ1aTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM&md5=3d004438b6f78fc3a33d11c058d2ebd4</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2009.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2009.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%26aufirst%3DA.%26aulast%3DTaha%26aufirst%3DO.%26aulast%3DNseir%26aufirst%3DW.%26aulast%3DFarah%26aufirst%3DR.%26aulast%3DGrosovski%26aufirst%3DM.%26aulast%3DAssy%26aufirst%3DN.%26atitle%3DSoft%2520drink%2520consumption%2520is%2520associated%2520with%2520fatty%2520liver%2520disease%2520independent%2520of%2520metabolic%2520syndrome%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D51%26spage%3D918%26epage%3D924%26doi%3D10.1016%2Fj.jhep.2009.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colditz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stampfer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1001/jama.292.8.927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1001%2Fjama.292.8.927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=15328324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFWgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2004&pages=927-934&author=M.+B.+Schulzeauthor=J.+E.+Mansonauthor=D.+S.+Ludwigauthor=G.+A.+Colditzauthor=M.+J.+Stampferauthor=W.+C.+Willettauthor=F.+B.+Hu&title=Sugar-sweetened+beverages%2C+weight+gain%2C+and+incidence+of+type+2+diabetes+in+young+and+middle-aged+women&doi=10.1001%2Fjama.292.8.927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women</span></div><div class="casAuthors">Schulze, Matthias B.; Manson, JoAnn E.; Ludwig, David S.; Colditz, Graham A.; Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Context: Sugar-sweetened beverages like soft drinks and fruit punches contain large amts. of readily absorbable sugars and may contribute to wt. gain and an increased risk of type 2 diabetes, but these relationships have been minimally addressed in adults.  Objective: To examine the assocn. between consumption of sugar-sweetened beverages and wt. change and risk of type 2 diabetes in women.  Design, Setting, and Participants: Prospective cohort analyses conducted from 1991 to 1999 among women in the Nurses' Health Study II.  The diabetes anal. included 91 249 women free of diabetes and other major chronic diseases at baseline in 1991.  The wt. change anal. included 51 603 women for whom complete dietary information and body wt. were ascertained in 1991, 1995, and 1999.  We identified 741 incident cases of confirmed type 2 diabetes during 716300 person-years of follow-up.  Main Outcome Measures: Wt. gain and incidence of type 2 diabetes.  Results: Those with stable consumption patterns had no difference in wt. gain, but wt. gain over a 4-yr period was highest among women who increased their sugar-sweetened soft drink consumption from 1 or fewer drinks per wk to 1 or more drinks per day (multivariate-adjusted means, 4.69 kg for 1991 to 1995 and 4.20 kg for 1995 to 1999) and was smallest among women who decreased their intake (1.34 and 0.15 kg for the 2 periods, resp.) after adjusting for lifestyle and dietary confounders.  Increased consumption of fruit punch was also assocd. with greater wt. gain compared with decreased consumption.  After adjustment for potential confounders, women consuming 1 or more sugar-sweetened soft drinks per day had a relative risk [RR] of type 2 diabetes of 1.83 (95% confidence interval [CI], 1.42-2.36; P<.001 for trend) compared with those who consumed less than 1 of these beverages per mo.  Similarly, consumption of fruit punch was assocd. with increased diabetes risk (RR for ≥1 drink per day compared with <1 drink per mo, 2.00; 95% CI, 1.33-3.03; P=.001).  Conclusion: Higher consumption of sugar-sweetened beverages is assocd. with a greater magnitude of wt. gain and an increased risk for development of type 2 diabetes in women, possibly by providing excessive calories and large amts. of rapidly absorbable sugars.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaCEtMGRlfQbVg90H21EOLACvtfcHk0lgV1_kzQ1aTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFWgsbw%253D&md5=b6a432095b16c6961b68dbbe40d5e0ad</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1001%2Fjama.292.8.927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.292.8.927%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DM.%2BB.%26aulast%3DManson%26aufirst%3DJ.%2BE.%26aulast%3DLudwig%26aufirst%3DD.%2BS.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DStampfer%26aufirst%3DM.%2BJ.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DSugar-sweetened%2520beverages%252C%2520weight%2520gain%252C%2520and%2520incidence%2520of%2520type%25202%2520diabetes%2520in%2520young%2520and%2520middle-aged%2520women%26jtitle%3DJAMA%26date%3D2004%26volume%3D292%26spage%3D927%26epage%3D934%26doi%3D10.1001%2Fjama.292.8.927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meigs, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Agostino, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaziano, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasan, R. S.</span></span> <span> </span><span class="NLM_article-title">Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.689935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1161%2FCIRCULATIONAHA.107.689935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=17646581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A280%3ADC%252BD2svksF2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=480-488&author=R.+Dhingraauthor=L.+Sullivanauthor=P.+F.+Jacquesauthor=T.+J.+Wangauthor=C.+S.+Foxauthor=J.+B.+Meigsauthor=R.+B.+D%E2%80%99Agostinoauthor=J.+M.+Gazianoauthor=R.+S.+Vasan&title=Soft+drink+consumption+and+risk+of+developing+cardiometabolic+risk+factors+and+the+metabolic+syndrome+in+middle-aged+adults+in+the+community&doi=10.1161%2FCIRCULATIONAHA.107.689935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community</span></div><div class="casAuthors">Dhingra Ravi; Sullivan Lisa; Jacques Paul F; Wang Thomas J; Fox Caroline S; Meigs James B; D'Agostino Ralph B; Gaziano J Michael; Vasan Ramachandran S</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">480-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Consumption of soft drinks has been linked to obesity in children and adolescents, but it is unclear whether it increases metabolic risk in middle-aged individuals.  METHODS AND RESULTS:  We related the incidence of metabolic syndrome and its components to soft drink consumption in participants in the Framingham Heart Study (6039 person-observations, 3470 in women; mean age 52.9 years) who were free of baseline metabolic syndrome.  Metabolic syndrome was defined as the presence of > or = 3 of the following: waist circumference > or = 35 inches (women) or > or = 40 inches (men); fasting blood glucose > or = 100 mg/dL; serum triglycerides > or = 150 mg/dL; blood pressure > or = 135/85 mm Hg; and high-density lipoprotein cholesterol < 40 mg/dL (men) or < 50 mg/dL (women).  Multivariable models included adjustments for age, sex, physical activity, smoking, dietary intake of saturated fat, trans fat, fiber, magnesium, total calories, and glycemic index.  Cross-sectionally, individuals consuming > or = 1 soft drink per day had a higher prevalence of metabolic syndrome (odds ratio [OR], 1.48; 95% CI, 1.30 to 1.69) than those consuming < 1 drink per day.  On follow-up (mean of 4 years), new-onset metabolic syndrome developed in 717 of 4033 participants (17.8%) consuming < 1 drink/day and in 433 of 2006 persons (21.6%) [corrected] consuming > or = 1 soft drink/day [corrected] Consumption of > or = 1 soft drink per day was associated with increased odds of developing metabolic syndrome (OR, 1.44; 95% CI, 1.20 to 1.74), obesity (OR, 1.31; 95% CI, 1.02 to 1.68), increased waist circumference (OR, 1.30; 95% CI, 1.09 to 1.56), impaired fasting glucose (OR, 1.25; 95% CI, 1.05 to 1.48), higher blood pressure (OR, 1.18; 95% CI, 0.96 to 1.44), hypertriglyceridemia (OR, 1.25; 95% CI, 1.04 to 1.51), and low high-density lipoprotein cholesterol (OR, 1.32; 95% CI 1.06 to 1.64).  CONCLUSIONS:  In middle-aged adults, soft drink consumption is associated with a higher prevalence and incidence of multiple metabolic risk factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVqQi9e4v6oBBrI9DTGjC0fW6udTcc2eY46h-0UGYs4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svksF2msA%253D%253D&md5=9114e05da09665b85de1308d37fb5ce4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.689935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.689935%26sid%3Dliteratum%253Aachs%26aulast%3DDhingra%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DL.%26aulast%3DJacques%26aufirst%3DP.%2BF.%26aulast%3DWang%26aufirst%3DT.%2BJ.%26aulast%3DFox%26aufirst%3DC.%2BS.%26aulast%3DMeigs%26aufirst%3DJ.%2BB.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%2BB.%26aulast%3DGaziano%26aufirst%3DJ.%2BM.%26aulast%3DVasan%26aufirst%3DR.%2BS.%26atitle%3DSoft%2520drink%2520consumption%2520and%2520risk%2520of%2520developing%2520cardiometabolic%2520risk%2520factors%2520and%2520the%2520metabolic%2520syndrome%2520in%2520middle-aged%2520adults%2520in%2520the%2520community%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3D480%26epage%3D488%26doi%3D10.1161%2FCIRCULATIONAHA.107.689935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccavello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkin-Cakmak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noworolski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span> <span> </span><span class="NLM_article-title">Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2016.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.atherosclerosis.2016.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=27451002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Slu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=2016&pages=171-177&author=A.+Gugliucciauthor=R.+H.+Lustigauthor=R.+Caccavelloauthor=A.+Erkin-Cakmakauthor=S.+M.+Noworolskiauthor=V.+W.+Taiauthor=M.+J.+Wenauthor=K.+Mulliganauthor=J.+M.+Schwarz&title=Short-term+isocaloric+fructose+restriction+lowers+apoC-III+levels+and+yields+less+atherogenic+lipoprotein+profiles+in+children+with+obesity+and+metabolic+syndrome&doi=10.1016%2Fj.atherosclerosis.2016.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome</span></div><div class="casAuthors">Gugliucci, Alejandro; Lustig, Robert H.; Caccavello, Russell; Erkin-Cakmak, Ayca; Noworolski, Susan M.; Tai, Viva W.; Wen, Michael J.; Mulligan, Kathleen; Schwarz, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">171-177</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dietary fructose may play a role in the pathogenesis of metabolic syndrome (MetS).  In a recently published study of obese children with MetS, we showed that isocaloric fructose restriction reduced fasting triglyceride (TG) and LDL-cholesterol (LDL-C).  In these ancillary analyses, we tested the hypothesis that these effects were also accompanied by improved quant. and qual. changes in LDL and HDL subclasses and their apolipoproteins; as well as change in VLDL, particularly apoC-III.  Obese children with MetS (n = 37) consumed a diet that matched self-reported macronutrient compn. for nine days, with the exception that dietary fructose was reduced from 11.7 ± 4.0% to 3.8 ± 0.5% of daily calories and substituted with glucose (in starch).  Participants underwent fasting biochem. analyses on Days 0 and 10.  HDL and LDL subclasses were analyzed using the Lipoprint HDL and LDL subfraction anal. systems from Quantimetrix.  Significant redns. in apoB (78 ± 24 vs. 66 ± 24 mg/dL) apoC-III (8.7 ± 3.5 vs. 6.5 ± 2.6 mg/dL) and apoE (4.6 ± 2.3 vs. 3.6 ± 1.1 mg/dL), all p < 0.001) were obsd.  LDL size increased by 0.87 Å (p = 0.008).  Small dense LDL was present in 25% of our cohort and decreased by 68% (p = 0.04).  Small HDL decreased by 2.7% (p < 0.001) and large HDL increased by 2.4% (p = 0.04).  The TG/HDL-C ratio decreased from 3.1 ± 2.5 to 2.4 ± 1.4 (p = 0.02).  These changes in fasting lipid profiles correlated with changes in insulin sensitivity.  Isocaloric fructose restriction for 9 days improved lipoprotein markers of CVD risk in children with obesity and MetS.  The most dramatic redn. was seen for apoC-III, which has been assocd. with atherogenic hypertriglyceridemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFIEndRHyndbVg90H21EOLACvtfcHk0lioQ3Z3tGx2hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Slu7zM&md5=532e7940e97a54cecf0f1ee95e39722d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2016.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2016.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DMulligan%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26atitle%3DShort-term%2520isocaloric%2520fructose%2520restriction%2520lowers%2520apoC-III%2520levels%2520and%2520yields%2520less%2520atherogenic%2520lipoprotein%2520profiles%2520in%2520children%2520with%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DAtherosclerosis%26date%3D2016%26volume%3D253%26spage%3D171%26epage%3D177%26doi%3D10.1016%2Fj.atherosclerosis.2016.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noworolski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkin-Cakmak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span> <span> </span><span class="NLM_article-title">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span>. <i>Obesity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1002/oby.21371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Foby.21371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=26499447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=453-460&author=R.+H.+Lustigauthor=K.+Mulliganauthor=S.+M.+Noworolskiauthor=V.+W.+Taiauthor=M.+J.+Wenauthor=A.+Erkin-Cakmakauthor=A.+Gugliucciauthor=J.+M.+Schwarz&title=Isocaloric+fructose+restriction+and+metabolic+improvement+in+children+with+obesity+and+metabolic+syndrome&doi=10.1002%2Foby.21371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span></div><div class="casAuthors">Lustig, Robert H.; Mulligan, Kathleen; Noworolski, Susan M.; Tai, Viva W.; Wen, Michael J.; Erkin-Cakmak, Ayca; Gugliucci, Alejandro; Schwarz, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Dietary fructose is implicated in metabolic syndrome, but intervention studies are confounded by pos. caloric balance, changes in adiposity, or artifactually high amts.  This study detd. whether isocaloric substitution of starch for sugar would improve metabolic parameters in Latino (n = 27) and African-American (n = 16) children with obesity and metabolic syndrome.  Methods : Participants consumed a diet for 9 days to deliver comparable percentages of protein, fat, and carbohydrate as their self-reported diet; however, dietary sugar was reduced from 28% to 10% and substituted with starch.  Participants recorded daily wts., with calories adjusted for wt. maintenance.  Participants underwent dual-energy X-ray absorptiometry and oral glucose tolerance testing on Days 0 and 10.  Biochem. analyses were controlled for wt. change by repeated measures ANCOVA.  Results : Redns. in diastolic blood pressure (-5 mmHg; P = 0.002), lactate (-0.3 mmol/L; P < 0.001), triglyceride, and LDL-cholesterol (-46% and -0.3 mmol/L; P < 0.001) were noted.  Glucose tolerance and hyperinsulinemia improved (P < 0.001).  Wt. reduced by 0.9 ± 0.2 kg (P < 0.001) and fat-free mass by 0.6 kg (P = 0.04).  Post hoc sensitivity anal. demonstrates that results in the subcohort that did not lose wt. (n = 10) were directionally consistent.  Conclusions : Isocaloric fructose restriction improved surrogate metabolic parameters in children with obesity and metabolic syndrome irresp. of wt. change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK8UFgsIj787Vg90H21EOLACvtfcHk0lhcWNYyAU9YaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D&md5=4486cd76573a96339298ecb5b7694da8</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Foby.21371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Foby.21371%26sid%3Dliteratum%253Aachs%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DK.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26atitle%3DIsocaloric%2520fructose%2520restriction%2520and%2520metabolic%2520improvement%2520in%2520children%2520with%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DObesity%26date%3D2016%26volume%3D24%26spage%3D453%26epage%3D460%26doi%3D10.1002%2Foby.21371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noworolski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkin-Cakmak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korn, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palii, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco-Alin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, K.</span></span> <span> </span><span class="NLM_article-title">Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2017.05.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1053%2Fj.gastro.2017.05.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=28579536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVSltLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2017&pages=743-752&author=J.+M.+Schwarzauthor=S.+M.+Noworolskiauthor=A.+Erkin-Cakmakauthor=N.+J.+Kornauthor=M.+J.+Wenauthor=V.+W.+Taiauthor=G.+M.+Jonesauthor=S.+P.+Paliiauthor=M.+Velasco-Alinauthor=K.+Panauthor=B.+W.+Pattersonauthor=A.+Gugliucciauthor=R.+H.+Lustigauthor=K.+Mulligan&title=Effects+of+dietary+fructose+restriction+on+liver+fat%2C+de+novo+lipogenesis%2C+and+insulin+kinetics+in+children+with+obesity&doi=10.1053%2Fj.gastro.2017.05.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity</span></div><div class="casAuthors">Schwarz, Jean-Marc; Noworolski, Susan M.; Erkin-Cakmak, Ayca; Korn, Natalie J.; Wen, Michael J.; Tai, Viva W.; Jones, Grace M.; Palii, Sergiu P.; Velasco-Alin, Moises; Pan, Karen; Patterson, Bruce W.; Gugliucci, Alejandro; Lustig, Robert H.; Mulligan, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">743-752</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Consumption of sugar is assocd. with obesity, type 2 diabetes mellitus, nonalcoholic fatty liver disease, and cardiovascular disease.  The conversion of fructose to fat in liver (de novo lipogenesis [DNL]) may be a modifiable pathogenetic pathway.  We detd. the effect of 9 days of isocaloric fructose restriction on DNL, liver fat, visceral fat (VAT), s.c. fat, and insulin kinetics in obese Latino and African American children with habitual high sugar consumption (fructose intake >50 g/d).  Children (9-18 years old; n = 41) had all meals provided for 9 days with the same energy and macronutrient compn. as their std. diet, but with starch substituted for sugar, yielding a final fructose content of 4% of total kilocalories.  Metabolic assessments were performed before and after fructose restriction.  Liver fat, VAT, and s.c. fat were detd. by magnetic resonance spectroscopy and imaging.  The fractional DNL area under the curve value was measured using stable isotope tracers and gas chromatog./mass spectrometry.  Insulin kinetics were calcd. from oral glucose tolerance tests.  Paired analyses compared change from day 0 to day 10 within each child.  Compared with baseline, on day 10, liver fat decreased from a median of 7.2% (interquartile range [IQR], 2.5%-14.8%) to 3.8% (IQR, 1.7%-15.5%) (P < .001) and VAT decreased from 123 cm3 (IQR, 85-145 cm3) to 110 cm3 (IQR, 84-134 cm3) (P < .001).  The DNL area under the curve decreased from 68% (IQR, 46%-83%) to 26% (IQR, 16%-37%) (P < .001).  Insulin kinetics improved (P < .001).  These changes occurred irresp. of baseline liver fat.  Short-term (9 days) isocaloric fructose restriction decreased liver fat, VAT, and DNL, and improved insulin kinetics in children with obesity.  These findings support efforts to reduce sugar consumption.  ClinicalTrials.gov No.: NCT01200043.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrBB4uX9noIrVg90H21EOLACvtfcHk0lhcWNYyAU9YaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVSltLbI&md5=5883c71c9e7e945b78c05f044955f164</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2017.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2017.05.043%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DKorn%26aufirst%3DN.%2BJ.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DJones%26aufirst%3DG.%2BM.%26aulast%3DPalii%26aufirst%3DS.%2BP.%26aulast%3DVelasco-Alin%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DK.%26aulast%3DPatterson%26aufirst%3DB.%2BW.%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DK.%26atitle%3DEffects%2520of%2520dietary%2520fructose%2520restriction%2520on%2520liver%2520fat%252C%2520de%2520novo%2520lipogenesis%252C%2520and%2520insulin%2520kinetics%2520in%2520children%2520with%2520obesity%26jtitle%3DGastroenterology%26date%3D2017%26volume%3D153%26spage%3D743%26epage%3D752%26doi%3D10.1053%2Fj.gastro.2017.05.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cori, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochoa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slein, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cori, C. F.</span></span> <span> </span><span class="NLM_article-title">The metabolism of fructose in liver; isolation of fructose-I-phosphate and inorganic pyrophosphate</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1016/0006-3002(51)90032-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2F0006-3002%2851%2990032-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=14858418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaG38XlvFSl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1951&pages=304-317&author=G.+T.+Coriauthor=S.+Ochoaauthor=M.+W.+Sleinauthor=C.+F.+Cori&title=The+metabolism+of+fructose+in+liver%3B+isolation+of+fructose-I-phosphate+and+inorganic+pyrophosphate&doi=10.1016%2F0006-3002%2851%2990032-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of fructose in liver. Isolation of fructose-1-phosphate and inorganic pyrophosphate</span></div><div class="casAuthors">Cori, Gerty T.; Ochoa, Severo; Slein, Milton W.; Cori, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">304-17</span>CODEN:
                <span class="NLM_cas:coden">BBACAQ</span>;
        ISSN:<span class="NLM_cas:issn">0006-3002</span>.
    </div><div class="casAbstract">cf. Leuthardt and Testa, C.A. 45, 8568f.  The conversion of fructose to glucose in liver homogenates involves the intermediary formation of fructose-1-phosphate.  The latter accumulates in soln. in the presence of fluoride, and was characterized polarimetrically, by chemical tests, and by comparison with a synthetic sample.  Inorg. pyrophosphate was also formed.  A protein fraction pptd. from liver exts. catalyzes the conversion of fructose-1-phosphate to hexose-6-phosphate.  This reaction is accelerated by Mg and inhibited by fluoride.  In liver homogenate the hexose-6-phosphate is dephosphorylated to glucose and inorg. phosphate.  The mechanism leading to the formation of the isolated intermediate is therefore fully explained.  The formation of fructose-1-phosphate was also studied, and found not to be inhibited by glucose.  The responsible enzyme, liver fructokinase, is more active in aerobic systems with small amts. of adenosine triphosphate (ATP) than in anaerobic systems with excess ATP.  A summary of all enzymic processes concerned with fructose metabolism is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphi8XNP7_EsrVg90H21EOLACvtfcHk0liQj0wcMuVBAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XlvFSl&md5=6549bfe3a28d3862d6a37d4f80233985</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2F0006-3002%2851%2990032-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3002%252851%252990032-7%26sid%3Dliteratum%253Aachs%26aulast%3DCori%26aufirst%3DG.%2BT.%26aulast%3DOchoa%26aufirst%3DS.%26aulast%3DSlein%26aufirst%3DM.%2BW.%26aulast%3DCori%26aufirst%3DC.%2BF.%26atitle%3DThe%2520metabolism%2520of%2520fructose%2520in%2520liver%253B%2520isolation%2520of%2520fructose-I-phosphate%2520and%2520inorganic%2520pyrophosphate%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1951%26volume%3D7%26spage%3D304%26epage%3D317%26doi%3D10.1016%2F0006-3002%2851%2990032-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmann, B.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1631</span>, <span class="refDoi"> DOI: 10.1093/hmg/3.9.1627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1093%2Fhmg%2F3.9.1627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=7833921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=1627-1631&author=D.+T.+Bonthronauthor=N.+Bradyauthor=I.+A.+Donaldsonauthor=B.+Steinmann&title=Molecular+basis+of+essential+fructosuria%3A+molecular+cloning+and+mutational+analysis+of+human+ketohexokinase+%28fructokinase%29&doi=10.1093%2Fhmg%2F3.9.1627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span></div><div class="casAuthors">Bonthron, David T.; Brady, Nicola; Donaldson, Iain A.; Steinmann, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1627-31</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    </div><div class="casAbstract">Essential fructosuria is one of the oldest known inborn errors of metab.  It is a benign condition which is believed to result from deficiency of hepatic fructokinase (ketohexokinase, KHK, E.C.2.7.1.3.).  This enzyme catalyzes the first step of metab. of dietary fructose, conversion of fructose to fructose-1-phosphate.  Despite the early recognition of this disorder, the primary structure of human KHK and the mol. basis of essential fructosuria have not been previously defined.  In this report, the isolation and sequencing of full-length cDNA clones encoding human ketohexokinase are described.  Alternative mRNA species and alternative KHK isoenzymes are produced by alternative polyadenylation and splicing of the KHK gene.  The KHK proteins show a high level of sequence conservation relative to rat KHK.  Direct evidence that mutation of the KHK structural gene is the cause of essential fructosuria was also obtained.  In a well-characterized family, in which 3 of 8 siblings have fructosuria, all affected individuals are compd. heterozygotes for 2 mutations Gly40Arg and Ala43Thr.  Both mutations result from G→A transitions, and each alters the same conserved region of the KHK protein.  Neither mutation was seen in a sample of 52 unrelated control individuals.  An addnl. conservative amino acid change (Val49IIe) was present on the KHK allele bearing Ala43Thr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhKZtroZ3uLVg90H21EOLACvtfcHk0liQj0wcMuVBAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D&md5=1e3f908a2d87d3a49c4897aa84ac3345</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F3.9.1627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F3.9.1627%26sid%3Dliteratum%253Aachs%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DBrady%26aufirst%3DN.%26aulast%3DDonaldson%26aufirst%3DI.%2BA.%26aulast%3DSteinmann%26aufirst%3DB.%26atitle%3DMolecular%2520basis%2520of%2520essential%2520fructosuria%253A%2520molecular%2520cloning%2520and%2520mutational%2520analysis%2520of%2520human%2520ketohexokinase%2520%2528fructokinase%2529%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1994%26volume%3D3%26spage%3D1627%26epage%3D1631%26doi%3D10.1093%2Fhmg%2F3.9.1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hers, H. G.</span></span> <span> </span><span class="NLM_article-title">Liver fructokinase</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/0006-3002(52)90067-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2F0006-3002%2852%2990067-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=13208667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaG38Xkt1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1952&pages=416-423&author=H.+G.+Hers&title=Liver+fructokinase&doi=10.1016%2F0006-3002%2852%2990067-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Fructokinase of liver</span></div><div class="casAuthors">Hers, H. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">416-23</span>CODEN:
                <span class="NLM_cas:coden">BBACAQ</span>;
        ISSN:<span class="NLM_cas:issn">0006-3002</span>.
    </div><div class="casAbstract">An enzyme (I), catalyzing the phosphorylation of fructose and sorbose with the aid of adenosine triphosphate, and inactive toward aldohexoses, has been purified from beef liver.  The product of the fructokinase reaction has been isolated and identified as fructose I-phosphate.  It is probable that sorbose 1-phosphate is formed when sorbose is phosphorytated by I.  I is inactive in the absence of Mg or Mn and is strongly activated by M AcOK or KCl.  Between 5.5 and 7.8, the pH does not influence the rate of the reaction.  The affinity of I for fructose is large, the Michaelis const. being certainly lower than 5 × 10-4 M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQiCFXFq1bV7Vg90H21EOLACvtfcHk0liyFOjBKt1cyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38Xkt1Gkug%253D%253D&md5=3e916eaef4953444fbe6a378a7de4a62</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2F0006-3002%2852%2990067-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3002%252852%252990067-X%26sid%3Dliteratum%253Aachs%26aulast%3DHers%26aufirst%3DH.%2BG.%26atitle%3DLiver%2520fructokinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1952%26volume%3D8%26spage%3D416%26epage%3D423%26doi%3D10.1016%2F0006-3002%2852%2990067-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanaspa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclean, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asipu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal-Jimenez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Iturbe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Lozada, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautin, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. J.</span></span> <span> </span><span class="NLM_article-title">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4325</span>, <span class="refDoi"> DOI: 10.1073/pnas.1119908109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1073%2Fpnas.1119908109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=22371574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=4320-4325&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=M.+T.+Leauthor=G.+E.+Garciaauthor=C.+P.+Diggleauthor=P.+S.+Macleanauthor=M.+R.+Jackmanauthor=A.+Asipuauthor=C.+A.+Roncal-Jimenezauthor=T.+Kosugiauthor=C.+J.+Rivardauthor=S.+Maruyamaauthor=B.+Rodriguez-Iturbeauthor=L.+G.+Sanchez-Lozadaauthor=D.+T.+Bonthronauthor=Y.+Y.+Sautinauthor=R.+J.+Johnson&title=Opposing+effects+of+fructokinase+C+and+A+isoforms+on+fructose-induced+metabolic+syndrome+in+mice&doi=10.1073%2Fpnas.1119908109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Le, My Phuong T.; Garcia, Gabriela E.; Diggle, Christine P.; MacLean, Paul S.; Jackman, Matthew R.; Asipu, Aruna; Roncal-Jimenez, Carlos A.; Kosugi, Tomoki; Rivard, Christopher J.; Maruyama, Shoichi; Rodriguez-Iturbe, Bernardo; Snchez-Lozada, Laura G.; Bonthron, David T.; Sautin, Yuri Y.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4325, S4320/1-S4320/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fructose intake from added sugars correlates with the epidemic rise in obesity, metabolic syndrome, and nonalcoholic fatty liver disease.  Fructose intake also causes features of metabolic syndrome in lab. animals and humans.  The first enzyme in fructose metab. is fructokinase, which exists as two isoforms, A and C.  Here we show that fructose-induced metabolic syndrome is prevented in mice lacking both isoforms but is exacerbated in mice lacking fructokinase A.  Fructokinase C is expressed primarily in liver, intestine, and kidney and has high affinity for fructose, resulting in rapid metab. and marked ATP depletion.  In contrast, fructokinase A is widely distributed, has low affinity for fructose, and has less dramatic effects on ATP levels.  By reducing the amt. of fructose for metab. in the liver, fructokinase A protects against fructokinase C-mediated metabolic syndrome.  These studies provide insights into the mechanisms by which fructose causes obesity and metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobK1Ob9TEhNbVg90H21EOLACvtfcHk0liyFOjBKt1cyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D&md5=fd8c85c10a00df73910e0937a4220b47</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1119908109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1119908109%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DLe%26aufirst%3DM.%2BT.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DMaclean%26aufirst%3DP.%2BS.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DRodriguez-Iturbe%26aufirst%3DB.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DOpposing%2520effects%2520of%2520fructokinase%2520C%2520and%2520A%2520isoforms%2520on%2520fructose-induced%2520metabolic%2520syndrome%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D4320%26epage%3D4325%26doi%3D10.1073%2Fpnas.1119908109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morscher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span> <span> </span><span class="NLM_article-title">The small intestine converts dietary fructose into glucose and organic acids</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2017.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.cmet.2017.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=29414685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvFylsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=351-361&author=C.+Jangauthor=S.+Huiauthor=W.+Luauthor=A.+J.+Cowanauthor=R.+J.+Morscherauthor=G.+Leeauthor=W.+Liuauthor=G.+J.+Teszauthor=M.+J.+Birnbaumauthor=J.+D.+Rabinowitz&title=The+small+intestine+converts+dietary+fructose+into+glucose+and+organic+acids&doi=10.1016%2Fj.cmet.2017.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids</span></div><div class="casAuthors">Jang, Cholsoon; Hui, Sheng; Lu, Wenyun; Cowan, Alexis J.; Morscher, Raphael J.; Lee, Gina; Liu, Wei; Tesz, Gregory J.; Birnbaum, Morris J.; Rabinowitz, Joshua D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-361.e3</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Excessive consumption of sweets is a risk factor for metabolic syndrome.  A major chem. feature of sweets is fructose.  Despite strong ties between fructose and disease, the metabolic fate of fructose in mammals remains incompletely understood.  Here we use isotope tracing and mass spectrometry to track the fate of glucose and fructose carbons in vivo, finding that dietary fructose is cleared by the small intestine.  Clearance requires the fructose-phosphorylating enzyme ketohexokinase.  Low doses of fructose are ∼90% cleared by the intestine, with only trace fructose but extensive fructose-derived glucose, lactate, and glycerate found in the portal blood.  High doses of fructose (≥1 g/kg) overwhelm intestinal fructose absorption and clearance, resulting in fructose reaching both the liver and colonic microbiota.  Intestinal fructose clearance is augmented both by prior exposure to fructose and by feeding.  We propose that the small intestine shields the liver from otherwise toxic fructose exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAo4sKE7cITrVg90H21EOLACvtfcHk0lhK1vYi6-6-VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvFylsr4%253D&md5=b32174b2c64a2d3bd662d8ecde0becc2</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DC.%26aulast%3DHui%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DCowan%26aufirst%3DA.%2BJ.%26aulast%3DMorscher%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520small%2520intestine%2520converts%2520dietary%2520fructose%2520into%2520glucose%2520and%2520organic%2520acids%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26spage%3D351%26epage%3D361%26doi%3D10.1016%2Fj.cmet.2017.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shires, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markham, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asipu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span> <span> </span><span class="NLM_article-title">Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1369/jhc.2009.953190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1369%2Fjhc.2009.953190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=19365088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFeqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=763-774&author=C.+P.+Diggleauthor=M.+Shiresauthor=D.+Leitchauthor=D.+Brookeauthor=I.+M.+Carrauthor=A.+F.+Markhamauthor=B.+E.+Haywardauthor=A.+Asipuauthor=D.+T.+Bonthron&title=Ketohexokinase%3A+expression+and+localization+of+the+principal+fructose-metabolizing+enzyme&doi=10.1369%2Fjhc.2009.953190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme</span></div><div class="casAuthors">Diggle, Christine P.; Shires, Michael; Leitch, Derek; Brooke, David; Carr, Ian M.; Markham, Alex F.; Hayward, Bruce E.; Asipu, Aruna; Bonthron, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">763-774</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Ketohexokinase (KHK, also known as fructokinase) initiates the pathway through which most dietary fructose is metabolized.  Very little is known about the cellular localization of this enzyme.  Alternatively spliced KHK-C and KHK-A mRNAs are known, but the existence of the KHK-A protein isoform has not been demonstrated in vivo.  Using antibodies to KHK for immunohistochem. and Western blotting of rodent tissues, including those from mouse knockouts, coupled with RT-PCR assays, we detd. the distribution of the splice variants.  The highly expressed KHK-C isoform localized to hepatocytes in the liver and to the straight segment of the proximal renal tubule.  In both tissues, cytoplasmic and nuclear staining was obsd.  The KHK-A mRNA isoform was obsd. exclusively in a range of other tissues, and by Western blotting, the presence of endogenous immunoreactive KHK-A protein was shown for the first time, proving that the KHK-A mRNA is translated into KHK-A protein in vivo, and supporting the suggestion that this evolutionarily conserved isoform is physiol. functional.  However, the low levels of KHK-A expression prevented its immunohistochem. localization within these tissues.  Our results highlight that the use of in vivo biol. controls (tissues from knockout animals) is required to distinguish genuine KHK immunoreactivity from exptl. artifact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcqnTh2qq4ELVg90H21EOLACvtfcHk0lhK1vYi6-6-VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFeqsrs%253D&md5=924a1224cecba428fc2cbe80af3e4ccb</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1369%2Fjhc.2009.953190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.2009.953190%26sid%3Dliteratum%253Aachs%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DShires%26aufirst%3DM.%26aulast%3DLeitch%26aufirst%3DD.%26aulast%3DBrooke%26aufirst%3DD.%26aulast%3DCarr%26aufirst%3DI.%2BM.%26aulast%3DMarkham%26aufirst%3DA.%2BF.%26aulast%3DHayward%26aufirst%3DB.%2BE.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26atitle%3DKetohexokinase%253A%2520expression%2520and%2520localization%2520of%2520the%2520principal%2520fructose-metabolizing%2520enzyme%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2009%26volume%3D57%26spage%3D763%26epage%3D774%26doi%3D10.1369%2Fjhc.2009.953190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanaspa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal-Jimenez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlicky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicerchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahan, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmalek, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asipu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Lozada, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautin, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. J.</span></span> <span> </span><span class="NLM_article-title">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1632</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.1002/hep.26594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Fhep.26594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=23813872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=1632-1643&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=C.+J.+Rivardauthor=C.+A.+Roncal-Jimenezauthor=D.+J.+Orlickyauthor=C.+Cicerchiauthor=R.+H.+McMahanauthor=M.+F.+Abdelmalekauthor=H.+R.+Rosenauthor=M.+R.+Jackmanauthor=P.+S.+MacLeanauthor=C.+P.+Diggleauthor=A.+Asipuauthor=S.+Inabaauthor=T.+Kosugiauthor=W.+Satoauthor=S.+Maruyamaauthor=L.+G.+Sanchez-Lozadaauthor=Y.+Y.+Sautinauthor=J.+O.+Hillauthor=D.+T.+Bonthronauthor=R.+J.+Johnson&title=High-fat+and+high-sucrose+%28western%29+diet+induces+steatohepatitis+that+is+dependent+on+fructokinase&doi=10.1002%2Fhep.26594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Rivard, Christopher J.; Roncal-Jimenez, Carlos A.; Orlicky, David J.; Cicerchi, Christina; McMahan, Rachel H.; Abdelmalek, Manal F.; Rosen, Hugo R.; Jackman, Matthew R.; MacLean, Paul S.; Diggle, Christine P.; Asipu, Aruna; Inaba, Shinichiro; Kosugi, Tomoki; Sato, Waichi; Maruyama, Shoichi; Sanchez-Lozada, Laura G.; Sautin, Yuri Y.; Hill, James O.; Bonthron, David T.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1632-1643</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Fructose intake from added sugars has been implicated as a cause of nonalcoholic fatty liver disease.  Here we tested the hypothesis that fructose may interact with a high-fat diet to induce fatty liver, and to det. if this was dependent on a key enzyme in fructose metab., fructokinase.  Wild-type or fructokinase knockout mice were fed a low-fat (11%), high-fat (36%), or high-fat (36%) and high-sucrose (30%) diet for 15 wk.  Both wild-type and fructokinase knockout mice developed obesity with mild hepatic steatosis and no evidence of hepatic inflammation on a high-fat diet compared to a low-fat diet.  In contrast, wild-type mice fed a high-fat and high-sucrose diet developed more severe hepatic steatosis with low-grade inflammation and fibrosis, as noted by increased CD68, tumor necrosis factor alpha, monocyte chemoattractant protein-1, alpha-smooth muscle actin, and collagen I and TIMP1 expression.  These changes were prevented in the fructokinase knockout mice.  Conclusion: An additive effect of high-fat and high-sucrose diet on the development of hepatic steatosis exists.  Further, the combination of sucrose with high-fat diet may induce steatohepatitis.  The protection in fructokinase knockout mice suggests a key role for fructose (from sucrose) in this development of steatohepatitis.  These studies emphasize the important role of fructose in the development of fatty liver and nonalcoholic steatohepatitis. (Hepatol. 2013;58:1632-1643).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FrhsSKjOl7Vg90H21EOLACvtfcHk0lgglR_dp_64Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE&md5=d4544aba25dd28f735c4e0b76e02cc48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fhep.26594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26594%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DOrlicky%26aufirst%3DD.%2BJ.%26aulast%3DCicerchi%26aufirst%3DC.%26aulast%3DMcMahan%26aufirst%3DR.%2BH.%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DRosen%26aufirst%3DH.%2BR.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DMacLean%26aufirst%3DP.%2BS.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DW.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DHill%26aufirst%3DJ.%2BO.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DHigh-fat%2520and%2520high-sucrose%2520%2528western%2529%2520diet%2520induces%2520steatohepatitis%2520that%2520is%2520dependent%2520on%2520fructokinase%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26spage%3D1632%26epage%3D1643%26doi%3D10.1002%2Fhep.26594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tounge, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandowski, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struble, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span> <span> </span><span class="NLM_article-title">Electron density guided fragment-based lead discovery of ketohexokinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7979</span>– <span class="NLM_lpage">7991</span>, <span class="refDoi"> DOI: 10.1021/jm100677s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100677s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7979-7991&author=A.+C.+Gibbsauthor=M.+C.+Abadauthor=X.+Zhangauthor=B.+A.+Toungeauthor=F.+A.+Lewandowskiauthor=G.+T.+Strubleauthor=W.+Sunauthor=Z.+Suiauthor=L.+C.+Kuo&title=Electron+density+guided+fragment-based+lead+discovery+of+ketohexokinase+inhibitors&doi=10.1021%2Fjm100677s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors</span></div><div class="casAuthors">Gibbs, Alan C.; Abad, Marta C.; Zhang, Xuqing; Tounge, Brett A.; Lewandowski, Francis A.; Struble, Geoffrey T.; Sun, Weimei; Sui, Zhihua; Kuo, Lawrence C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7979-7991</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fragment-based drug design paradigm has been successfully applied in the discovery of lead series of ketohexokinase inhibitors.  The paradigm consists of three iterations of design, synthesis, and x-ray crystallog. screening to progress low mol. wt. fragments to leadlike compds.  Applying electron d. of fragments within the protein binding site as defined by x-ray crystallog., one can generate target specific leads without the use of affinity data.  Our approach contrasts with most fragment-based drug design methodol. where soln. activity is a main design guide.  Herein we describe the discovery of submicromolar ketohexokinase inhibitors with promising druglike properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOp4ro7Ui4WrVg90H21EOLACvtfcHk0li-phCNn-TdmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF&md5=3abdf4ac63d4afcf6a4db484d0d87259</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm100677s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100677s%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLewandowski%26aufirst%3DF.%2BA.%26aulast%3DStruble%26aufirst%3DG.%2BT.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26atitle%3DElectron%2520density%2520guided%2520fragment-based%2520lead%2520discovery%2520of%2520ketohexokinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7979%26epage%3D7991%26doi%3D10.1021%2Fjm100677s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McComsey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabut, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luci, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. A.</span></span> <span> </span><span class="NLM_article-title">Pyrimidinopyrimidine inhibitors of ketohexokinase: exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5326</span>– <span class="NLM_lpage">5229</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.bmcl.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=22795331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5326-5229&author=B.+E.+Maryanoffauthor=J.+C.+O%E2%80%99Neillauthor=D.+F.+McComseyauthor=S.+C.+Yabutauthor=D.+K.+Luciauthor=A.+C.+Gibbsauthor=M.+A.+Connelly&title=Pyrimidinopyrimidine+inhibitors+of+ketohexokinase%3A+exploring+the+ring+C2+group+that+interacts+with+Asp-27B+in+the+ligand+binding+pocket&doi=10.1016%2Fj.bmcl.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span></div><div class="casAuthors">Maryanoff, Bruce E.; O'Neill, John C.; McComsey, David F.; Yabut, Stephen C.; Luci, Diane K.; Gibbs, Alan C.; Connelly, Margery A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5326-5329</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of ketohexokinase (KHK) have potential for the treatment of diabetes and obesity.  We have continued studies on a pyrimidinopyrimidine series of potent KHK inhibitors by exploring the 2-position substituent (R3) that interacts with Asp-27B in the ATP-binding region of KHK (viz. 1, 2; Table 1).  We found that increased spacing between the terminal ammonium group and the heterocyclic scaffold (viz. 16-20), such that interaction with Asp-27B is not possible, still results in potent KHK inhibition (IC50 = 15-50 nM).  We propose a new interaction with Asp-194, which serves to expand the pyrimidinopyrimidine pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradcYZ9M9bdLVg90H21EOLACvtfcHk0li-phCNn-TdmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK&md5=0da67e40de493f46030c88682482270e</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BC.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DConnelly%26aufirst%3DM.%2BA.%26atitle%3DPyrimidinopyrimidine%2520inhibitors%2520of%2520ketohexokinase%253A%2520exploring%2520the%2520ring%2520C2%2520group%2520that%2520interacts%2520with%2520Asp-27B%2520in%2520the%2520ligand%2520binding%2520pocket%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5326%26epage%3D5229%26doi%3D10.1016%2Fj.bmcl.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrunyk, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culp, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgoglione, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knafels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfefferkorn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subashi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, T. V.</span></span> <span> </span><span class="NLM_article-title">Discovery of fragment-derived small molecules for in vivo Inhibition of ketohexokinase (KHK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7835</span>– <span class="NLM_lpage">7849</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVagu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7835-7849&author=K.+Huardauthor=K.+Ahnauthor=P.+Amorauthor=D.+A.+Beebeauthor=K.+A.+Borzilleriauthor=B.+A.+Chrunykauthor=S.+B.+Coffeyauthor=Y.+Congauthor=E.+L.+Connauthor=J.+S.+Culpauthor=M.+S.+Dowlingauthor=M.+F.+Gorgoglioneauthor=J.+A.+Gutierrezauthor=J.+D.+Knafelsauthor=E.+A.+Lachapelleauthor=J.+Panditauthor=K.+D.+Parrisauthor=S.+Perezauthor=J.+A.+Pfefferkornauthor=D.+A.+Priceauthor=B.+Raymerauthor=T.+T.+Rossauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=T.+A.+Subashiauthor=G.+J.+Teszauthor=B.+A.+Thumaauthor=M.+Tuauthor=J.+D.+Weaverauthor=Y.+Wengauthor=J.+M.+Withkaauthor=G.+Xingauthor=T.+V.+Magee&title=Discovery+of+fragment-derived+small+molecules+for+in+vivo+Inhibition+of+ketohexokinase+%28KHK%29&doi=10.1021%2Facs.jmedchem.7b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)</span></div><div class="casAuthors">Huard, Kim; Ahn, Kay; Amor, Paul; Beebe, David A.; Borzilleri, Kris A.; Chrunyk, Boris A.; Coffey, Steven B.; Cong, Yang; Conn, Edward L.; Culp, Jeffrey S.; Dowling, Matthew S.; Gorgoglione, Matthew F.; Gutierrez, Jemy A.; Knafels, John D.; Lachapelle, Erik A.; Pandit, Jayvardhan; Parris, Kevin D.; Perez, Sylvie; Pfefferkorn, Jeffrey A.; Price, David A.; Raymer, Brian; Ross, Trenton T.; Shavnya, Andre; Smith, Aaron C.; Subashi, Timothy A.; Tesz, Gregory J.; Thuma, Benjamin A.; Tu, Meihua; Weaver, John D.; Weng, Yan; Withka, Jane M.; Xing, Gang; Magee, Thomas V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7835-7849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Increased fructose consumption and its subsequent metab. have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans.  Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metab., identification of a selective KHK inhibitor may help to further elucidate the effect of KHK inhibition on these metabolic disorders.  Until now, studies on KHK inhibition with small mols. have been limited due to the lack of viable in vivo pharmacol. tools.  Herein the authors report the discovery of 12 (6-((3S,4S)-3,4-dihydroxypyrrolidin-1-yl)-2-((S)-3-hydroxy-3-methylpyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile), a selective KHK inhibitor with potency and properties suitable for evaluating KHK inhibition in rat models.  Key structural features interacting with KHK were discovered through fragment-based screening and subsequent optimization using structure-based drug design, and parallel medicinal chem. led to the identification of pyridine 12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7-O0s6H7lYrVg90H21EOLACvtfcHk0li-phCNn-TdmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVagu7jK&md5=d83bc39986e54a0f41e8f310b725ab92</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00947%26sid%3Dliteratum%253Aachs%26aulast%3DHuard%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DAmor%26aufirst%3DP.%26aulast%3DBeebe%26aufirst%3DD.%2BA.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DChrunyk%26aufirst%3DB.%2BA.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DCong%26aufirst%3DY.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCulp%26aufirst%3DJ.%2BS.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DGorgoglione%26aufirst%3DM.%2BF.%26aulast%3DGutierrez%26aufirst%3DJ.%2BA.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DParris%26aufirst%3DK.%2BD.%26aulast%3DPerez%26aufirst%3DS.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DRaymer%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DT.%2BT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DSubashi%26aufirst%3DT.%2BA.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWeaver%26aufirst%3DJ.%2BD.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DXing%26aufirst%3DG.%26aulast%3DMagee%26aufirst%3DT.%2BV.%26atitle%3DDiscovery%2520of%2520fragment-derived%2520small%2520molecules%2520for%2520in%2520vivo%2520Inhibition%2520of%2520ketohexokinase%2520%2528KHK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7835%26epage%3D7849%26doi%3D10.1021%2Facs.jmedchem.7b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikedo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubotani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maezaki, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a 3-pyridylacetic acid derivative (TAK-100) as a potent, selective and orally active dipeptidyl peptidase IV (DPP-4) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1021/jm101236h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101236h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=831-850&author=Y.+Miyamotoauthor=Y.+Bannoauthor=T.+Yamashitaauthor=T.+Fujimotoauthor=S.+Oiauthor=Y.+Moritohauthor=T.+Asakawaauthor=O.+Kataokaauthor=H.+Yashiroauthor=K.+Takeuchiauthor=N.+Suzukiauthor=K.+Ikedoauthor=T.+Kosakaauthor=S.+Tsubotaniauthor=A.+Taniauthor=M.+Sasakiauthor=M.+Funamiauthor=M.+Amanoauthor=Y.+Yamamotoauthor=K.+Aertgeertsauthor=J.+Yanoauthor=H.+Maezaki&title=Discovery+of+a+3-pyridylacetic+acid+derivative+%28TAK-100%29+as+a+potent%2C+selective+and+orally+active+dipeptidyl+peptidase+IV+%28DPP-4%29+inhibitor&doi=10.1021%2Fjm101236h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor</span></div><div class="casAuthors">Miyamoto, Yasufumi; Banno, Yoshihiro; Yamashita, Tohru; Fujimoto, Tatsuhiko; Oi, Satoru; Moritoh, Yusuke; Asakawa, Tomoko; Kataoka, Osamu; Yashiro, Hiroaki; Takeuchi, Koji; Suzuki, Nobuhiro; Ikedo, Koji; Kosaka, Takuo; Tsubotani, Shigetoshi; Tani, Akiyoshi; Sasaki, Masako; Funami, Miyuki; Amano, Michiko; Yamamoto, Yoshio; Aertgeerts, Kathleen; Yano, Jason; Maezaki, Hironobu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">831-850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes.  To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed into clin. trials.  Originating from the discovery of the structurally novel quinoline deriv. 1 (I), we designed novel pyridine derivs. contg. a carboxy group.  In our design, the carboxy group interacted with the targeted amino acid residues around the catalytic region and thereby increased the inhibitory activity.  After further optimization, we identified a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (30c) as a potent and selective DPP-4 inhibitor.  The desired interactions with the crit. active-site residues, such as a salt-bridge interaction with Arg125, were confirmed by X-ray cocrystal structure anal.  In addn., compd. 30c showed a desired preclin. safety profile, and it was encoded as TAK-100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7OfqMis4tyrVg90H21EOLACvtfcHk0lhhF8U5vVVHzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsA%253D%253D&md5=6f8a789777bf833b9baf92ae6d3cee9e</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm101236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101236h%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DOi%26aufirst%3DS.%26aulast%3DMoritoh%26aufirst%3DY.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DKataoka%26aufirst%3DO.%26aulast%3DYashiro%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIkedo%26aufirst%3DK.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DTsubotani%26aufirst%3DS.%26aulast%3DTani%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DMaezaki%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%25203-pyridylacetic%2520acid%2520derivative%2520%2528TAK-100%2529%2520as%2520a%2520potent%252C%2520selective%2520and%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-4%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D831%26epage%3D850%26doi%3D10.1021%2Fjm101236h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weltrowska, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkes, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, P. W.</span></span> <span> </span><span class="NLM_article-title">″Carba″-analogues of fentanyl are opioid receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2875</span>– <span class="NLM_lpage">2881</span>, <span class="refDoi"> DOI: 10.1021/jm9019068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9019068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2875-2881&author=G.+Weltrowskaauthor=N.+N.+Chungauthor=C.+Lemieuxauthor=J.+Guoauthor=Y.+Luauthor=B.+C.+Wilkesauthor=P.+W.+Schiller&title=%E2%80%B3Carba%E2%80%B3-analogues+of+fentanyl+are+opioid+receptor+agonists&doi=10.1021%2Fjm9019068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">"Carba"-Analogues of Fentanyl are Opioid Receptor Agonists</span></div><div class="casAuthors">Weltrowska, Grazyna; Chung, Nga N.; Lemieux, Carole; Guo, Jianxin; Lu, Yixin; Wilkes, Brian C.; Schiller, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2875-2881</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is evidence to indicate that the Asp residue in the third transmembrane helix (TMH) of opioid receptors forms a salt bridge with the pos. charged nitrogen of endogenous and exogenous opioid ligands.  To further examine the role of this electrostatic interaction in receptor binding and activation, we synthesized "carba"-analogs of a published fentanyl analog contg. a 3-(guanidinomethyl)-benzyl group in place of the Ph moiety attached to the ethylamido group, in which the piperidine ring nitrogen was replaced with a carbon.  As expected, the resulting cis and trans isomers I showed reduced μ and κ opioid receptor binding affinities as compared to 1 but, surprisingly, retained opioid full agonist activity with about half the potency of leucine-enkephalin in the guinea pig ileum assay.  In conjunction with performed receptor docking studies, these results indicate that the electrostatic interaction of the protonated nitrogen in the piperidine ring of fentanyl analogs with the Asp residue in the third TMH is not a conditio sine qua non for opioid receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQRIMetsmqw7Vg90H21EOLACvtfcHk0lhr23WJNM0LFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVyisro%253D&md5=2ddddb63e95c57b43eaecad3e3bbee71</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm9019068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9019068%26sid%3Dliteratum%253Aachs%26aulast%3DWeltrowska%26aufirst%3DG.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWilkes%26aufirst%3DB.%2BC.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3D%25E2%2580%25B3Carba%25E2%2580%25B3-analogues%2520of%2520fentanyl%2520are%2520opioid%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2875%26epage%3D2881%26doi%3D10.1021%2Fjm9019068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span>; <span class="NLM_string-name">Bakken, G.</span></span> <span> </span><span class="NLM_article-title">Water’s role in compound design for drug discovery</span>.  <i>Poster Session Presented at Chemical Computing Group UGM & Conference, June 27, 2013, Montreal, Canada</i>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Zhu&author=G.+Bakken&title=Water%E2%80%99s+role+in+compound+design+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DWater%25E2%2580%2599s%2520role%2520in%2520compound%2520design%2520for%2520drug%2520discovery%26jtitle%3DPoster%2520Session%2520Presented%2520at%2520Chemical%2520Computing%2520Group%2520UGM%2520%2526%2520Conference%252C%2520June%252027%252C%25202013%252C%2520Montreal%252C%2520Canada%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">A docking protocol with Glide in Maestro software package (Schrodinger Inc., New York City, NY) was developed. The receptor grid file was generated with compound <b>3</b>/KHK structure complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W">6W0W</a>). Virtual compounds were first prepared with LigPrep module and then docked and scored.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selwood, D. L.</span></span> <span> </span><span class="NLM_article-title">Chemical fragments that hydrogen bond to Asp, Glu, Arg, and His side chains in protein binding sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3086</span>– <span class="NLM_lpage">3094</span>, <span class="refDoi"> DOI: 10.1021/jm901696w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901696w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1enu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3086-3094&author=A.+W.+E.+Chanauthor=R.+A.+Laskowskiauthor=D.+L.+Selwood&title=Chemical+fragments+that+hydrogen+bond+to+Asp%2C+Glu%2C+Arg%2C+and+His+side+chains+in+protein+binding+sites&doi=10.1021%2Fjm901696w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Fragments that Hydrogen Bond to Asp, Glu, Arg, and His Side Chains in Protein Binding Sites</span></div><div class="casAuthors">Chan, A. W. Edith; Laskowski, Roman A.; Selwood, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3086-3094</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an anal. of the chem. fragments from lead-like ligands in the Protein Data Bank (PDB) that form hydrogen bonds to the side chains of Asp, Glu, Arg, and His, which are the most common residues found in ligand binding sites.  A fragment is defined as the largest ring assembly contg. the atoms involved in hydrogen bonding.  In total, 462 fragments were found in 2038 ligands from over 8000 protein-ligand structures in the PDB.  The results show which fragments have a higher propensity for interaction with specific side chains.  Some fragments interact with Asp but not with Glu, and vice versa, despite these side chains sharing the same chem. moiety.  Arg side chains form hydrogen bonds almost exclusively with O-mediated ligands, and the fragments are the most diverse.  Hydrogen bond distances from the imidazole of His showed a wider range than the other three amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNNuJszKkQobVg90H21EOLACvtfcHk0lhr23WJNM0LFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1enu7o%253D&md5=ae7c315b3974738b610bd82fff960d06</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm901696w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901696w%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DA.%2BW.%2BE.%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26atitle%3DChemical%2520fragments%2520that%2520hydrogen%2520bond%2520to%2520Asp%252C%2520Glu%252C%2520Arg%252C%2520and%2520His%2520side%2520chains%2520in%2520protein%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3086%26epage%3D3094%26doi%3D10.1021%2Fjm901696w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessire, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, A. E.</span></span> <span> </span><span class="NLM_article-title">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1002/rcm.4621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Frcm.4621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=20552710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2109-2121&author=A.+D.+Vazauthor=W.+W.+Wangauthor=A.+J.+Bessireauthor=R.+Sharmaauthor=A.+E.+Hagen&title=A+rapid+and+specific+derivatization+procedure+to+identify+acyl-glucuronides+by+mass+spectrometry&doi=10.1002%2Frcm.4621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span></div><div class="casAuthors">Vaz, Alfin D. N.; Wang, Wei Wei; Bessire, Andrew J.; Sharma, Raman; Hagen, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2109-2121</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A simple procedure is described to identify acyl-glucuronides by coupled liq. chromatog./mass spectrometry after derivatization to a hydroxamic acid with hydroxylamine.  The reaction specificity obviates the need for isolation of the acyl-glucuronide from an ext.  Glucuronides derived from carbamic acids, and alkyl- and arom. amines, are inert to the derivatization reaction conditions, making the hydroxamic acid deriv. a fingerprint for acyl-glucuronides.  This derivatization procedure provides a key advantage for the quant. anal. of acyl-glucuronide metabolites in a drug discovery setting.  Copyright © 2010 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDR6oEUBtuHbVg90H21EOLACvtfcHk0lh4FEfWDtsz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D&md5=1f282304cec298e7db621c9478d14d3e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Frcm.4621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4621%26sid%3Dliteratum%253Aachs%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DW.%2BW.%26aulast%3DBessire%26aufirst%3DA.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DHagen%26aufirst%3DA.%2BE.%26atitle%3DA%2520rapid%2520and%2520specific%2520derivatization%2520procedure%2520to%2520identify%2520acyl-glucuronides%2520by%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2010%26volume%3D24%26spage%3D2109%26epage%3D2121%26doi%3D10.1002%2Frcm.4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lh4FEfWDtsz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shook, B. C.</span></span> <span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7902</span>– <span class="NLM_lpage">7917</span>, <span class="refDoi"> DOI: 10.1021/jm100762r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-7917&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+efficacious+roles+of+the+nitrile+pharmacophore&doi=10.1021%2Fjm100762r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></div><div class="casAuthors">Fleming, Fraser F.; Yao, Lihua; Ravikumar, P. C.; Funk, Lee; Shook, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7902-7917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review is structured according to the nature of the nitrile-bearing substituent.  As the no. of nitrile-contg. drug leads is vast, the review has focused on launched nitrile-contg. pharmaceuticals and currently active clin. candidates.  Most nitrile-contg. pharmaceuticals are aroms. with aliph.-, alkene-, and nitrogen-bearing nitriles being progressively less frequent.  Within each class, the bioactive nitriles are collated according to common structural elements and mode of action.  The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6kPPdWVuvLVg90H21EOLACvtfcHk0lip6aVVSTrI4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP&md5=040bbaebd9e8c9999d195b9a22221fea</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7902%26epage%3D7917%26doi%3D10.1021%2Fjm100762r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">A novel relay method for determining low-clearance values</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1860</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1124%2Fdmd.112.046425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=22645091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1860-1865&author=L.+Diauthor=P.+Trapaauthor=R.+S.+Obachauthor=K.+Atkinsonauthor=Y.+A.+Biauthor=A.+C.+Wolfordauthor=B.+Tanauthor=T.+S.+McDonaldauthor=Y.+Laiauthor=L.+M.+Tremaine&title=A+novel+relay+method+for+determining+low-clearance+values&doi=10.1124%2Fdmd.112.046425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel relay method for determining low-clearance values</span></div><div class="casAuthors">Di, Li; Trapa, Patrick; Obach, R. Scott; Atkinson, Karen; Bi, Yi-An; Wolford, Angela C.; Tan, Beijing; McDonald, Thomas S.; Lai, Yurong; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1860-1865</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compds.  The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes.  An accumulative incubation time of 20 h or longer in hepatocytes can be achieved using the method.  The relay method was validated using seven com. drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approx. 2 to 15 mL · min-1 · kg-1.  The results showed that the relay method produced excellent predictions of human in vivo clearance.  The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compds., which is similar to the std. prediction accuracy for moderate to high clearance compds. using hepatocytes.  The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1LvwK-CqOLVg90H21EOLACvtfcHk0lip6aVVSTrI4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O&md5=faab456749ff398ad63d11eff6412fbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046425%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DY.%2BA.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DA%2520novel%2520relay%2520method%2520for%2520determining%2520low-clearance%2520values%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1860%26epage%3D1865%26doi%3D10.1124%2Fdmd.112.046425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Reversible modes of inhibitor interactions with enzymes</span>. In  <i>Evaluation of Enzyme Inhibitors in Drug Discovery</i>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>, Ed. <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">121</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2F9781118540398.ch3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=57-121&author=R.+A.+Copelandauthor=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F9781118540398.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398.ch3%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DReversible%2520modes%2520of%2520inhibitor%2520interactions%2520with%2520enzymes%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2013%26spage%3D57%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frigola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrocal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, J.</span></span> <span> </span><span class="NLM_article-title">7-azetidinylquinolones as antibacterial agents. 2. Synthesis and biological activity of 7-(2,3-disubstituted-1-azetidinyl)-4-oxoquinoline- and −1,8-naphthyridine-3-carboxylic acids. Properties and structure-activity relationships of quinolones with an azetidine moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">4195</span>– <span class="NLM_lpage">4210</span>, <span class="refDoi"> DOI: 10.1021/jm00050a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00050a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaK2MXhvFKmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=4195-4210&author=J.+Frigolaauthor=A.+Torrensauthor=J.+A.+Castrilloauthor=J.+Masauthor=D.+Vanoauthor=J.+M.+Berrocalauthor=C.+Calvetauthor=L.+Salgadoauthor=J.+Redondo&title=7-azetidinylquinolones+as+antibacterial+agents.+2.+Synthesis+and+biological+activity+of+7-%282%2C3-disubstituted-1-azetidinyl%29-4-oxoquinoline-+and+%E2%88%921%2C8-naphthyridine-3-carboxylic+acids.+Properties+and+structure-activity+relationships+of+quinolones+with+an+azetidine+moiety&doi=10.1021%2Fjm00050a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azetidinylquinolones as Antibacterial Agents. 2. Synthesis and Biological Activity of 7-(2,3-Disubstituted-1-azetidinyl)-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic Acids. Properties and Structure-Activity Relationships of Quinolones with an Azetidine Moiety</span></div><div class="casAuthors">Frigola, Jordi; Torrens, Antoni; Castrillo, Jose A.; Mas, Josep; Vano, David; Berrocal, Juana M.; Calvet, Carme; Salgado, Leonardo; Redondo, Jordi; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4195-210</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 7-(2,3-disubstituted-1-azetidinyl)-1,4-dihydro-6-fluoro-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids, with varied substituents at the 1-, 5-, and 8-positions, e. g. I (X = CH, CF, N), was prepd. to study the effects on potency and physicochem. properties of the substituent at position 2 of the azetidine moiety.  The activity of the title compds. was detd. in vitro against Gram-pos. and Gram-neg. bacteria, and the in vivo efficacy of selected derivs. was detd. using a mouse infection model.  The x-ray crystal structures were found to be in reasonable agreement with the corresponding AM1 calcd. geometries.  Correlations between antibacterial potency of all the synthesized 7-azetidinylquinolones and naphthyridines and their calcd. electronic properties and exptl. capacity factors were established.  Antibacterial efficacy and pharmacokinetic and physicochem. properties of selected derivs. were compared to the relevant 7-(3-amino-1-azetidinyl) and 7-(3-amino-3-methyl-1-azetidinyl) analogs.  A combination of a cyclopropyl or a substituted Ph group at N-1 and a trans-3-amino-2-methyl-1-azetidinyl group at C-7 conferred the best overall antibacterial, pharmacokinetic, and physicochem. properties to the azetidinylquinolones studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKA1eDGNnzLVg90H21EOLACvtfcHk0ljKYcUvai4Urw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhvFKmsbs%253D&md5=9c6791dd332aa9a62931fb96c26d4404</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm00050a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00050a016%26sid%3Dliteratum%253Aachs%26aulast%3DFrigola%26aufirst%3DJ.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DCastrillo%26aufirst%3DJ.%2BA.%26aulast%3DMas%26aufirst%3DJ.%26aulast%3DVano%26aufirst%3DD.%26aulast%3DBerrocal%26aufirst%3DJ.%2BM.%26aulast%3DCalvet%26aufirst%3DC.%26aulast%3DSalgado%26aufirst%3DL.%26aulast%3DRedondo%26aufirst%3DJ.%26atitle%3D7-azetidinylquinolones%2520as%2520antibacterial%2520agents.%25202.%2520Synthesis%2520and%2520biological%2520activity%2520of%25207-%25282%252C3-disubstituted-1-azetidinyl%2529-4-oxoquinoline-%2520and%2520%25E2%2588%25921%252C8-naphthyridine-3-carboxylic%2520acids.%2520Properties%2520and%2520structure-activity%2520relationships%2520of%2520quinolones%2520with%2520an%2520azetidine%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D4195%26epage%3D4210%26doi%3D10.1021%2Fjm00050a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frigola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Gomar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Granda, S.</span></span> <span> </span><span class="NLM_article-title">7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1215</span>, <span class="refDoi"> DOI: 10.1021/jm00007a017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaK2MXksVymtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1203-1215&author=J.+Frigolaauthor=D.+Vanoauthor=A.+Torrensauthor=A.+Gomez-Gomarauthor=E.+Ortegaauthor=S.+Garcia-Granda&title=7-Azetidinylquinolones+as+antibacterial+agents.+3.+Synthesis%2C+properties+and+structure-activity+relationships+of+the+stereoisomers+containing+a+7-%283-amino-2-methyl-1-azetidinyl%29+moiety&doi=10.1021%2Fjm00007a017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azetidinylquinolones as Antibacterial Agents. 3. Synthesis, Properties and Structure-Activity Relationships of the Stereoisomers Containing a 7-(3-Amino-2-methyl-1-azetidinyl) Moiety</span></div><div class="casAuthors">Frigola, Jordi; Vano, David; Torrens, Antoni; Gomez-Gomar, Angels; Ortega, Edmundo; Garcia-Granda, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1203-15</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Title stereoisomers I (A = CH, CF, N, CCl; R1 = cyclopropyl, Et, 4-fluorophenyl, 2,4-difluorophenyl; R2 = H, NH2, Me; R3, R4 = H, Me; R5, R6 = H, NH2) were prepd. to det. the effects of chirality on potency and in vivo efficacy relative to the racemic mixts.  Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acids II (R, R1, R2, R3 = H, Me; R5 = H, NH2, NHMe, NMe2, CH2NHEt; R6 = H, Me, NH2) was prepd. to study the effect of the azetidine moiety on tricyclic quinolone antibacterial agents.  A series of amino acid prodrugs of chiral naphthyridines I (A = N, R1 = cyclopropyl, R2 = H, R3 = Me, R4 = H, R5 = H, R6 = NH2; A = N, R1 = cyclopropyl, R2 = H, R3 = H, R4 = H, R5 = NH2, R6 = H) and quinolone I (A = CH, R1 = 2,4-difluorophenyl, R2 = H, R3 = Me, R4 = H, R5 = H, R6 = NH2) (cetefloxacin) was prepd. and evaluated for antibacterial activity, soly., and pharmacokinetic behavior.  The abs. configuration of the new azetidinylquinolones was established by x-ray anal. of one of the diastereomeric salts of the resolved azetidinols and of compd. I (A = CCl, R1 = cyclopropyl, R2 = H, R3 = Me, R4 = H, R5 = H, R6 = NH2) (E-4767), which showed the best in vitro and in vivo overall profile.  Structure-activity relationship studies indicated that the abs. stereochem. at the asym. centers of both the azetidine and the oxazine rings was crit. to increase in vitro activity and oral efficacy.  The 3S configuration in the pyridobenzoxazine series and the (2S,3R) configuration of the 3-amino-2-methylazetidine moiety for all new compds. conferred the best antibacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFl683UVUyJrVg90H21EOLACvtfcHk0ljKYcUvai4Urw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVymtbs%253D&md5=08b50ba32ebbbc445fd0246b1a39241a</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a017%26sid%3Dliteratum%253Aachs%26aulast%3DFrigola%26aufirst%3DJ.%26aulast%3DVano%26aufirst%3DD.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DGomez-Gomar%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DGarcia-Granda%26aufirst%3DS.%26atitle%3D7-Azetidinylquinolones%2520as%2520antibacterial%2520agents.%25203.%2520Synthesis%252C%2520properties%2520and%2520structure-activity%2520relationships%2520of%2520the%2520stereoisomers%2520containing%2520a%25207-%25283-amino-2-methyl-1-azetidinyl%2529%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1203%26epage%3D1215%26doi%3D10.1021%2Fjm00007a017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">The stereochemistry course of this route contradicts the ref <a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> and <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a>. According to Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> in the ref <a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> and the synthetic procedure for <b>16a</b> and <b>15</b> in the ref <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a>, (2<i>Z</i>)-buten-1-ol leads to the formation of <i>trans</i>-2-methyl-3-hydroxyazetidine. However, based on the mechanism of the bromination reaction, the <i>syn</i>-dibromo product would be expected in that instance which would lead to the antiepibromohydrin. Subsequently, the <i>cis</i>-2-methyl-3-hydroxyazetidine would be formed upon S<sub>N</sub>2 displacement of the bromide and ring-opening of the epoxide with benzhydrylamine. As shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> (vide supra), (2<i>E</i>)-buten-1-ol would lead to antidibromo <b>19</b> and <i>syn</i>-epibromohydrin <b>20</b>. This would lead to formation of <i>trans</i>-2-methyl-3-hydroxyazetidine when reacted with benzyhydrylamine. To provide evidence of the correct assignment of <b>21</b>/(<i>R</i>)-CSA, we have included the X-ray cocrystal structure of <b>6</b> and single crystal X-ray of <b>21</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Additionally, the direction of optical rotation of <b>21</b>/(<i>R</i>)-CSA matches <b>15</b> from the ref <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a>, which also describes the same single crystal X-ray structure. It appears that the ref <a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> described the incorrect starting material that they employed in the analogous chemistry.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berliner, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubant, S. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Use of an iridium-catalyzed redox-neutral alcohol-amine coupling on kilogram scale for the synthesis of a GlyT1 Inhibitor</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1052</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1021/op200174k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op200174k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=1052-1062&author=M.+A.+Berlinerauthor=S.+P.+A.+Dubantauthor=T.+Makowskiauthor=K.+Ngauthor=B.+Sitterauthor=C.+Wagerauthor=Y.+Zhang&title=Use+of+an+iridium-catalyzed+redox-neutral+alcohol-amine+coupling+on+kilogram+scale+for+the+synthesis+of+a+GlyT1+Inhibitor&doi=10.1021%2Fop200174k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an Iridium-Catalyzed Redox-Neutral Alcohol-Amine Coupling on Kilogram Scale for the Synthesis of a GlyT1 Inhibitor</span></div><div class="casAuthors">Berliner, Martin A.; Dubant, Stephane P. A.; Makowski, Teresa; Ng, Karl; Sitter, Barbara; Wager, Carrie; Zhang, Yinsheng</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1052-1062</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent development for the efficient and environmentally friendly synthesis of aliph. amines is the transition-metal-catalyzed redox-neutral coupling of an alc. and an amine, generally referred to as a "borrowing hydrogen" reaction.  In this work, we describe the first kilogram-scale application of this technol. in the synthesis of PF-03463275, a GlyT1 inhibitor developed for the treatment of schizophrenia.  Using (Cp*IrCl2)2 the reaction has been optimized to achieve catalyst loadings lower than 0.05 mol % iridium (S/C ≥ 2000) while retaining reasonable reaction times (<24 h).  Water and a tertiary amine are essential for high catalytic activity, resulting in dramatically increased reaction rates compared to existing literature protocols.  Methods for iridium removal are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjHPL35gPxW7Vg90H21EOLACvtfcHk0lgB_rcEeCxSMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvF&md5=8d2ba6a742fff108a7106ff59a393876</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fop200174k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop200174k%26sid%3Dliteratum%253Aachs%26aulast%3DBerliner%26aufirst%3DM.%2BA.%26aulast%3DDubant%26aufirst%3DS.%2BP.%2BA.%26aulast%3DMakowski%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DSitter%26aufirst%3DB.%26aulast%3DWager%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DUse%2520of%2520an%2520iridium-catalyzed%2520redox-neutral%2520alcohol-amine%2520coupling%2520on%2520kilogram%2520scale%2520for%2520the%2520synthesis%2520of%2520a%2520GlyT1%2520Inhibitor%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2011%26volume%3D15%26spage%3D1052%26epage%3D1062%26doi%3D10.1021%2Fop200174k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span> <span> </span><span class="NLM_article-title">Two scalable syntheses of (S)-2-methylazetidine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">3031</span>– <span class="NLM_lpage">3036</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b00149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b00149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVeltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=3031-3036&author=M.+S.+Dowlingauthor=D.+P.+Fernandoauthor=J.+Houauthor=B.+Liuauthor=A.+C.+Smith&title=Two+scalable+syntheses+of+%28S%29-2-methylazetidine&doi=10.1021%2Facs.joc.6b00149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Two Scalable Syntheses of (S)-2-Methylazetidine</span></div><div class="casAuthors">Dowling, Matthew S.; Fernando, Dilinie P.; Hou, Jie; Liu, Bo; Smith, Aaron C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3031-3036</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two orthogonal routes for prepg. (S)-2-methylazetidine as a bench stable, cryst. (R)-(-)-CSA salt are presented.  One route features the in situ generation and cyclization of a 1,3-bis-triflate to form the azetidine ring, while the second route involves chemoselective redn. of N-Boc azetidine-2-carboxylic acid.  Both sequences afford the desired product in good overall yields (61% and 49%) and high enantiomeric excess (>99% ee), avoid column chromatog., and are suitable for the large-scale prodn. of this material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp71h_oOE1SD7Vg90H21EOLACvtfcHk0lgB_rcEeCxSMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVeltbw%253D&md5=8af47f5c27916c56994c6689440af87c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b00149%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26atitle%3DTwo%2520scalable%2520syntheses%2520of%2520%2528S%2529-2-methylazetidine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D3031%26epage%3D3036%26doi%3D10.1021%2Facs.joc.6b00149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':[],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':[],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kendra K.  Bence</span>, <span class="hlFld-ContribAuthor ">Morris J.  Birnbaum</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic drivers of non-alcoholic fatty liver disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2021,</strong> <em>50 </em>, 101143. <a href="https://doi.org/10.1016/j.molmet.2020.101143" title="DOI URL">https://doi.org/10.1016/j.molmet.2020.101143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2020.101143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2020.101143%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DMetabolic%252Bdrivers%252Bof%252Bnon-alcoholic%252Bfatty%252Bliver%252Bdisease%26aulast%3DBence%26aufirst%3DKendra%2BK.%26date%3D2021%26volume%3D50%26spage%3D101143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amalia  Gastaldelli</span>, <span class="hlFld-ContribAuthor ">Norbert  Stefan</span>, <span class="hlFld-ContribAuthor ">Hans-Ulrich  Häring</span>. </span><span class="cited-content_cbyCitation_article-title">Liver-targeting drugs and their effect on blood glucose and hepatic lipids. </span><span class="cited-content_cbyCitation_journal-name">Diabetologia</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 1461-1479. <a href="https://doi.org/10.1007/s00125-021-05442-2" title="DOI URL">https://doi.org/10.1007/s00125-021-05442-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00125-021-05442-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00125-021-05442-2%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetologia%26atitle%3DLiver-targeting%252Bdrugs%252Band%252Btheir%252Beffect%252Bon%252Bblood%252Bglucose%252Band%252Bhepatic%252Blipids%26aulast%3DGastaldelli%26aufirst%3DAmalia%26date%3D2021%26date%3D2021%26volume%3D64%26issue%3D7%26spage%3D1461%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongfei  Jiang</span>, <span class="hlFld-ContribAuthor ">Qian  Lin</span>, <span class="hlFld-ContribAuthor ">Leina  Ma</span>, <span class="hlFld-ContribAuthor ">Shudi  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing  Fang</span>, <span class="hlFld-ContribAuthor ">Zhimin  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Fructose and fructose kinase in cancer and other pathologies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Genetics and Genomics</span><span> <strong>2021,</strong> <em>38 </em><a href="https://doi.org/10.1016/j.jgg.2021.06.006" title="DOI URL">https://doi.org/10.1016/j.jgg.2021.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jgg.2021.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jgg.2021.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Genetics%2520and%2520Genomics%26atitle%3DFructose%252Band%252Bfructose%252Bkinase%252Bin%252Bcancer%252Band%252Bother%252Bpathologies%26aulast%3DJiang%26aufirst%3DHongfei%26date%3D2021%26volume%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jemy A.  Gutierrez</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Sylvie  Perez</span>, <span class="hlFld-ContribAuthor ">Gang  Xing</span>, <span class="hlFld-ContribAuthor ">Gabriele  Sonnenberg</span>, <span class="hlFld-ContribAuthor ">Kou  Kou</span>, <span class="hlFld-ContribAuthor ">Matt  Blatnik</span>, <span class="hlFld-ContribAuthor ">Richard  Allen</span>, <span class="hlFld-ContribAuthor ">Yan  Weng</span>, <span class="hlFld-ContribAuthor ">Nicholas B.  Vera</span>, <span class="hlFld-ContribAuthor ">Kristin  Chidsey</span>, <span class="hlFld-ContribAuthor ">Arthur  Bergman</span>, <span class="hlFld-ContribAuthor ">Veena  Somayaji</span>, <span class="hlFld-ContribAuthor ">Collin  Crowley</span>, <span class="hlFld-ContribAuthor ">Michelle F.  Clasquin</span>, <span class="hlFld-ContribAuthor ">Anu  Nigam</span>, <span class="hlFld-ContribAuthor ">Melissa A.  Fulham</span>, <span class="hlFld-ContribAuthor ">Derek M.  Erion</span>, <span class="hlFld-ContribAuthor ">Trenton T.  Ross</span>, <span class="hlFld-ContribAuthor ">William P.  Esler</span>, <span class="hlFld-ContribAuthor ">Thomas V.  Magee</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Pfefferkorn</span>, <span class="hlFld-ContribAuthor ">Kendra K.  Bence</span>, <span class="hlFld-ContribAuthor ">Morris J.  Birnbaum</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Tesz</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2021,</strong> <em>48 </em>, 101196. <a href="https://doi.org/10.1016/j.molmet.2021.101196" title="DOI URL">https://doi.org/10.1016/j.molmet.2021.101196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2021.101196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2021.101196%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DPharmacologic%252Binhibition%252Bof%252Bketohexokinase%252Bprevents%252Bfructose-induced%252Bmetabolic%252Bdysfunction%26aulast%3DGutierrez%26aufirst%3DJemy%2BA.%26date%3D2021%26volume%3D48%26spage%3D101196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Somaya  Albhaisi</span>, <span class="hlFld-ContribAuthor ">Arun J.  Sanyal</span>. </span><span class="cited-content_cbyCitation_article-title">Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.665987" title="DOI URL">https://doi.org/10.3389/fendo.2021.665987</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.665987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.665987%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DGene-Environmental%252BInteractions%252Bas%252BMetabolic%252BDrivers%252Bof%252BNonalcoholic%252BSteatohepatitis%26aulast%3DAlbhaisi%26aufirst%3DSomaya%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grace  Park</span>, <span class="hlFld-ContribAuthor ">Sunhee  Jung</span>, <span class="hlFld-ContribAuthor ">Kathryn E.  Wellen</span>, <span class="hlFld-ContribAuthor ">Cholsoon  Jang</span>. </span><span class="cited-content_cbyCitation_article-title">The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. </span><span class="cited-content_cbyCitation_journal-name">Experimental & Molecular Medicine</span><span> <strong>2021,</strong> <em>53 </em>
                                    (5)
                                     , 809-822. <a href="https://doi.org/10.1038/s12276-021-00614-x" title="DOI URL">https://doi.org/10.1038/s12276-021-00614-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s12276-021-00614-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs12276-021-00614-x%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520%2526%2520Molecular%2520Medicine%26atitle%3DThe%252Binteraction%252Bbetween%252Bthe%252Bgut%252Bmicrobiota%252Band%252Bdietary%252Bcarbohydrates%252Bin%252Bnonalcoholic%252Bfatty%252Bliver%252Bdisease%26aulast%3DPark%26aufirst%3DGrace%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D5%26spage%3D809%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Synthesis of PF-06835919. </span><span class="cited-content_cbyCitation_journal-name">Synfacts</span><span> <strong>2021,</strong>,, 0132. <a href="https://doi.org/10.1055/s-0040-1719323" title="DOI URL">https://doi.org/10.1055/s-0040-1719323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1719323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1719323%26sid%3Dliteratum%253Aachs%26jtitle%3DSynfacts%26atitle%3DSynthesis%252Bof%252BPF-06835919%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D02%26spage%3D0132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0016.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) In vitro profile of <b>1</b>. (B) Co-crystal structure of <b>1</b> in human KHK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ">5WBZ</a>), highlighting four different interaction subregions in the ATP pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Genesis of the azetidine-based KHK inhibitor <b>3</b>. (B) Compound <b>3</b> (shown in green) in the KHK crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W">6W0W</a>). For comparison, compound <b>2</b> (shown in dark gray) was overlaid (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0N">6W0N</a>). (C) Detailed view of compound <b>3</b> (shown in green) in the KHK crystal structure. A sphere represents a simulated water by HydroSite analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Genesis of <b>4</b> bearing the 3-azabicyclo[3.1.0]hexane group. (B) The binding mode of compound <b>4</b> (shown in green; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0X">6W0X</a>). Arg-108 and Thr-253 are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Co-crystal structure of <b>6</b> in human KHK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Y">6W0Y</a>) highlighting key hydrogen-bonding interactions. Gly-257 and Gly-255 (backbone NH’s within the hydrogen-bonding distances), a bound water, and Arg-108 are highlighted. The dotted lines indicate potential hydrogen-bonding distances.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Design strategy to reduce glucuronidation of <b>6</b> by UGTs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Biochemical characterizations of <b>8</b>. (i) Effect of substrate concentrations on KHK-C IC<sub>50</sub>. (ii) tight binding inhibition of KHK-C by <b>8</b>. (iii) Modality of compound <b>8</b> inhibition. (iv) Reversibility of compound <b>8</b> inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Binding mode of <b>8</b> in the crystal structure highlighting key hydrogen-bonding interactions (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Z">6W0Z</a>). Backbone NHs of Phe-245, Gly-257, and Gly-255, two bound waters, and Arg-108 are highlighted. The dotted lines indicate potential hydrogen-bonding distances.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Hepatic and renal concentration of fructose 1-phosphate (F1P) following oral administrations of <b>8</b> and iv fructose bolus in Sprague–Dawley rats. A nonlinear dose–response curve was fitted to a variable slope (four parameter) using GraphPad Prism, and the calculated ED<sub>50</sub> values for kidney and liver F1P reduction are reported. Data are presented as mean values (±standard error) with <i>n</i> = 7–8 per data points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyridines <b>2</b>–<b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>11</b>, Et<sub>3</sub>N, DMF; (b) <b>12</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (c) (i) <i>rac</i>-<b>13</b>, Et<sub>3</sub>N, DMF, 60 °C, (ii) SFC separation; (d) (i) <b>14</b>, K<sub>2</sub>CO<sub>3</sub>, NaHCO<sub>3</sub>, 85%, (ii) <b>13</b>/(<i>R</i>)-CSA, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 85 °C, 53%; (e) (i) <b>15</b>, Et<sub>3</sub>N, DMF, (ii) <b>13</b>·HCl, Et<sub>3</sub>N, CH<sub>3</sub>CN, 60 °C, (iii) 2 M NaOH, EtOH; (f) (i) <b>16</b>, NaHCO<sub>3</sub>, EtOH, (ii) <b>13</b>/(<i>R</i>)-CSA, NaHCO<sub>3</sub>, EtOH, 80 °C, (iii) 1 M NaOH, EtOH, 44% over three steps.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Precedented Amines Used in S<sub>N</sub>Ar Chemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Azetidine <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Br<sub>2</sub>, CHCl<sub>3</sub>, 0–15 °C; (b) aq KOH, THF, 15 °C to rt; (c) Ph<sub>2</sub>CHNH<sub>2</sub>, NaHCO<sub>3</sub>, EtOH, rt to 80 °C; 37% over three steps; (d) Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (55 psi), EtOH, quant, or (i) SFC separation, (ii) 4 M HCl in dioxane, EtOH, Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (50 psi), 89%; (e) (i) (<i>R</i>)-CSA, EtOH, (ii) MTBE crystallization, (iii) CH<sub>2</sub>Cl<sub>2</sub>, EtOAc recrystallization; 32% over two steps; (f) Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (60 psi), MeOH, 95%.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Amino Esters <b>16</b> and <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) Et<sub>3</sub>N, MsCl, DMF, THF, 0–10 °C, (ii) NaCN, DMF, 73%, over two steps; (b) (i) HCl, MeOH, (ii) SOCl<sub>2</sub>, PhCH<sub>3</sub>, 91%, (iii) NaCN, DMF, 93%; (c) (i) H<sub>2</sub>SO<sub>4</sub>, EtOH, 80 °C, 82%, (ii) Pd(OH)<sub>2</sub>/C, H<sub>2</sub> (50 psi), 50 °C, 91%; (d) (i) AcCl, MeOH, 0–65 °C, 82%, (ii) HCl, MeOH, 88%, (iii) Pd(OH)<sub>2</sub>, H<sub>2</sub> (100 psi), MeOH, 70 °C, 99%.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/medium/jm0c00944_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthesis of Pyrimidines <b>7</b> and <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00944/20201120/images/large/jm0c00944_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00944&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>16</b>, NaHCO<sub>3</sub>, EtOH, 81%; (b) <b>26</b>·HCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, −70 to −60 °C; (c) <b>13</b>/(<i>R</i>)-CSA, Et<sub>3</sub>N, CH<sub>3</sub>CN, 70 °C, 87%; (d) <b>17</b>/(<i>R</i>)-CSA, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, 60 °C; (e) aq NaOH, EtOH, 97%; (f) (i) aq NaOH, MeOH, (ii) crystallization from MTBE–heptane, 73% yield over four steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stanhope, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyachenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGahan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otokozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beysen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerstein, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havel, P. J.</span></span> <span> </span><span class="NLM_article-title">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1172/JCI37385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1172%2FJCI37385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=19381015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=1322-1334&author=K.+L.+Stanhopeauthor=J.+M.+Schwarzauthor=N.+L.+Keimauthor=S.+C.+Griffenauthor=A.+A.+Bremerauthor=J.+L.+Grahamauthor=B.+Hatcherauthor=C.+L.+Coxauthor=A.+Dyachenkoauthor=W.+Zhangauthor=J.+P.+McGahanauthor=A.+Seibertauthor=R.+M.+Kraussauthor=S.+Chiuauthor=E.+J.+Schaeferauthor=M.+Aiauthor=S.+Otokozawaauthor=K.+Nakajimaauthor=T.+Nakanoauthor=C.+Beysenauthor=M.+K.+Hellersteinauthor=L.+Berglundauthor=P.+J.+Havel&title=Consuming+fructose-sweetened%2C+not+glucose-sweetened%2C+beverages+increases+visceral+adiposity+and+lipids+and+decreases+insulin+sensitivity+in+overweight%2Fobese+humans&doi=10.1172%2FJCI37385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</span></div><div class="casAuthors">Stanhope, Kimber L.; Schwarz, Jean Marc; Keim, Nancy L.; Griffen, Steven C.; Bremer, Andrew A.; Graham, James L.; Hatcher, Bonnie; Cox, Chad L.; Dyachenko, Artem; Zhang, Wei; McGahan, John P.; Seibert, Anthony; Krauss, Ronald M.; Chiu, Sally; Schaefer, Ernst J.; Ai, Masumi; Otokozawa, Seiko; Nakajima, Katsuyuki; Nakano, Takamitsu; Beysen, Carine; Hellerstein, Marc K.; Berglund, Lars; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1322-1334</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance.  To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 wk.  Although both groups exhibited similar wt. gain during the intervention, visceral adipose vol. was significantly increased only in subjects consuming fructose.  Fasting plasma triglyceride concns. increased by approx. 10% during 10 wk of glucose consumption but not after fructose consumption.  In contrast, hepatic de novo lipogenesis (DNL) and the 23-h postprandial triglyceride AUC were increased specifically during fructose consumption.  Similarly, markers of altered lipid metab. and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concns. of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption.  In addn., fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose.  These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGNXGbG-wmzLVg90H21EOLACvtfcHk0liPExQrtTEOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFyrtrg%253D&md5=aeac5902da6dc4d0ae1a023f3b22d536</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1172%2FJCI37385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI37385%26sid%3Dliteratum%253Aachs%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DGriffen%26aufirst%3DS.%2BC.%26aulast%3DBremer%26aufirst%3DA.%2BA.%26aulast%3DGraham%26aufirst%3DJ.%2BL.%26aulast%3DHatcher%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DDyachenko%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMcGahan%26aufirst%3DJ.%2BP.%26aulast%3DSeibert%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DChiu%26aufirst%3DS.%26aulast%3DSchaefer%26aufirst%3DE.%2BJ.%26aulast%3DAi%26aufirst%3DM.%26aulast%3DOtokozawa%26aufirst%3DS.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DBeysen%26aufirst%3DC.%26aulast%3DHellerstein%26aufirst%3DM.%2BK.%26aulast%3DBerglund%26aufirst%3DL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DConsuming%2520fructose-sweetened%252C%2520not%2520glucose-sweetened%252C%2520beverages%2520increases%2520visceral%2520adiposity%2520and%2520lipids%2520and%2520decreases%2520insulin%2520sensitivity%2520in%2520overweight%252Fobese%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D1322%26epage%3D1334%26doi%3D10.1172%2FJCI37385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swarbrick, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanhope, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havel, P. J.</span></span> <span> </span><span class="NLM_article-title">Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1017/S0007114508968252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1017%2FS0007114508968252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=18384705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlehtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=947-952&author=M.+M.+Swarbrickauthor=K.+L.+Stanhopeauthor=S.+S.+Elliottauthor=J.+L.+Grahamauthor=R.+M.+Kraussauthor=M.+P.+Christiansenauthor=S.+C.+Griffenauthor=N.+L.+Keimauthor=P.+J.+Havel&title=Consumption+of+fructose-sweetened+beverages+for+10+weeks+increases+postprandial+triacylglycerol+and+apolipoprotein-B+concentrations+in+overweight+and+obese+women&doi=10.1017%2FS0007114508968252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women</span></div><div class="casAuthors">Swarbrick, Michael M.; Stanhope, Kimber L.; Elliott, Sharon S.; Graham, James L.; Krauss, Ronald M.; Christiansen, Mark P.; Griffen, Steven C.; Keim, Nancy L.; Havel, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">947-952</span>CODEN:
                <span class="NLM_cas:coden">BJNUAV</span>;
        ISSN:<span class="NLM_cas:issn">0007-1145</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Fructose consumption in the USA has increased over the past three decades.  During this time, obesity, insulin resistance and the metabolic syndrome have also increased in prevalence.  While diets high in fructose have been shown to promote insulin resistance and increase TAG concns. in animals, there are insufficient data available regarding the long-term metabolic effects of fructose consumption in humans.  The objective of the present study was to investigate the metabolic effects of 10-wk consumption of fructose-sweetened beverages in human subjects under energy-balanced conditions in a controlled research setting.  Following a 4-wk wt.-maintaining complex carbohydrate diet, seven overweight or obese (BMI 26·8-33·3 kg/m2) postmenopausal women were fed an isoenergetic intervention diet, which included a fructose-sweetened beverage with each meal, for 10 wk.  The intervention diet provided 15 % of energy from protein, 30 % from fat and 55 % from carbohydrate (30 % complex carbohydrate, 25 % fructose).  Fasting and postprandial glucose, insulin, TAG and apoB concns. were measured.  Fructose consumption increased fasting glucose concns. and decreased meal-assocd. glucose and insulin responses (P = 0·0002, P = 0·007 and P = 0·013, resp.).  Moreover, after 10 wk of fructose consumption, 14 h postprandial TAG profiles were significantly increased, with the area under the curve at 10 wk being 141 % higher than at baseline (P = 0·04).  Fructose also increased fasting apoB concns. by 19 % (P = 0·043 v. baseline).  In summary, consumption of fructose-sweetened beverages increased postprandial TAG and fasting apoB concns., and the present results suggest that long-term consumption of diets high in fructose could lead to an increased risk of CVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxN4Z-TVdcwbVg90H21EOLACvtfcHk0liGnJVOyHIx5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlehtrrM&md5=f2a74325880c3ce3aeaf732521cf4f5c</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1017%2FS0007114508968252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114508968252%26sid%3Dliteratum%253Aachs%26aulast%3DSwarbrick%26aufirst%3DM.%2BM.%26aulast%3DStanhope%26aufirst%3DK.%2BL.%26aulast%3DElliott%26aufirst%3DS.%2BS.%26aulast%3DGraham%26aufirst%3DJ.%2BL.%26aulast%3DKrauss%26aufirst%3DR.%2BM.%26aulast%3DChristiansen%26aufirst%3DM.%2BP.%26aulast%3DGriffen%26aufirst%3DS.%2BC.%26aulast%3DKeim%26aufirst%3DN.%2BL.%26aulast%3DHavel%26aufirst%3DP.%2BJ.%26atitle%3DConsumption%2520of%2520fructose-sweetened%2520beverages%2520for%252010%2520weeks%2520increases%2520postprandial%2520triacylglycerol%2520and%2520apolipoprotein-B%2520concentrations%2520in%2520overweight%2520and%2520obese%2520women%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2008%26volume%3D100%26spage%3D947%26epage%3D952%26doi%3D10.1017%2FS0007114508968252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmalek, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unalp-Arida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colvin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, A. M.</span></span> <span> </span><span class="NLM_article-title">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1961</span>– <span class="NLM_lpage">1971</span>, <span class="refDoi"> DOI: 10.1002/hep.23535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Fhep.23535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=20301112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1961-1971&author=M.+F.+Abdelmalekauthor=A.+Suzukiauthor=C.+Guyauthor=A.+Unalp-Aridaauthor=R.+Colvinauthor=R.+J.+Johnsonauthor=A.+M.+Diehl&title=Increased+fructose+consumption+is+associated+with+fibrosis+severity+in+patients+with+nonalcoholic+fatty+liver+disease&doi=10.1002%2Fhep.23535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</span></div><div class="casAuthors">Abdelmalek, Manal F.; Suzuki, Ayako; Guy, Cynthia; Unalp-Arida, Aynur; Colvin, Ryan; Johnson, Richard J.; Diehl, Anna Mae</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1961-1971</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption.  Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls.  Because fructose elicits metabolic perturbations that may be hepatotoxic, we investigated the relationship between fructose consumption and disease severity in NAFLD.  We studied 427 adults enrolled in the NASH Clin. Research Network for whom Block food questionnaire data were collected within 3 mo of a liver biopsy.  Fructose consumption was estd. based on reporting (frequency × amt.) of Kool-aid, fruit juices, and nondietary soda intake, expressed as servings per wk, and classified into none, min. to moderate (<7 servings/wk), and daily (≥7 servings/wk).  The assocn. of fructose intake with metabolic and histol. features of NAFLD was analyzed using multiple linear and ordinal logistic regression analyses with and without controlling for other confounding factors.  Increased fructose consumption was univariately assocd. with decreased age (P < 0.0001), male sex (P < 0.0001), hypertriglyceridemia (P < 0.04), low high-d. lipoprotein (HDL) cholesterol (<0.0001), decreased serum glucose (P < 0.001), increased calorie intake (P < 0.0001), and hyperuricemia (P < 0.0001).  After controlling for age, sex, BMI, and total calorie intake, daily fructose consumption was assocd. with lower steatosis grade and higher fibrosis stage (P < 0.05 for each).  In older adults (age ≥ 48 years), daily fructose consumption was assocd. with increased hepatic inflammation (P < 0.05) and hepatocyte ballooning (P = 0.05).  Conclusion: In patients with NAFLD, daily fructose ingestion is assocd. with reduced hepatic steatosis but increased fibrosis.  These results identify a readily modifiable environmental risk factor that may ameliorate disease progression in patients with NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoelIWrtgd0ZrVg90H21EOLACvtfcHk0liGnJVOyHIx5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnslyqsbg%253D&md5=7b9b16653f15980048b9bc3148262989</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1002%2Fhep.23535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.23535%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DC.%26aulast%3DUnalp-Arida%26aufirst%3DA.%26aulast%3DColvin%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26aulast%3DDiehl%26aufirst%3DA.%2BM.%26atitle%3DIncreased%2520fructose%2520consumption%2520is%2520associated%2520with%2520fibrosis%2520severity%2520in%2520patients%2520with%2520nonalcoholic%2520fatty%2520liver%2520disease%26jtitle%3DHepatology%26date%3D2010%26volume%3D51%26spage%3D1961%26epage%3D1971%26doi%3D10.1002%2Fhep.23535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nseir, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosovski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assy, N.</span></span> <span> </span><span class="NLM_article-title">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2009.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.jhep.2009.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=19765850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2009&pages=918-924&author=A.+Abidauthor=O.+Tahaauthor=W.+Nseirauthor=R.+Farahauthor=M.+Grosovskiauthor=N.+Assy&title=Soft+drink+consumption+is+associated+with+fatty+liver+disease+independent+of+metabolic+syndrome&doi=10.1016%2Fj.jhep.2009.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome</span></div><div class="casAuthors">Abid, Ali; Taha, Ola; Nseir, William; Farah, Raymond; Grosovski, Maria; Assy, Nimer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">918-924</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background/Aims: The independent role of soft drink consumption in non-alc. fatty liver disease (NAFLD) patients remains unclear.  We aimed to assess the assocn. between consumption of soft drinks and fatty liver in patients with or without metabolic syndrome.  Methods: We recruited 31 patients (age: 43 ± 12 years) with NAFLD and risk factors for metabolic syndrome, 29 patients with NAFLD and without risk factors for metabolic syndrome, and 30 gender- and age-matched individuals without NAFLD.  The degree of fatty infiltration was measured by ultrasound.  Data on phys. activity and intake of food and soft drinks were collected during two 7-day periods over 6 mo using a food questionnaire.  Insulin resistance, inflammation, and oxidant-antioxidant markers were measured.  Results: We found that 80% of patients with NAFLD had excessive intake of soft drink beverages (>500 cm3/day) compared to 17% of healthy controls (p < 0.001).  The NAFLD group consumed five times more carbohydrates from soft drinks compared to healthy controls (40% vs. 8%, p < 0.001).  Seven percent of patients consumed one soft drink per day, 55% consumed two or three soft drinks per day, and 38% consumed more than four soft drinks per day for most days and for the 6-mo period.  The most common soft drinks were Coca-Cola (regular: 32%; diet: 21%) followed by fruit juices (47%).  Patients with NAFLD with metabolic syndrome had similar malonyldialdehyde, paraoxonase, and C-reactive protein (CRP) levels but higher homeostasis model assessment (HOMA) and higher ferritin than NAFLD patients without metabolic syndrome (HOMA: 8.3 ± 8 vs. 3.7 ± 3.7 mg/dL, p < 0.001; ferritin: 186 ± 192 vs. 87 ± 84 mg/dL, p < 0.01).  Logistic regression anal. showed that soft drink consumption is a strong predictor of fatty liver (odds ratio: 2.0; p < 0.04) independent of metabolic syndrome and CRP level.  Conclusions: NAFLD patients display higher soft drink consumption independent of metabolic syndrome diagnosis.  These findings might optimize NAFLD risk stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMa47NLmenfrVg90H21EOLACvtfcHk0lga9YORlQAf3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1CqurvM&md5=3d004438b6f78fc3a33d11c058d2ebd4</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2009.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2009.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%26aufirst%3DA.%26aulast%3DTaha%26aufirst%3DO.%26aulast%3DNseir%26aufirst%3DW.%26aulast%3DFarah%26aufirst%3DR.%26aulast%3DGrosovski%26aufirst%3DM.%26aulast%3DAssy%26aufirst%3DN.%26atitle%3DSoft%2520drink%2520consumption%2520is%2520associated%2520with%2520fatty%2520liver%2520disease%2520independent%2520of%2520metabolic%2520syndrome%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D51%26spage%3D918%26epage%3D924%26doi%3D10.1016%2Fj.jhep.2009.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colditz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stampfer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, F. B.</span></span> <span> </span><span class="NLM_article-title">Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1001/jama.292.8.927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1001%2Fjama.292.8.927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=15328324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFWgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2004&pages=927-934&author=M.+B.+Schulzeauthor=J.+E.+Mansonauthor=D.+S.+Ludwigauthor=G.+A.+Colditzauthor=M.+J.+Stampferauthor=W.+C.+Willettauthor=F.+B.+Hu&title=Sugar-sweetened+beverages%2C+weight+gain%2C+and+incidence+of+type+2+diabetes+in+young+and+middle-aged+women&doi=10.1001%2Fjama.292.8.927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women</span></div><div class="casAuthors">Schulze, Matthias B.; Manson, JoAnn E.; Ludwig, David S.; Colditz, Graham A.; Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Context: Sugar-sweetened beverages like soft drinks and fruit punches contain large amts. of readily absorbable sugars and may contribute to wt. gain and an increased risk of type 2 diabetes, but these relationships have been minimally addressed in adults.  Objective: To examine the assocn. between consumption of sugar-sweetened beverages and wt. change and risk of type 2 diabetes in women.  Design, Setting, and Participants: Prospective cohort analyses conducted from 1991 to 1999 among women in the Nurses' Health Study II.  The diabetes anal. included 91 249 women free of diabetes and other major chronic diseases at baseline in 1991.  The wt. change anal. included 51 603 women for whom complete dietary information and body wt. were ascertained in 1991, 1995, and 1999.  We identified 741 incident cases of confirmed type 2 diabetes during 716300 person-years of follow-up.  Main Outcome Measures: Wt. gain and incidence of type 2 diabetes.  Results: Those with stable consumption patterns had no difference in wt. gain, but wt. gain over a 4-yr period was highest among women who increased their sugar-sweetened soft drink consumption from 1 or fewer drinks per wk to 1 or more drinks per day (multivariate-adjusted means, 4.69 kg for 1991 to 1995 and 4.20 kg for 1995 to 1999) and was smallest among women who decreased their intake (1.34 and 0.15 kg for the 2 periods, resp.) after adjusting for lifestyle and dietary confounders.  Increased consumption of fruit punch was also assocd. with greater wt. gain compared with decreased consumption.  After adjustment for potential confounders, women consuming 1 or more sugar-sweetened soft drinks per day had a relative risk [RR] of type 2 diabetes of 1.83 (95% confidence interval [CI], 1.42-2.36; P<.001 for trend) compared with those who consumed less than 1 of these beverages per mo.  Similarly, consumption of fruit punch was assocd. with increased diabetes risk (RR for ≥1 drink per day compared with <1 drink per mo, 2.00; 95% CI, 1.33-3.03; P=.001).  Conclusion: Higher consumption of sugar-sweetened beverages is assocd. with a greater magnitude of wt. gain and an increased risk for development of type 2 diabetes in women, possibly by providing excessive calories and large amts. of rapidly absorbable sugars.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaCEtMGRlfQbVg90H21EOLACvtfcHk0lga9YORlQAf3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFWgsbw%253D&md5=b6a432095b16c6961b68dbbe40d5e0ad</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1001%2Fjama.292.8.927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.292.8.927%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DM.%2BB.%26aulast%3DManson%26aufirst%3DJ.%2BE.%26aulast%3DLudwig%26aufirst%3DD.%2BS.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DStampfer%26aufirst%3DM.%2BJ.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26aulast%3DHu%26aufirst%3DF.%2BB.%26atitle%3DSugar-sweetened%2520beverages%252C%2520weight%2520gain%252C%2520and%2520incidence%2520of%2520type%25202%2520diabetes%2520in%2520young%2520and%2520middle-aged%2520women%26jtitle%3DJAMA%26date%3D2004%26volume%3D292%26spage%3D927%26epage%3D934%26doi%3D10.1001%2Fjama.292.8.927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhingra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meigs, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Agostino, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaziano, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasan, R. S.</span></span> <span> </span><span class="NLM_article-title">Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.689935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1161%2FCIRCULATIONAHA.107.689935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=17646581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A280%3ADC%252BD2svksF2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=480-488&author=R.+Dhingraauthor=L.+Sullivanauthor=P.+F.+Jacquesauthor=T.+J.+Wangauthor=C.+S.+Foxauthor=J.+B.+Meigsauthor=R.+B.+D%E2%80%99Agostinoauthor=J.+M.+Gazianoauthor=R.+S.+Vasan&title=Soft+drink+consumption+and+risk+of+developing+cardiometabolic+risk+factors+and+the+metabolic+syndrome+in+middle-aged+adults+in+the+community&doi=10.1161%2FCIRCULATIONAHA.107.689935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community</span></div><div class="casAuthors">Dhingra Ravi; Sullivan Lisa; Jacques Paul F; Wang Thomas J; Fox Caroline S; Meigs James B; D'Agostino Ralph B; Gaziano J Michael; Vasan Ramachandran S</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">480-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Consumption of soft drinks has been linked to obesity in children and adolescents, but it is unclear whether it increases metabolic risk in middle-aged individuals.  METHODS AND RESULTS:  We related the incidence of metabolic syndrome and its components to soft drink consumption in participants in the Framingham Heart Study (6039 person-observations, 3470 in women; mean age 52.9 years) who were free of baseline metabolic syndrome.  Metabolic syndrome was defined as the presence of > or = 3 of the following: waist circumference > or = 35 inches (women) or > or = 40 inches (men); fasting blood glucose > or = 100 mg/dL; serum triglycerides > or = 150 mg/dL; blood pressure > or = 135/85 mm Hg; and high-density lipoprotein cholesterol < 40 mg/dL (men) or < 50 mg/dL (women).  Multivariable models included adjustments for age, sex, physical activity, smoking, dietary intake of saturated fat, trans fat, fiber, magnesium, total calories, and glycemic index.  Cross-sectionally, individuals consuming > or = 1 soft drink per day had a higher prevalence of metabolic syndrome (odds ratio [OR], 1.48; 95% CI, 1.30 to 1.69) than those consuming < 1 drink per day.  On follow-up (mean of 4 years), new-onset metabolic syndrome developed in 717 of 4033 participants (17.8%) consuming < 1 drink/day and in 433 of 2006 persons (21.6%) [corrected] consuming > or = 1 soft drink/day [corrected] Consumption of > or = 1 soft drink per day was associated with increased odds of developing metabolic syndrome (OR, 1.44; 95% CI, 1.20 to 1.74), obesity (OR, 1.31; 95% CI, 1.02 to 1.68), increased waist circumference (OR, 1.30; 95% CI, 1.09 to 1.56), impaired fasting glucose (OR, 1.25; 95% CI, 1.05 to 1.48), higher blood pressure (OR, 1.18; 95% CI, 0.96 to 1.44), hypertriglyceridemia (OR, 1.25; 95% CI, 1.04 to 1.51), and low high-density lipoprotein cholesterol (OR, 1.32; 95% CI 1.06 to 1.64).  CONCLUSIONS:  In middle-aged adults, soft drink consumption is associated with a higher prevalence and incidence of multiple metabolic risk factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVqQi9e4v6oBBrI9DTGjC0fW6udTcc2eZVjnYd3KlKKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svksF2msA%253D%253D&md5=9114e05da09665b85de1308d37fb5ce4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.689935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.689935%26sid%3Dliteratum%253Aachs%26aulast%3DDhingra%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DL.%26aulast%3DJacques%26aufirst%3DP.%2BF.%26aulast%3DWang%26aufirst%3DT.%2BJ.%26aulast%3DFox%26aufirst%3DC.%2BS.%26aulast%3DMeigs%26aufirst%3DJ.%2BB.%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DR.%2BB.%26aulast%3DGaziano%26aufirst%3DJ.%2BM.%26aulast%3DVasan%26aufirst%3DR.%2BS.%26atitle%3DSoft%2520drink%2520consumption%2520and%2520risk%2520of%2520developing%2520cardiometabolic%2520risk%2520factors%2520and%2520the%2520metabolic%2520syndrome%2520in%2520middle-aged%2520adults%2520in%2520the%2520community%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3D480%26epage%3D488%26doi%3D10.1161%2FCIRCULATIONAHA.107.689935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccavello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkin-Cakmak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noworolski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span> <span> </span><span class="NLM_article-title">Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2016.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.atherosclerosis.2016.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=27451002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Slu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=2016&pages=171-177&author=A.+Gugliucciauthor=R.+H.+Lustigauthor=R.+Caccavelloauthor=A.+Erkin-Cakmakauthor=S.+M.+Noworolskiauthor=V.+W.+Taiauthor=M.+J.+Wenauthor=K.+Mulliganauthor=J.+M.+Schwarz&title=Short-term+isocaloric+fructose+restriction+lowers+apoC-III+levels+and+yields+less+atherogenic+lipoprotein+profiles+in+children+with+obesity+and+metabolic+syndrome&doi=10.1016%2Fj.atherosclerosis.2016.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome</span></div><div class="casAuthors">Gugliucci, Alejandro; Lustig, Robert H.; Caccavello, Russell; Erkin-Cakmak, Ayca; Noworolski, Susan M.; Tai, Viva W.; Wen, Michael J.; Mulligan, Kathleen; Schwarz, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">171-177</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dietary fructose may play a role in the pathogenesis of metabolic syndrome (MetS).  In a recently published study of obese children with MetS, we showed that isocaloric fructose restriction reduced fasting triglyceride (TG) and LDL-cholesterol (LDL-C).  In these ancillary analyses, we tested the hypothesis that these effects were also accompanied by improved quant. and qual. changes in LDL and HDL subclasses and their apolipoproteins; as well as change in VLDL, particularly apoC-III.  Obese children with MetS (n = 37) consumed a diet that matched self-reported macronutrient compn. for nine days, with the exception that dietary fructose was reduced from 11.7 ± 4.0% to 3.8 ± 0.5% of daily calories and substituted with glucose (in starch).  Participants underwent fasting biochem. analyses on Days 0 and 10.  HDL and LDL subclasses were analyzed using the Lipoprint HDL and LDL subfraction anal. systems from Quantimetrix.  Significant redns. in apoB (78 ± 24 vs. 66 ± 24 mg/dL) apoC-III (8.7 ± 3.5 vs. 6.5 ± 2.6 mg/dL) and apoE (4.6 ± 2.3 vs. 3.6 ± 1.1 mg/dL), all p < 0.001) were obsd.  LDL size increased by 0.87 Å (p = 0.008).  Small dense LDL was present in 25% of our cohort and decreased by 68% (p = 0.04).  Small HDL decreased by 2.7% (p < 0.001) and large HDL increased by 2.4% (p = 0.04).  The TG/HDL-C ratio decreased from 3.1 ± 2.5 to 2.4 ± 1.4 (p = 0.02).  These changes in fasting lipid profiles correlated with changes in insulin sensitivity.  Isocaloric fructose restriction for 9 days improved lipoprotein markers of CVD risk in children with obesity and MetS.  The most dramatic redn. was seen for apoC-III, which has been assocd. with atherogenic hypertriglyceridemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFIEndRHyndbVg90H21EOLACvtfcHk0lgtMr2yslNIJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Slu7zM&md5=532e7940e97a54cecf0f1ee95e39722d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2016.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2016.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DMulligan%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26atitle%3DShort-term%2520isocaloric%2520fructose%2520restriction%2520lowers%2520apoC-III%2520levels%2520and%2520yields%2520less%2520atherogenic%2520lipoprotein%2520profiles%2520in%2520children%2520with%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DAtherosclerosis%26date%3D2016%26volume%3D253%26spage%3D171%26epage%3D177%26doi%3D10.1016%2Fj.atherosclerosis.2016.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noworolski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkin-Cakmak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span> <span> </span><span class="NLM_article-title">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span>. <i>Obesity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1002/oby.21371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Foby.21371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=26499447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=453-460&author=R.+H.+Lustigauthor=K.+Mulliganauthor=S.+M.+Noworolskiauthor=V.+W.+Taiauthor=M.+J.+Wenauthor=A.+Erkin-Cakmakauthor=A.+Gugliucciauthor=J.+M.+Schwarz&title=Isocaloric+fructose+restriction+and+metabolic+improvement+in+children+with+obesity+and+metabolic+syndrome&doi=10.1002%2Foby.21371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</span></div><div class="casAuthors">Lustig, Robert H.; Mulligan, Kathleen; Noworolski, Susan M.; Tai, Viva W.; Wen, Michael J.; Erkin-Cakmak, Ayca; Gugliucci, Alejandro; Schwarz, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Dietary fructose is implicated in metabolic syndrome, but intervention studies are confounded by pos. caloric balance, changes in adiposity, or artifactually high amts.  This study detd. whether isocaloric substitution of starch for sugar would improve metabolic parameters in Latino (n = 27) and African-American (n = 16) children with obesity and metabolic syndrome.  Methods : Participants consumed a diet for 9 days to deliver comparable percentages of protein, fat, and carbohydrate as their self-reported diet; however, dietary sugar was reduced from 28% to 10% and substituted with starch.  Participants recorded daily wts., with calories adjusted for wt. maintenance.  Participants underwent dual-energy X-ray absorptiometry and oral glucose tolerance testing on Days 0 and 10.  Biochem. analyses were controlled for wt. change by repeated measures ANCOVA.  Results : Redns. in diastolic blood pressure (-5 mmHg; P = 0.002), lactate (-0.3 mmol/L; P < 0.001), triglyceride, and LDL-cholesterol (-46% and -0.3 mmol/L; P < 0.001) were noted.  Glucose tolerance and hyperinsulinemia improved (P < 0.001).  Wt. reduced by 0.9 ± 0.2 kg (P < 0.001) and fat-free mass by 0.6 kg (P = 0.04).  Post hoc sensitivity anal. demonstrates that results in the subcohort that did not lose wt. (n = 10) were directionally consistent.  Conclusions : Isocaloric fructose restriction improved surrogate metabolic parameters in children with obesity and metabolic syndrome irresp. of wt. change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK8UFgsIj787Vg90H21EOLACvtfcHk0li8SMaot2Pppg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2lsbs%253D&md5=4486cd76573a96339298ecb5b7694da8</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Foby.21371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Foby.21371%26sid%3Dliteratum%253Aachs%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DK.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26atitle%3DIsocaloric%2520fructose%2520restriction%2520and%2520metabolic%2520improvement%2520in%2520children%2520with%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DObesity%26date%3D2016%26volume%3D24%26spage%3D453%26epage%3D460%26doi%3D10.1002%2Foby.21371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noworolski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erkin-Cakmak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korn, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palii, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco-Alin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, K.</span></span> <span> </span><span class="NLM_article-title">Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2017.05.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1053%2Fj.gastro.2017.05.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=28579536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVSltLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2017&pages=743-752&author=J.+M.+Schwarzauthor=S.+M.+Noworolskiauthor=A.+Erkin-Cakmakauthor=N.+J.+Kornauthor=M.+J.+Wenauthor=V.+W.+Taiauthor=G.+M.+Jonesauthor=S.+P.+Paliiauthor=M.+Velasco-Alinauthor=K.+Panauthor=B.+W.+Pattersonauthor=A.+Gugliucciauthor=R.+H.+Lustigauthor=K.+Mulligan&title=Effects+of+dietary+fructose+restriction+on+liver+fat%2C+de+novo+lipogenesis%2C+and+insulin+kinetics+in+children+with+obesity&doi=10.1053%2Fj.gastro.2017.05.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity</span></div><div class="casAuthors">Schwarz, Jean-Marc; Noworolski, Susan M.; Erkin-Cakmak, Ayca; Korn, Natalie J.; Wen, Michael J.; Tai, Viva W.; Jones, Grace M.; Palii, Sergiu P.; Velasco-Alin, Moises; Pan, Karen; Patterson, Bruce W.; Gugliucci, Alejandro; Lustig, Robert H.; Mulligan, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">743-752</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Consumption of sugar is assocd. with obesity, type 2 diabetes mellitus, nonalcoholic fatty liver disease, and cardiovascular disease.  The conversion of fructose to fat in liver (de novo lipogenesis [DNL]) may be a modifiable pathogenetic pathway.  We detd. the effect of 9 days of isocaloric fructose restriction on DNL, liver fat, visceral fat (VAT), s.c. fat, and insulin kinetics in obese Latino and African American children with habitual high sugar consumption (fructose intake >50 g/d).  Children (9-18 years old; n = 41) had all meals provided for 9 days with the same energy and macronutrient compn. as their std. diet, but with starch substituted for sugar, yielding a final fructose content of 4% of total kilocalories.  Metabolic assessments were performed before and after fructose restriction.  Liver fat, VAT, and s.c. fat were detd. by magnetic resonance spectroscopy and imaging.  The fractional DNL area under the curve value was measured using stable isotope tracers and gas chromatog./mass spectrometry.  Insulin kinetics were calcd. from oral glucose tolerance tests.  Paired analyses compared change from day 0 to day 10 within each child.  Compared with baseline, on day 10, liver fat decreased from a median of 7.2% (interquartile range [IQR], 2.5%-14.8%) to 3.8% (IQR, 1.7%-15.5%) (P < .001) and VAT decreased from 123 cm3 (IQR, 85-145 cm3) to 110 cm3 (IQR, 84-134 cm3) (P < .001).  The DNL area under the curve decreased from 68% (IQR, 46%-83%) to 26% (IQR, 16%-37%) (P < .001).  Insulin kinetics improved (P < .001).  These changes occurred irresp. of baseline liver fat.  Short-term (9 days) isocaloric fructose restriction decreased liver fat, VAT, and DNL, and improved insulin kinetics in children with obesity.  These findings support efforts to reduce sugar consumption.  ClinicalTrials.gov No.: NCT01200043.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrBB4uX9noIrVg90H21EOLACvtfcHk0li8SMaot2Pppg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVSltLbI&md5=5883c71c9e7e945b78c05f044955f164</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2017.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2017.05.043%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DJ.%2BM.%26aulast%3DNoworolski%26aufirst%3DS.%2BM.%26aulast%3DErkin-Cakmak%26aufirst%3DA.%26aulast%3DKorn%26aufirst%3DN.%2BJ.%26aulast%3DWen%26aufirst%3DM.%2BJ.%26aulast%3DTai%26aufirst%3DV.%2BW.%26aulast%3DJones%26aufirst%3DG.%2BM.%26aulast%3DPalii%26aufirst%3DS.%2BP.%26aulast%3DVelasco-Alin%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DK.%26aulast%3DPatterson%26aufirst%3DB.%2BW.%26aulast%3DGugliucci%26aufirst%3DA.%26aulast%3DLustig%26aufirst%3DR.%2BH.%26aulast%3DMulligan%26aufirst%3DK.%26atitle%3DEffects%2520of%2520dietary%2520fructose%2520restriction%2520on%2520liver%2520fat%252C%2520de%2520novo%2520lipogenesis%252C%2520and%2520insulin%2520kinetics%2520in%2520children%2520with%2520obesity%26jtitle%3DGastroenterology%26date%3D2017%26volume%3D153%26spage%3D743%26epage%3D752%26doi%3D10.1053%2Fj.gastro.2017.05.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cori, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochoa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slein, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cori, C. F.</span></span> <span> </span><span class="NLM_article-title">The metabolism of fructose in liver; isolation of fructose-I-phosphate and inorganic pyrophosphate</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1016/0006-3002(51)90032-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2F0006-3002%2851%2990032-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=14858418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaG38XlvFSl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1951&pages=304-317&author=G.+T.+Coriauthor=S.+Ochoaauthor=M.+W.+Sleinauthor=C.+F.+Cori&title=The+metabolism+of+fructose+in+liver%3B+isolation+of+fructose-I-phosphate+and+inorganic+pyrophosphate&doi=10.1016%2F0006-3002%2851%2990032-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of fructose in liver. Isolation of fructose-1-phosphate and inorganic pyrophosphate</span></div><div class="casAuthors">Cori, Gerty T.; Ochoa, Severo; Slein, Milton W.; Cori, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">304-17</span>CODEN:
                <span class="NLM_cas:coden">BBACAQ</span>;
        ISSN:<span class="NLM_cas:issn">0006-3002</span>.
    </div><div class="casAbstract">cf. Leuthardt and Testa, C.A. 45, 8568f.  The conversion of fructose to glucose in liver homogenates involves the intermediary formation of fructose-1-phosphate.  The latter accumulates in soln. in the presence of fluoride, and was characterized polarimetrically, by chemical tests, and by comparison with a synthetic sample.  Inorg. pyrophosphate was also formed.  A protein fraction pptd. from liver exts. catalyzes the conversion of fructose-1-phosphate to hexose-6-phosphate.  This reaction is accelerated by Mg and inhibited by fluoride.  In liver homogenate the hexose-6-phosphate is dephosphorylated to glucose and inorg. phosphate.  The mechanism leading to the formation of the isolated intermediate is therefore fully explained.  The formation of fructose-1-phosphate was also studied, and found not to be inhibited by glucose.  The responsible enzyme, liver fructokinase, is more active in aerobic systems with small amts. of adenosine triphosphate (ATP) than in anaerobic systems with excess ATP.  A summary of all enzymic processes concerned with fructose metabolism is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphi8XNP7_EsrVg90H21EOLACvtfcHk0li8UTf1t4Xuqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XlvFSl&md5=6549bfe3a28d3862d6a37d4f80233985</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2F0006-3002%2851%2990032-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3002%252851%252990032-7%26sid%3Dliteratum%253Aachs%26aulast%3DCori%26aufirst%3DG.%2BT.%26aulast%3DOchoa%26aufirst%3DS.%26aulast%3DSlein%26aufirst%3DM.%2BW.%26aulast%3DCori%26aufirst%3DC.%2BF.%26atitle%3DThe%2520metabolism%2520of%2520fructose%2520in%2520liver%253B%2520isolation%2520of%2520fructose-I-phosphate%2520and%2520inorganic%2520pyrophosphate%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1951%26volume%3D7%26spage%3D304%26epage%3D317%26doi%3D10.1016%2F0006-3002%2851%2990032-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmann, B.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1631</span>, <span class="refDoi"> DOI: 10.1093/hmg/3.9.1627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1093%2Fhmg%2F3.9.1627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=7833921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1994&pages=1627-1631&author=D.+T.+Bonthronauthor=N.+Bradyauthor=I.+A.+Donaldsonauthor=B.+Steinmann&title=Molecular+basis+of+essential+fructosuria%3A+molecular+cloning+and+mutational+analysis+of+human+ketohexokinase+%28fructokinase%29&doi=10.1093%2Fhmg%2F3.9.1627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase)</span></div><div class="casAuthors">Bonthron, David T.; Brady, Nicola; Donaldson, Iain A.; Steinmann, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1627-31</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    </div><div class="casAbstract">Essential fructosuria is one of the oldest known inborn errors of metab.  It is a benign condition which is believed to result from deficiency of hepatic fructokinase (ketohexokinase, KHK, E.C.2.7.1.3.).  This enzyme catalyzes the first step of metab. of dietary fructose, conversion of fructose to fructose-1-phosphate.  Despite the early recognition of this disorder, the primary structure of human KHK and the mol. basis of essential fructosuria have not been previously defined.  In this report, the isolation and sequencing of full-length cDNA clones encoding human ketohexokinase are described.  Alternative mRNA species and alternative KHK isoenzymes are produced by alternative polyadenylation and splicing of the KHK gene.  The KHK proteins show a high level of sequence conservation relative to rat KHK.  Direct evidence that mutation of the KHK structural gene is the cause of essential fructosuria was also obtained.  In a well-characterized family, in which 3 of 8 siblings have fructosuria, all affected individuals are compd. heterozygotes for 2 mutations Gly40Arg and Ala43Thr.  Both mutations result from G→A transitions, and each alters the same conserved region of the KHK protein.  Neither mutation was seen in a sample of 52 unrelated control individuals.  An addnl. conservative amino acid change (Val49IIe) was present on the KHK allele bearing Ala43Thr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhKZtroZ3uLVg90H21EOLACvtfcHk0li8UTf1t4Xuqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVGnt78%253D&md5=1e3f908a2d87d3a49c4897aa84ac3345</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F3.9.1627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F3.9.1627%26sid%3Dliteratum%253Aachs%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DBrady%26aufirst%3DN.%26aulast%3DDonaldson%26aufirst%3DI.%2BA.%26aulast%3DSteinmann%26aufirst%3DB.%26atitle%3DMolecular%2520basis%2520of%2520essential%2520fructosuria%253A%2520molecular%2520cloning%2520and%2520mutational%2520analysis%2520of%2520human%2520ketohexokinase%2520%2528fructokinase%2529%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1994%26volume%3D3%26spage%3D1627%26epage%3D1631%26doi%3D10.1093%2Fhmg%2F3.9.1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hers, H. G.</span></span> <span> </span><span class="NLM_article-title">Liver fructokinase</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/0006-3002(52)90067-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2F0006-3002%2852%2990067-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=13208667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaG38Xkt1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1952&pages=416-423&author=H.+G.+Hers&title=Liver+fructokinase&doi=10.1016%2F0006-3002%2852%2990067-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Fructokinase of liver</span></div><div class="casAuthors">Hers, H. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">416-23</span>CODEN:
                <span class="NLM_cas:coden">BBACAQ</span>;
        ISSN:<span class="NLM_cas:issn">0006-3002</span>.
    </div><div class="casAbstract">An enzyme (I), catalyzing the phosphorylation of fructose and sorbose with the aid of adenosine triphosphate, and inactive toward aldohexoses, has been purified from beef liver.  The product of the fructokinase reaction has been isolated and identified as fructose I-phosphate.  It is probable that sorbose 1-phosphate is formed when sorbose is phosphorytated by I.  I is inactive in the absence of Mg or Mn and is strongly activated by M AcOK or KCl.  Between 5.5 and 7.8, the pH does not influence the rate of the reaction.  The affinity of I for fructose is large, the Michaelis const. being certainly lower than 5 × 10-4 M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQiCFXFq1bV7Vg90H21EOLACvtfcHk0li8UTf1t4Xuqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38Xkt1Gkug%253D%253D&md5=3e916eaef4953444fbe6a378a7de4a62</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2F0006-3002%2852%2990067-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3002%252852%252990067-X%26sid%3Dliteratum%253Aachs%26aulast%3DHers%26aufirst%3DH.%2BG.%26atitle%3DLiver%2520fructokinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1952%26volume%3D8%26spage%3D416%26epage%3D423%26doi%3D10.1016%2F0006-3002%2852%2990067-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanaspa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclean, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asipu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal-Jimenez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Iturbe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Lozada, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautin, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. J.</span></span> <span> </span><span class="NLM_article-title">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4325</span>, <span class="refDoi"> DOI: 10.1073/pnas.1119908109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1073%2Fpnas.1119908109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=22371574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=4320-4325&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=M.+T.+Leauthor=G.+E.+Garciaauthor=C.+P.+Diggleauthor=P.+S.+Macleanauthor=M.+R.+Jackmanauthor=A.+Asipuauthor=C.+A.+Roncal-Jimenezauthor=T.+Kosugiauthor=C.+J.+Rivardauthor=S.+Maruyamaauthor=B.+Rodriguez-Iturbeauthor=L.+G.+Sanchez-Lozadaauthor=D.+T.+Bonthronauthor=Y.+Y.+Sautinauthor=R.+J.+Johnson&title=Opposing+effects+of+fructokinase+C+and+A+isoforms+on+fructose-induced+metabolic+syndrome+in+mice&doi=10.1073%2Fpnas.1119908109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Le, My Phuong T.; Garcia, Gabriela E.; Diggle, Christine P.; MacLean, Paul S.; Jackman, Matthew R.; Asipu, Aruna; Roncal-Jimenez, Carlos A.; Kosugi, Tomoki; Rivard, Christopher J.; Maruyama, Shoichi; Rodriguez-Iturbe, Bernardo; Snchez-Lozada, Laura G.; Bonthron, David T.; Sautin, Yuri Y.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4325, S4320/1-S4320/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fructose intake from added sugars correlates with the epidemic rise in obesity, metabolic syndrome, and nonalcoholic fatty liver disease.  Fructose intake also causes features of metabolic syndrome in lab. animals and humans.  The first enzyme in fructose metab. is fructokinase, which exists as two isoforms, A and C.  Here we show that fructose-induced metabolic syndrome is prevented in mice lacking both isoforms but is exacerbated in mice lacking fructokinase A.  Fructokinase C is expressed primarily in liver, intestine, and kidney and has high affinity for fructose, resulting in rapid metab. and marked ATP depletion.  In contrast, fructokinase A is widely distributed, has low affinity for fructose, and has less dramatic effects on ATP levels.  By reducing the amt. of fructose for metab. in the liver, fructokinase A protects against fructokinase C-mediated metabolic syndrome.  These studies provide insights into the mechanisms by which fructose causes obesity and metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobK1Ob9TEhNbVg90H21EOLACvtfcHk0lhFy47A0xkbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslGltbc%253D&md5=fd8c85c10a00df73910e0937a4220b47</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1119908109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1119908109%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DLe%26aufirst%3DM.%2BT.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DMaclean%26aufirst%3DP.%2BS.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DRodriguez-Iturbe%26aufirst%3DB.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DOpposing%2520effects%2520of%2520fructokinase%2520C%2520and%2520A%2520isoforms%2520on%2520fructose-induced%2520metabolic%2520syndrome%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D4320%26epage%3D4325%26doi%3D10.1073%2Fpnas.1119908109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morscher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span> <span> </span><span class="NLM_article-title">The small intestine converts dietary fructose into glucose and organic acids</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2017.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.cmet.2017.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=29414685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvFylsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=351-361&author=C.+Jangauthor=S.+Huiauthor=W.+Luauthor=A.+J.+Cowanauthor=R.+J.+Morscherauthor=G.+Leeauthor=W.+Liuauthor=G.+J.+Teszauthor=M.+J.+Birnbaumauthor=J.+D.+Rabinowitz&title=The+small+intestine+converts+dietary+fructose+into+glucose+and+organic+acids&doi=10.1016%2Fj.cmet.2017.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids</span></div><div class="casAuthors">Jang, Cholsoon; Hui, Sheng; Lu, Wenyun; Cowan, Alexis J.; Morscher, Raphael J.; Lee, Gina; Liu, Wei; Tesz, Gregory J.; Birnbaum, Morris J.; Rabinowitz, Joshua D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-361.e3</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Excessive consumption of sweets is a risk factor for metabolic syndrome.  A major chem. feature of sweets is fructose.  Despite strong ties between fructose and disease, the metabolic fate of fructose in mammals remains incompletely understood.  Here we use isotope tracing and mass spectrometry to track the fate of glucose and fructose carbons in vivo, finding that dietary fructose is cleared by the small intestine.  Clearance requires the fructose-phosphorylating enzyme ketohexokinase.  Low doses of fructose are ∼90% cleared by the intestine, with only trace fructose but extensive fructose-derived glucose, lactate, and glycerate found in the portal blood.  High doses of fructose (≥1 g/kg) overwhelm intestinal fructose absorption and clearance, resulting in fructose reaching both the liver and colonic microbiota.  Intestinal fructose clearance is augmented both by prior exposure to fructose and by feeding.  We propose that the small intestine shields the liver from otherwise toxic fructose exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAo4sKE7cITrVg90H21EOLACvtfcHk0lhFy47A0xkbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvFylsr4%253D&md5=b32174b2c64a2d3bd662d8ecde0becc2</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DC.%26aulast%3DHui%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DCowan%26aufirst%3DA.%2BJ.%26aulast%3DMorscher%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520small%2520intestine%2520converts%2520dietary%2520fructose%2520into%2520glucose%2520and%2520organic%2520acids%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26spage%3D351%26epage%3D361%26doi%3D10.1016%2Fj.cmet.2017.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shires, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markham, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asipu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span> <span> </span><span class="NLM_article-title">Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1369/jhc.2009.953190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1369%2Fjhc.2009.953190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=19365088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFeqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=763-774&author=C.+P.+Diggleauthor=M.+Shiresauthor=D.+Leitchauthor=D.+Brookeauthor=I.+M.+Carrauthor=A.+F.+Markhamauthor=B.+E.+Haywardauthor=A.+Asipuauthor=D.+T.+Bonthron&title=Ketohexokinase%3A+expression+and+localization+of+the+principal+fructose-metabolizing+enzyme&doi=10.1369%2Fjhc.2009.953190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme</span></div><div class="casAuthors">Diggle, Christine P.; Shires, Michael; Leitch, Derek; Brooke, David; Carr, Ian M.; Markham, Alex F.; Hayward, Bruce E.; Asipu, Aruna; Bonthron, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">763-774</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Ketohexokinase (KHK, also known as fructokinase) initiates the pathway through which most dietary fructose is metabolized.  Very little is known about the cellular localization of this enzyme.  Alternatively spliced KHK-C and KHK-A mRNAs are known, but the existence of the KHK-A protein isoform has not been demonstrated in vivo.  Using antibodies to KHK for immunohistochem. and Western blotting of rodent tissues, including those from mouse knockouts, coupled with RT-PCR assays, we detd. the distribution of the splice variants.  The highly expressed KHK-C isoform localized to hepatocytes in the liver and to the straight segment of the proximal renal tubule.  In both tissues, cytoplasmic and nuclear staining was obsd.  The KHK-A mRNA isoform was obsd. exclusively in a range of other tissues, and by Western blotting, the presence of endogenous immunoreactive KHK-A protein was shown for the first time, proving that the KHK-A mRNA is translated into KHK-A protein in vivo, and supporting the suggestion that this evolutionarily conserved isoform is physiol. functional.  However, the low levels of KHK-A expression prevented its immunohistochem. localization within these tissues.  Our results highlight that the use of in vivo biol. controls (tissues from knockout animals) is required to distinguish genuine KHK immunoreactivity from exptl. artifact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcqnTh2qq4ELVg90H21EOLACvtfcHk0lhFy47A0xkbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFeqsrs%253D&md5=924a1224cecba428fc2cbe80af3e4ccb</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1369%2Fjhc.2009.953190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.2009.953190%26sid%3Dliteratum%253Aachs%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DShires%26aufirst%3DM.%26aulast%3DLeitch%26aufirst%3DD.%26aulast%3DBrooke%26aufirst%3DD.%26aulast%3DCarr%26aufirst%3DI.%2BM.%26aulast%3DMarkham%26aufirst%3DA.%2BF.%26aulast%3DHayward%26aufirst%3DB.%2BE.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26atitle%3DKetohexokinase%253A%2520expression%2520and%2520localization%2520of%2520the%2520principal%2520fructose-metabolizing%2520enzyme%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2009%26volume%3D57%26spage%3D763%26epage%3D774%26doi%3D10.1369%2Fjhc.2009.953190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanaspa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal-Jimenez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlicky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicerchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahan, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmalek, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asipu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Lozada, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautin, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. J.</span></span> <span> </span><span class="NLM_article-title">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1632</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.1002/hep.26594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Fhep.26594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=23813872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=1632-1643&author=T.+Ishimotoauthor=M.+A.+Lanaspaauthor=C.+J.+Rivardauthor=C.+A.+Roncal-Jimenezauthor=D.+J.+Orlickyauthor=C.+Cicerchiauthor=R.+H.+McMahanauthor=M.+F.+Abdelmalekauthor=H.+R.+Rosenauthor=M.+R.+Jackmanauthor=P.+S.+MacLeanauthor=C.+P.+Diggleauthor=A.+Asipuauthor=S.+Inabaauthor=T.+Kosugiauthor=W.+Satoauthor=S.+Maruyamaauthor=L.+G.+Sanchez-Lozadaauthor=Y.+Y.+Sautinauthor=J.+O.+Hillauthor=D.+T.+Bonthronauthor=R.+J.+Johnson&title=High-fat+and+high-sucrose+%28western%29+diet+induces+steatohepatitis+that+is+dependent+on+fructokinase&doi=10.1002%2Fhep.26594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase</span></div><div class="casAuthors">Ishimoto, Takuji; Lanaspa, Miguel A.; Rivard, Christopher J.; Roncal-Jimenez, Carlos A.; Orlicky, David J.; Cicerchi, Christina; McMahan, Rachel H.; Abdelmalek, Manal F.; Rosen, Hugo R.; Jackman, Matthew R.; MacLean, Paul S.; Diggle, Christine P.; Asipu, Aruna; Inaba, Shinichiro; Kosugi, Tomoki; Sato, Waichi; Maruyama, Shoichi; Sanchez-Lozada, Laura G.; Sautin, Yuri Y.; Hill, James O.; Bonthron, David T.; Johnson, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1632-1643</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Fructose intake from added sugars has been implicated as a cause of nonalcoholic fatty liver disease.  Here we tested the hypothesis that fructose may interact with a high-fat diet to induce fatty liver, and to det. if this was dependent on a key enzyme in fructose metab., fructokinase.  Wild-type or fructokinase knockout mice were fed a low-fat (11%), high-fat (36%), or high-fat (36%) and high-sucrose (30%) diet for 15 wk.  Both wild-type and fructokinase knockout mice developed obesity with mild hepatic steatosis and no evidence of hepatic inflammation on a high-fat diet compared to a low-fat diet.  In contrast, wild-type mice fed a high-fat and high-sucrose diet developed more severe hepatic steatosis with low-grade inflammation and fibrosis, as noted by increased CD68, tumor necrosis factor alpha, monocyte chemoattractant protein-1, alpha-smooth muscle actin, and collagen I and TIMP1 expression.  These changes were prevented in the fructokinase knockout mice.  Conclusion: An additive effect of high-fat and high-sucrose diet on the development of hepatic steatosis exists.  Further, the combination of sucrose with high-fat diet may induce steatohepatitis.  The protection in fructokinase knockout mice suggests a key role for fructose (from sucrose) in this development of steatohepatitis.  These studies emphasize the important role of fructose in the development of fatty liver and nonalcoholic steatohepatitis. (Hepatol. 2013;58:1632-1643).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4FrhsSKjOl7Vg90H21EOLACvtfcHk0ljPjD2yoegebA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqsLvE&md5=d4544aba25dd28f735c4e0b76e02cc48</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fhep.26594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26594%26sid%3Dliteratum%253Aachs%26aulast%3DIshimoto%26aufirst%3DT.%26aulast%3DLanaspa%26aufirst%3DM.%2BA.%26aulast%3DRivard%26aufirst%3DC.%2BJ.%26aulast%3DRoncal-Jimenez%26aufirst%3DC.%2BA.%26aulast%3DOrlicky%26aufirst%3DD.%2BJ.%26aulast%3DCicerchi%26aufirst%3DC.%26aulast%3DMcMahan%26aufirst%3DR.%2BH.%26aulast%3DAbdelmalek%26aufirst%3DM.%2BF.%26aulast%3DRosen%26aufirst%3DH.%2BR.%26aulast%3DJackman%26aufirst%3DM.%2BR.%26aulast%3DMacLean%26aufirst%3DP.%2BS.%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DAsipu%26aufirst%3DA.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DW.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DSanchez-Lozada%26aufirst%3DL.%2BG.%26aulast%3DSautin%26aufirst%3DY.%2BY.%26aulast%3DHill%26aufirst%3DJ.%2BO.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DJohnson%26aufirst%3DR.%2BJ.%26atitle%3DHigh-fat%2520and%2520high-sucrose%2520%2528western%2529%2520diet%2520induces%2520steatohepatitis%2520that%2520is%2520dependent%2520on%2520fructokinase%26jtitle%3DHepatology%26date%3D2013%26volume%3D58%26spage%3D1632%26epage%3D1643%26doi%3D10.1002%2Fhep.26594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tounge, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandowski, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struble, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span> <span> </span><span class="NLM_article-title">Electron density guided fragment-based lead discovery of ketohexokinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7979</span>– <span class="NLM_lpage">7991</span>, <span class="refDoi"> DOI: 10.1021/jm100677s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100677s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7979-7991&author=A.+C.+Gibbsauthor=M.+C.+Abadauthor=X.+Zhangauthor=B.+A.+Toungeauthor=F.+A.+Lewandowskiauthor=G.+T.+Strubleauthor=W.+Sunauthor=Z.+Suiauthor=L.+C.+Kuo&title=Electron+density+guided+fragment-based+lead+discovery+of+ketohexokinase+inhibitors&doi=10.1021%2Fjm100677s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors</span></div><div class="casAuthors">Gibbs, Alan C.; Abad, Marta C.; Zhang, Xuqing; Tounge, Brett A.; Lewandowski, Francis A.; Struble, Geoffrey T.; Sun, Weimei; Sui, Zhihua; Kuo, Lawrence C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7979-7991</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fragment-based drug design paradigm has been successfully applied in the discovery of lead series of ketohexokinase inhibitors.  The paradigm consists of three iterations of design, synthesis, and x-ray crystallog. screening to progress low mol. wt. fragments to leadlike compds.  Applying electron d. of fragments within the protein binding site as defined by x-ray crystallog., one can generate target specific leads without the use of affinity data.  Our approach contrasts with most fragment-based drug design methodol. where soln. activity is a main design guide.  Herein we describe the discovery of submicromolar ketohexokinase inhibitors with promising druglike properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOp4ro7Ui4WrVg90H21EOLACvtfcHk0ljPjD2yoegebA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGntr%252FF&md5=3abdf4ac63d4afcf6a4db484d0d87259</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm100677s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100677s%26sid%3Dliteratum%253Aachs%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DAbad%26aufirst%3DM.%2BC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLewandowski%26aufirst%3DF.%2BA.%26aulast%3DStruble%26aufirst%3DG.%2BT.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26atitle%3DElectron%2520density%2520guided%2520fragment-based%2520lead%2520discovery%2520of%2520ketohexokinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7979%26epage%3D7991%26doi%3D10.1021%2Fjm100677s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McComsey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabut, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luci, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. A.</span></span> <span> </span><span class="NLM_article-title">Pyrimidinopyrimidine inhibitors of ketohexokinase: exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5326</span>– <span class="NLM_lpage">5229</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1016%2Fj.bmcl.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=22795331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5326-5229&author=B.+E.+Maryanoffauthor=J.+C.+O%E2%80%99Neillauthor=D.+F.+McComseyauthor=S.+C.+Yabutauthor=D.+K.+Luciauthor=A.+C.+Gibbsauthor=M.+A.+Connelly&title=Pyrimidinopyrimidine+inhibitors+of+ketohexokinase%3A+exploring+the+ring+C2+group+that+interacts+with+Asp-27B+in+the+ligand+binding+pocket&doi=10.1016%2Fj.bmcl.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket</span></div><div class="casAuthors">Maryanoff, Bruce E.; O'Neill, John C.; McComsey, David F.; Yabut, Stephen C.; Luci, Diane K.; Gibbs, Alan C.; Connelly, Margery A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5326-5329</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of ketohexokinase (KHK) have potential for the treatment of diabetes and obesity.  We have continued studies on a pyrimidinopyrimidine series of potent KHK inhibitors by exploring the 2-position substituent (R3) that interacts with Asp-27B in the ATP-binding region of KHK (viz. 1, 2; Table 1).  We found that increased spacing between the terminal ammonium group and the heterocyclic scaffold (viz. 16-20), such that interaction with Asp-27B is not possible, still results in potent KHK inhibition (IC50 = 15-50 nM).  We propose a new interaction with Asp-194, which serves to expand the pyrimidinopyrimidine pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradcYZ9M9bdLVg90H21EOLACvtfcHk0ljIK_SgLYgpFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjtLzK&md5=0da67e40de493f46030c88682482270e</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BC.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DGibbs%26aufirst%3DA.%2BC.%26aulast%3DConnelly%26aufirst%3DM.%2BA.%26atitle%3DPyrimidinopyrimidine%2520inhibitors%2520of%2520ketohexokinase%253A%2520exploring%2520the%2520ring%2520C2%2520group%2520that%2520interacts%2520with%2520Asp-27B%2520in%2520the%2520ligand%2520binding%2520pocket%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5326%26epage%3D5229%26doi%3D10.1016%2Fj.bmcl.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrunyk, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culp, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgoglione, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knafels, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfefferkorn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subashi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, T. V.</span></span> <span> </span><span class="NLM_article-title">Discovery of fragment-derived small molecules for in vivo Inhibition of ketohexokinase (KHK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7835</span>– <span class="NLM_lpage">7849</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVagu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7835-7849&author=K.+Huardauthor=K.+Ahnauthor=P.+Amorauthor=D.+A.+Beebeauthor=K.+A.+Borzilleriauthor=B.+A.+Chrunykauthor=S.+B.+Coffeyauthor=Y.+Congauthor=E.+L.+Connauthor=J.+S.+Culpauthor=M.+S.+Dowlingauthor=M.+F.+Gorgoglioneauthor=J.+A.+Gutierrezauthor=J.+D.+Knafelsauthor=E.+A.+Lachapelleauthor=J.+Panditauthor=K.+D.+Parrisauthor=S.+Perezauthor=J.+A.+Pfefferkornauthor=D.+A.+Priceauthor=B.+Raymerauthor=T.+T.+Rossauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=T.+A.+Subashiauthor=G.+J.+Teszauthor=B.+A.+Thumaauthor=M.+Tuauthor=J.+D.+Weaverauthor=Y.+Wengauthor=J.+M.+Withkaauthor=G.+Xingauthor=T.+V.+Magee&title=Discovery+of+fragment-derived+small+molecules+for+in+vivo+Inhibition+of+ketohexokinase+%28KHK%29&doi=10.1021%2Facs.jmedchem.7b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)</span></div><div class="casAuthors">Huard, Kim; Ahn, Kay; Amor, Paul; Beebe, David A.; Borzilleri, Kris A.; Chrunyk, Boris A.; Coffey, Steven B.; Cong, Yang; Conn, Edward L.; Culp, Jeffrey S.; Dowling, Matthew S.; Gorgoglione, Matthew F.; Gutierrez, Jemy A.; Knafels, John D.; Lachapelle, Erik A.; Pandit, Jayvardhan; Parris, Kevin D.; Perez, Sylvie; Pfefferkorn, Jeffrey A.; Price, David A.; Raymer, Brian; Ross, Trenton T.; Shavnya, Andre; Smith, Aaron C.; Subashi, Timothy A.; Tesz, Gregory J.; Thuma, Benjamin A.; Tu, Meihua; Weaver, John D.; Weng, Yan; Withka, Jane M.; Xing, Gang; Magee, Thomas V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7835-7849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Increased fructose consumption and its subsequent metab. have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans.  Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metab., identification of a selective KHK inhibitor may help to further elucidate the effect of KHK inhibition on these metabolic disorders.  Until now, studies on KHK inhibition with small mols. have been limited due to the lack of viable in vivo pharmacol. tools.  Herein the authors report the discovery of 12 (6-((3S,4S)-3,4-dihydroxypyrrolidin-1-yl)-2-((S)-3-hydroxy-3-methylpyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile), a selective KHK inhibitor with potency and properties suitable for evaluating KHK inhibition in rat models.  Key structural features interacting with KHK were discovered through fragment-based screening and subsequent optimization using structure-based drug design, and parallel medicinal chem. led to the identification of pyridine 12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7-O0s6H7lYrVg90H21EOLACvtfcHk0ljIK_SgLYgpFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVagu7jK&md5=d83bc39986e54a0f41e8f310b725ab92</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00947%26sid%3Dliteratum%253Aachs%26aulast%3DHuard%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DAmor%26aufirst%3DP.%26aulast%3DBeebe%26aufirst%3DD.%2BA.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DChrunyk%26aufirst%3DB.%2BA.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DCong%26aufirst%3DY.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCulp%26aufirst%3DJ.%2BS.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DGorgoglione%26aufirst%3DM.%2BF.%26aulast%3DGutierrez%26aufirst%3DJ.%2BA.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DParris%26aufirst%3DK.%2BD.%26aulast%3DPerez%26aufirst%3DS.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DRaymer%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DT.%2BT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DSubashi%26aufirst%3DT.%2BA.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWeaver%26aufirst%3DJ.%2BD.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DXing%26aufirst%3DG.%26aulast%3DMagee%26aufirst%3DT.%2BV.%26atitle%3DDiscovery%2520of%2520fragment-derived%2520small%2520molecules%2520for%2520in%2520vivo%2520Inhibition%2520of%2520ketohexokinase%2520%2528KHK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7835%26epage%3D7849%26doi%3D10.1021%2Facs.jmedchem.7b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikedo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubotani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maezaki, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a 3-pyridylacetic acid derivative (TAK-100) as a potent, selective and orally active dipeptidyl peptidase IV (DPP-4) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1021/jm101236h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101236h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=831-850&author=Y.+Miyamotoauthor=Y.+Bannoauthor=T.+Yamashitaauthor=T.+Fujimotoauthor=S.+Oiauthor=Y.+Moritohauthor=T.+Asakawaauthor=O.+Kataokaauthor=H.+Yashiroauthor=K.+Takeuchiauthor=N.+Suzukiauthor=K.+Ikedoauthor=T.+Kosakaauthor=S.+Tsubotaniauthor=A.+Taniauthor=M.+Sasakiauthor=M.+Funamiauthor=M.+Amanoauthor=Y.+Yamamotoauthor=K.+Aertgeertsauthor=J.+Yanoauthor=H.+Maezaki&title=Discovery+of+a+3-pyridylacetic+acid+derivative+%28TAK-100%29+as+a+potent%2C+selective+and+orally+active+dipeptidyl+peptidase+IV+%28DPP-4%29+inhibitor&doi=10.1021%2Fjm101236h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor</span></div><div class="casAuthors">Miyamoto, Yasufumi; Banno, Yoshihiro; Yamashita, Tohru; Fujimoto, Tatsuhiko; Oi, Satoru; Moritoh, Yusuke; Asakawa, Tomoko; Kataoka, Osamu; Yashiro, Hiroaki; Takeuchi, Koji; Suzuki, Nobuhiro; Ikedo, Koji; Kosaka, Takuo; Tsubotani, Shigetoshi; Tani, Akiyoshi; Sasaki, Masako; Funami, Miyuki; Amano, Michiko; Yamamoto, Yoshio; Aertgeerts, Kathleen; Yano, Jason; Maezaki, Hironobu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">831-850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of dipeptidyl peptidase IV (DPP-4) is an exciting new approach for the treatment of diabetes.  To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed into clin. trials.  Originating from the discovery of the structurally novel quinoline deriv. 1 (I), we designed novel pyridine derivs. contg. a carboxy group.  In our design, the carboxy group interacted with the targeted amino acid residues around the catalytic region and thereby increased the inhibitory activity.  After further optimization, we identified a hydrate of [5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl-4-(4-methylphenyl)pyridin-3-yl]acetic acid (30c) as a potent and selective DPP-4 inhibitor.  The desired interactions with the crit. active-site residues, such as a salt-bridge interaction with Arg125, were confirmed by X-ray cocrystal structure anal.  In addn., compd. 30c showed a desired preclin. safety profile, and it was encoded as TAK-100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7OfqMis4tyrVg90H21EOLACvtfcHk0lgeTvPBSoTn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsA%253D%253D&md5=6f8a789777bf833b9baf92ae6d3cee9e</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm101236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101236h%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DOi%26aufirst%3DS.%26aulast%3DMoritoh%26aufirst%3DY.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DKataoka%26aufirst%3DO.%26aulast%3DYashiro%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIkedo%26aufirst%3DK.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DTsubotani%26aufirst%3DS.%26aulast%3DTani%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DMaezaki%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%25203-pyridylacetic%2520acid%2520derivative%2520%2528TAK-100%2529%2520as%2520a%2520potent%252C%2520selective%2520and%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-4%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D831%26epage%3D850%26doi%3D10.1021%2Fjm101236h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weltrowska, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkes, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, P. W.</span></span> <span> </span><span class="NLM_article-title">″Carba″-analogues of fentanyl are opioid receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2875</span>– <span class="NLM_lpage">2881</span>, <span class="refDoi"> DOI: 10.1021/jm9019068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9019068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2875-2881&author=G.+Weltrowskaauthor=N.+N.+Chungauthor=C.+Lemieuxauthor=J.+Guoauthor=Y.+Luauthor=B.+C.+Wilkesauthor=P.+W.+Schiller&title=%E2%80%B3Carba%E2%80%B3-analogues+of+fentanyl+are+opioid+receptor+agonists&doi=10.1021%2Fjm9019068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">"Carba"-Analogues of Fentanyl are Opioid Receptor Agonists</span></div><div class="casAuthors">Weltrowska, Grazyna; Chung, Nga N.; Lemieux, Carole; Guo, Jianxin; Lu, Yixin; Wilkes, Brian C.; Schiller, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2875-2881</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is evidence to indicate that the Asp residue in the third transmembrane helix (TMH) of opioid receptors forms a salt bridge with the pos. charged nitrogen of endogenous and exogenous opioid ligands.  To further examine the role of this electrostatic interaction in receptor binding and activation, we synthesized "carba"-analogs of a published fentanyl analog contg. a 3-(guanidinomethyl)-benzyl group in place of the Ph moiety attached to the ethylamido group, in which the piperidine ring nitrogen was replaced with a carbon.  As expected, the resulting cis and trans isomers I showed reduced μ and κ opioid receptor binding affinities as compared to 1 but, surprisingly, retained opioid full agonist activity with about half the potency of leucine-enkephalin in the guinea pig ileum assay.  In conjunction with performed receptor docking studies, these results indicate that the electrostatic interaction of the protonated nitrogen in the piperidine ring of fentanyl analogs with the Asp residue in the third TMH is not a conditio sine qua non for opioid receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQRIMetsmqw7Vg90H21EOLACvtfcHk0lgeTvPBSoTn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVyisro%253D&md5=2ddddb63e95c57b43eaecad3e3bbee71</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm9019068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9019068%26sid%3Dliteratum%253Aachs%26aulast%3DWeltrowska%26aufirst%3DG.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWilkes%26aufirst%3DB.%2BC.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3D%25E2%2580%25B3Carba%25E2%2580%25B3-analogues%2520of%2520fentanyl%2520are%2520opioid%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2875%26epage%3D2881%26doi%3D10.1021%2Fjm9019068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span>; <span class="NLM_string-name">Bakken, G.</span></span> <span> </span><span class="NLM_article-title">Water’s role in compound design for drug discovery</span>.  <i>Poster Session Presented at Chemical Computing Group UGM & Conference, June 27, 2013, Montreal, Canada</i>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Zhu&author=G.+Bakken&title=Water%E2%80%99s+role+in+compound+design+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DWater%25E2%2580%2599s%2520role%2520in%2520compound%2520design%2520for%2520drug%2520discovery%26jtitle%3DPoster%2520Session%2520Presented%2520at%2520Chemical%2520Computing%2520Group%2520UGM%2520%2526%2520Conference%252C%2520June%252027%252C%25202013%252C%2520Montreal%252C%2520Canada%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">A docking protocol with Glide in Maestro software package (Schrodinger Inc., New York City, NY) was developed. The receptor grid file was generated with compound <b>3</b>/KHK structure complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W">6W0W</a>). Virtual compounds were first prepared with LigPrep module and then docked and scored.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laskowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selwood, D. L.</span></span> <span> </span><span class="NLM_article-title">Chemical fragments that hydrogen bond to Asp, Glu, Arg, and His side chains in protein binding sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3086</span>– <span class="NLM_lpage">3094</span>, <span class="refDoi"> DOI: 10.1021/jm901696w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901696w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1enu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3086-3094&author=A.+W.+E.+Chanauthor=R.+A.+Laskowskiauthor=D.+L.+Selwood&title=Chemical+fragments+that+hydrogen+bond+to+Asp%2C+Glu%2C+Arg%2C+and+His+side+chains+in+protein+binding+sites&doi=10.1021%2Fjm901696w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Fragments that Hydrogen Bond to Asp, Glu, Arg, and His Side Chains in Protein Binding Sites</span></div><div class="casAuthors">Chan, A. W. Edith; Laskowski, Roman A.; Selwood, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3086-3094</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an anal. of the chem. fragments from lead-like ligands in the Protein Data Bank (PDB) that form hydrogen bonds to the side chains of Asp, Glu, Arg, and His, which are the most common residues found in ligand binding sites.  A fragment is defined as the largest ring assembly contg. the atoms involved in hydrogen bonding.  In total, 462 fragments were found in 2038 ligands from over 8000 protein-ligand structures in the PDB.  The results show which fragments have a higher propensity for interaction with specific side chains.  Some fragments interact with Asp but not with Glu, and vice versa, despite these side chains sharing the same chem. moiety.  Arg side chains form hydrogen bonds almost exclusively with O-mediated ligands, and the fragments are the most diverse.  Hydrogen bond distances from the imidazole of His showed a wider range than the other three amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNNuJszKkQobVg90H21EOLACvtfcHk0lgRkAIF2K9o_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1enu7o%253D&md5=ae7c315b3974738b610bd82fff960d06</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm901696w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901696w%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DA.%2BW.%2BE.%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26atitle%3DChemical%2520fragments%2520that%2520hydrogen%2520bond%2520to%2520Asp%252C%2520Glu%252C%2520Arg%252C%2520and%2520His%2520side%2520chains%2520in%2520protein%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3086%26epage%3D3094%26doi%3D10.1021%2Fjm901696w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessire, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, A. E.</span></span> <span> </span><span class="NLM_article-title">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1002/rcm.4621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Frcm.4621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=20552710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2109-2121&author=A.+D.+Vazauthor=W.+W.+Wangauthor=A.+J.+Bessireauthor=R.+Sharmaauthor=A.+E.+Hagen&title=A+rapid+and+specific+derivatization+procedure+to+identify+acyl-glucuronides+by+mass+spectrometry&doi=10.1002%2Frcm.4621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and specific derivatization procedure to identify acyl-glucuronides by mass spectrometry</span></div><div class="casAuthors">Vaz, Alfin D. N.; Wang, Wei Wei; Bessire, Andrew J.; Sharma, Raman; Hagen, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2109-2121</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A simple procedure is described to identify acyl-glucuronides by coupled liq. chromatog./mass spectrometry after derivatization to a hydroxamic acid with hydroxylamine.  The reaction specificity obviates the need for isolation of the acyl-glucuronide from an ext.  Glucuronides derived from carbamic acids, and alkyl- and arom. amines, are inert to the derivatization reaction conditions, making the hydroxamic acid deriv. a fingerprint for acyl-glucuronides.  This derivatization procedure provides a key advantage for the quant. anal. of acyl-glucuronide metabolites in a drug discovery setting.  Copyright © 2010 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDR6oEUBtuHbVg90H21EOLACvtfcHk0lj4kVP69td3XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVOgurk%253D&md5=1f282304cec298e7db621c9478d14d3e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Frcm.4621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4621%26sid%3Dliteratum%253Aachs%26aulast%3DVaz%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DW.%2BW.%26aulast%3DBessire%26aufirst%3DA.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DHagen%26aufirst%3DA.%2BE.%26atitle%3DA%2520rapid%2520and%2520specific%2520derivatization%2520procedure%2520to%2520identify%2520acyl-glucuronides%2520by%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2010%26volume%3D24%26spage%3D2109%26epage%3D2121%26doi%3D10.1002%2Frcm.4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0ljnU6rq4FmLbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shook, B. C.</span></span> <span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7902</span>– <span class="NLM_lpage">7917</span>, <span class="refDoi"> DOI: 10.1021/jm100762r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-7917&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+efficacious+roles+of+the+nitrile+pharmacophore&doi=10.1021%2Fjm100762r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></div><div class="casAuthors">Fleming, Fraser F.; Yao, Lihua; Ravikumar, P. C.; Funk, Lee; Shook, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7902-7917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review is structured according to the nature of the nitrile-bearing substituent.  As the no. of nitrile-contg. drug leads is vast, the review has focused on launched nitrile-contg. pharmaceuticals and currently active clin. candidates.  Most nitrile-contg. pharmaceuticals are aroms. with aliph.-, alkene-, and nitrogen-bearing nitriles being progressively less frequent.  Within each class, the bioactive nitriles are collated according to common structural elements and mode of action.  The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6kPPdWVuvLVg90H21EOLACvtfcHk0ljnU6rq4FmLbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP&md5=040bbaebd9e8c9999d195b9a22221fea</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7902%26epage%3D7917%26doi%3D10.1021%2Fjm100762r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">A novel relay method for determining low-clearance values</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1860</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1124%2Fdmd.112.046425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=22645091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1860-1865&author=L.+Diauthor=P.+Trapaauthor=R.+S.+Obachauthor=K.+Atkinsonauthor=Y.+A.+Biauthor=A.+C.+Wolfordauthor=B.+Tanauthor=T.+S.+McDonaldauthor=Y.+Laiauthor=L.+M.+Tremaine&title=A+novel+relay+method+for+determining+low-clearance+values&doi=10.1124%2Fdmd.112.046425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel relay method for determining low-clearance values</span></div><div class="casAuthors">Di, Li; Trapa, Patrick; Obach, R. Scott; Atkinson, Karen; Bi, Yi-An; Wolford, Angela C.; Tan, Beijing; McDonald, Thomas S.; Lai, Yurong; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1860-1865</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compds.  The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes.  An accumulative incubation time of 20 h or longer in hepatocytes can be achieved using the method.  The relay method was validated using seven com. drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approx. 2 to 15 mL · min-1 · kg-1.  The results showed that the relay method produced excellent predictions of human in vivo clearance.  The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compds., which is similar to the std. prediction accuracy for moderate to high clearance compds. using hepatocytes.  The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1LvwK-CqOLVg90H21EOLACvtfcHk0lgmL_IzdMJ3-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O&md5=faab456749ff398ad63d11eff6412fbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046425%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DY.%2BA.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DA%2520novel%2520relay%2520method%2520for%2520determining%2520low-clearance%2520values%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1860%26epage%3D1865%26doi%3D10.1124%2Fdmd.112.046425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Reversible modes of inhibitor interactions with enzymes</span>. In  <i>Evaluation of Enzyme Inhibitors in Drug Discovery</i>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>, Ed. <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">121</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=10.1002%2F9781118540398.ch3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=57-121&author=R.+A.+Copelandauthor=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F9781118540398.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398.ch3%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DReversible%2520modes%2520of%2520inhibitor%2520interactions%2520with%2520enzymes%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2013%26spage%3D57%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frigola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castrillo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrocal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, J.</span></span> <span> </span><span class="NLM_article-title">7-azetidinylquinolones as antibacterial agents. 2. Synthesis and biological activity of 7-(2,3-disubstituted-1-azetidinyl)-4-oxoquinoline- and −1,8-naphthyridine-3-carboxylic acids. Properties and structure-activity relationships of quinolones with an azetidine moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">4195</span>– <span class="NLM_lpage">4210</span>, <span class="refDoi"> DOI: 10.1021/jm00050a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00050a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaK2MXhvFKmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=4195-4210&author=J.+Frigolaauthor=A.+Torrensauthor=J.+A.+Castrilloauthor=J.+Masauthor=D.+Vanoauthor=J.+M.+Berrocalauthor=C.+Calvetauthor=L.+Salgadoauthor=J.+Redondo&title=7-azetidinylquinolones+as+antibacterial+agents.+2.+Synthesis+and+biological+activity+of+7-%282%2C3-disubstituted-1-azetidinyl%29-4-oxoquinoline-+and+%E2%88%921%2C8-naphthyridine-3-carboxylic+acids.+Properties+and+structure-activity+relationships+of+quinolones+with+an+azetidine+moiety&doi=10.1021%2Fjm00050a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azetidinylquinolones as Antibacterial Agents. 2. Synthesis and Biological Activity of 7-(2,3-Disubstituted-1-azetidinyl)-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic Acids. Properties and Structure-Activity Relationships of Quinolones with an Azetidine Moiety</span></div><div class="casAuthors">Frigola, Jordi; Torrens, Antoni; Castrillo, Jose A.; Mas, Josep; Vano, David; Berrocal, Juana M.; Calvet, Carme; Salgado, Leonardo; Redondo, Jordi; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4195-210</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 7-(2,3-disubstituted-1-azetidinyl)-1,4-dihydro-6-fluoro-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids, with varied substituents at the 1-, 5-, and 8-positions, e. g. I (X = CH, CF, N), was prepd. to study the effects on potency and physicochem. properties of the substituent at position 2 of the azetidine moiety.  The activity of the title compds. was detd. in vitro against Gram-pos. and Gram-neg. bacteria, and the in vivo efficacy of selected derivs. was detd. using a mouse infection model.  The x-ray crystal structures were found to be in reasonable agreement with the corresponding AM1 calcd. geometries.  Correlations between antibacterial potency of all the synthesized 7-azetidinylquinolones and naphthyridines and their calcd. electronic properties and exptl. capacity factors were established.  Antibacterial efficacy and pharmacokinetic and physicochem. properties of selected derivs. were compared to the relevant 7-(3-amino-1-azetidinyl) and 7-(3-amino-3-methyl-1-azetidinyl) analogs.  A combination of a cyclopropyl or a substituted Ph group at N-1 and a trans-3-amino-2-methyl-1-azetidinyl group at C-7 conferred the best overall antibacterial, pharmacokinetic, and physicochem. properties to the azetidinylquinolones studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKA1eDGNnzLVg90H21EOLACvtfcHk0lgmL_IzdMJ3-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhvFKmsbs%253D&md5=9c6791dd332aa9a62931fb96c26d4404</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm00050a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00050a016%26sid%3Dliteratum%253Aachs%26aulast%3DFrigola%26aufirst%3DJ.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DCastrillo%26aufirst%3DJ.%2BA.%26aulast%3DMas%26aufirst%3DJ.%26aulast%3DVano%26aufirst%3DD.%26aulast%3DBerrocal%26aufirst%3DJ.%2BM.%26aulast%3DCalvet%26aufirst%3DC.%26aulast%3DSalgado%26aufirst%3DL.%26aulast%3DRedondo%26aufirst%3DJ.%26atitle%3D7-azetidinylquinolones%2520as%2520antibacterial%2520agents.%25202.%2520Synthesis%2520and%2520biological%2520activity%2520of%25207-%25282%252C3-disubstituted-1-azetidinyl%2529-4-oxoquinoline-%2520and%2520%25E2%2588%25921%252C8-naphthyridine-3-carboxylic%2520acids.%2520Properties%2520and%2520structure-activity%2520relationships%2520of%2520quinolones%2520with%2520an%2520azetidine%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D4195%26epage%3D4210%26doi%3D10.1021%2Fjm00050a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Frigola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Gomar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Granda, S.</span></span> <span> </span><span class="NLM_article-title">7-Azetidinylquinolones as antibacterial agents. 3. Synthesis, properties and structure-activity relationships of the stereoisomers containing a 7-(3-amino-2-methyl-1-azetidinyl) moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1215</span>, <span class="refDoi"> DOI: 10.1021/jm00007a017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADyaK2MXksVymtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1203-1215&author=J.+Frigolaauthor=D.+Vanoauthor=A.+Torrensauthor=A.+Gomez-Gomarauthor=E.+Ortegaauthor=S.+Garcia-Granda&title=7-Azetidinylquinolones+as+antibacterial+agents.+3.+Synthesis%2C+properties+and+structure-activity+relationships+of+the+stereoisomers+containing+a+7-%283-amino-2-methyl-1-azetidinyl%29+moiety&doi=10.1021%2Fjm00007a017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azetidinylquinolones as Antibacterial Agents. 3. Synthesis, Properties and Structure-Activity Relationships of the Stereoisomers Containing a 7-(3-Amino-2-methyl-1-azetidinyl) Moiety</span></div><div class="casAuthors">Frigola, Jordi; Vano, David; Torrens, Antoni; Gomez-Gomar, Angels; Ortega, Edmundo; Garcia-Granda, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1203-15</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Title stereoisomers I (A = CH, CF, N, CCl; R1 = cyclopropyl, Et, 4-fluorophenyl, 2,4-difluorophenyl; R2 = H, NH2, Me; R3, R4 = H, Me; R5, R6 = H, NH2) were prepd. to det. the effects of chirality on potency and in vivo efficacy relative to the racemic mixts.  Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acids II (R, R1, R2, R3 = H, Me; R5 = H, NH2, NHMe, NMe2, CH2NHEt; R6 = H, Me, NH2) was prepd. to study the effect of the azetidine moiety on tricyclic quinolone antibacterial agents.  A series of amino acid prodrugs of chiral naphthyridines I (A = N, R1 = cyclopropyl, R2 = H, R3 = Me, R4 = H, R5 = H, R6 = NH2; A = N, R1 = cyclopropyl, R2 = H, R3 = H, R4 = H, R5 = NH2, R6 = H) and quinolone I (A = CH, R1 = 2,4-difluorophenyl, R2 = H, R3 = Me, R4 = H, R5 = H, R6 = NH2) (cetefloxacin) was prepd. and evaluated for antibacterial activity, soly., and pharmacokinetic behavior.  The abs. configuration of the new azetidinylquinolones was established by x-ray anal. of one of the diastereomeric salts of the resolved azetidinols and of compd. I (A = CCl, R1 = cyclopropyl, R2 = H, R3 = Me, R4 = H, R5 = H, R6 = NH2) (E-4767), which showed the best in vitro and in vivo overall profile.  Structure-activity relationship studies indicated that the abs. stereochem. at the asym. centers of both the azetidine and the oxazine rings was crit. to increase in vitro activity and oral efficacy.  The 3S configuration in the pyridobenzoxazine series and the (2S,3R) configuration of the 3-amino-2-methylazetidine moiety for all new compds. conferred the best antibacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFl683UVUyJrVg90H21EOLACvtfcHk0li9hlNvsxruDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVymtbs%253D&md5=08b50ba32ebbbc445fd0246b1a39241a</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a017%26sid%3Dliteratum%253Aachs%26aulast%3DFrigola%26aufirst%3DJ.%26aulast%3DVano%26aufirst%3DD.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DGomez-Gomar%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DGarcia-Granda%26aufirst%3DS.%26atitle%3D7-Azetidinylquinolones%2520as%2520antibacterial%2520agents.%25203.%2520Synthesis%252C%2520properties%2520and%2520structure-activity%2520relationships%2520of%2520the%2520stereoisomers%2520containing%2520a%25207-%25283-amino-2-methyl-1-azetidinyl%2529%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1203%26epage%3D1215%26doi%3D10.1021%2Fjm00007a017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">The stereochemistry course of this route contradicts the ref <a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> and <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a>. According to Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> in the ref <a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> and the synthetic procedure for <b>16a</b> and <b>15</b> in the ref <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a>, (2<i>Z</i>)-buten-1-ol leads to the formation of <i>trans</i>-2-methyl-3-hydroxyazetidine. However, based on the mechanism of the bromination reaction, the <i>syn</i>-dibromo product would be expected in that instance which would lead to the antiepibromohydrin. Subsequently, the <i>cis</i>-2-methyl-3-hydroxyazetidine would be formed upon S<sub>N</sub>2 displacement of the bromide and ring-opening of the epoxide with benzhydrylamine. As shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> (vide supra), (2<i>E</i>)-buten-1-ol would lead to antidibromo <b>19</b> and <i>syn</i>-epibromohydrin <b>20</b>. This would lead to formation of <i>trans</i>-2-methyl-3-hydroxyazetidine when reacted with benzyhydrylamine. To provide evidence of the correct assignment of <b>21</b>/(<i>R</i>)-CSA, we have included the X-ray cocrystal structure of <b>6</b> and single crystal X-ray of <b>21</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Additionally, the direction of optical rotation of <b>21</b>/(<i>R</i>)-CSA matches <b>15</b> from the ref <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a>, which also describes the same single crystal X-ray structure. It appears that the ref <a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> described the incorrect starting material that they employed in the analogous chemistry.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berliner, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubant, S. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Use of an iridium-catalyzed redox-neutral alcohol-amine coupling on kilogram scale for the synthesis of a GlyT1 Inhibitor</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1052</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1021/op200174k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op200174k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=1052-1062&author=M.+A.+Berlinerauthor=S.+P.+A.+Dubantauthor=T.+Makowskiauthor=K.+Ngauthor=B.+Sitterauthor=C.+Wagerauthor=Y.+Zhang&title=Use+of+an+iridium-catalyzed+redox-neutral+alcohol-amine+coupling+on+kilogram+scale+for+the+synthesis+of+a+GlyT1+Inhibitor&doi=10.1021%2Fop200174k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an Iridium-Catalyzed Redox-Neutral Alcohol-Amine Coupling on Kilogram Scale for the Synthesis of a GlyT1 Inhibitor</span></div><div class="casAuthors">Berliner, Martin A.; Dubant, Stephane P. A.; Makowski, Teresa; Ng, Karl; Sitter, Barbara; Wager, Carrie; Zhang, Yinsheng</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1052-1062</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent development for the efficient and environmentally friendly synthesis of aliph. amines is the transition-metal-catalyzed redox-neutral coupling of an alc. and an amine, generally referred to as a "borrowing hydrogen" reaction.  In this work, we describe the first kilogram-scale application of this technol. in the synthesis of PF-03463275, a GlyT1 inhibitor developed for the treatment of schizophrenia.  Using (Cp*IrCl2)2 the reaction has been optimized to achieve catalyst loadings lower than 0.05 mol % iridium (S/C ≥ 2000) while retaining reasonable reaction times (<24 h).  Water and a tertiary amine are essential for high catalytic activity, resulting in dramatically increased reaction rates compared to existing literature protocols.  Methods for iridium removal are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjHPL35gPxW7Vg90H21EOLACvtfcHk0li9hlNvsxruDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvF&md5=8d2ba6a742fff108a7106ff59a393876</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fop200174k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop200174k%26sid%3Dliteratum%253Aachs%26aulast%3DBerliner%26aufirst%3DM.%2BA.%26aulast%3DDubant%26aufirst%3DS.%2BP.%2BA.%26aulast%3DMakowski%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DSitter%26aufirst%3DB.%26aulast%3DWager%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DUse%2520of%2520an%2520iridium-catalyzed%2520redox-neutral%2520alcohol-amine%2520coupling%2520on%2520kilogram%2520scale%2520for%2520the%2520synthesis%2520of%2520a%2520GlyT1%2520Inhibitor%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2011%26volume%3D15%26spage%3D1052%26epage%3D1062%26doi%3D10.1021%2Fop200174k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span> <span> </span><span class="NLM_article-title">Two scalable syntheses of (S)-2-methylazetidine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">3031</span>– <span class="NLM_lpage">3036</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b00149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b00149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVeltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=3031-3036&author=M.+S.+Dowlingauthor=D.+P.+Fernandoauthor=J.+Houauthor=B.+Liuauthor=A.+C.+Smith&title=Two+scalable+syntheses+of+%28S%29-2-methylazetidine&doi=10.1021%2Facs.joc.6b00149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Two Scalable Syntheses of (S)-2-Methylazetidine</span></div><div class="casAuthors">Dowling, Matthew S.; Fernando, Dilinie P.; Hou, Jie; Liu, Bo; Smith, Aaron C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3031-3036</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two orthogonal routes for prepg. (S)-2-methylazetidine as a bench stable, cryst. (R)-(-)-CSA salt are presented.  One route features the in situ generation and cyclization of a 1,3-bis-triflate to form the azetidine ring, while the second route involves chemoselective redn. of N-Boc azetidine-2-carboxylic acid.  Both sequences afford the desired product in good overall yields (61% and 49%) and high enantiomeric excess (>99% ee), avoid column chromatog., and are suitable for the large-scale prodn. of this material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp71h_oOE1SD7Vg90H21EOLACvtfcHk0ljyvHI0VYjMXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVeltbw%253D&md5=8af47f5c27916c56994c6689440af87c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b00149%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26atitle%3DTwo%2520scalable%2520syntheses%2520of%2520%2528S%2529-2-methylazetidine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D3031%26epage%3D3036%26doi%3D10.1021%2Facs.joc.6b00149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WBZ','PDB','5WBZ'); return false;">PDB: 5WBZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W','PDB','6W0W'); return false;">PDB: 6W0W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0N','PDB','6W0N'); return false;">PDB: 6W0N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0X','PDB','6W0X'); return false;">PDB: 6W0X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Y','PDB','6W0Y'); return false;">PDB: 6W0Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Z','PDB','6W0Z'); return false;">PDB: 6W0Z</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i49"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00944">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53032"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00944?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00944</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Metabolite identification studies of compound <b>6</b>; supplementary in vitro pharmacology studies of compound <b>8</b>; in vitro selectivity data for compound <b>8</b>; maps of interactions between hKHK and compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b>; data collection of refinement statistics for the crystal structures of compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b>; procedures for growing a single crystal of <b>21</b>/(<i>R</i>)-<b>CSA</b> and associated data; HPLC traces of selected tested compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_001.pdf">jm0c00944_si_001.pdf (1.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00944/suppl_file/jm0c00944_si_002.csv">jm0c00944_si_002.csv (0.83 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for hKHK bound to compounds <b>2</b>, <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b> have been deposited to the RCSB with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0N">6W0N</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0W">6W0W</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0X">6W0X</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Y">6W0Y</a>,  and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W0Z">6W0Z</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00944&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00944%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00944" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799363c6a2f3c52","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
